var title_f1_63_2032="Prevalence of HTN in men";
var content_f1_63_2032=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F81756%7ENEPH%2F58221&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F81756%7ENEPH%2F58221&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 534px\">",
"   <div class=\"ttl\">",
"    Prevalence of hypertension in men in the United States",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 514px; height: 257px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Prevalence of hypertension in men according to age and race/ethnicity in the United States from the NHANES-III survey. Hypertension occurs earlier and more frequently in African-American men.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Burt, VL, Whelton, P, Roccella, EJ, et al, Hypertension 1995; 25:305.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 548px\">",
"   <div class=\"ttl\">",
"    Prevalence of hypertension in women in the United States",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 528px; height: 251px; background-image: url(data:image/gif;base64,R0lGODlhEAL7ANUAAP///wAzmf8AACBzOYCAgEBAQMDAwAAAAAAMJgAmchhWKggcDj8AAL8AABAQEKCgoPDw8CAgIGBgYH8AABA5HAAZTFBQUODg4NDQ0DAwMLCwsHBwcJCQkAAGEwATOQwrFQQOBx8AAF8AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAAQAvsAAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanqKmqq6ytrq+wsbKztLW2t7i5uru8vX0XGELAvsTFxkwEBUIGB8fOz8UFEQ4F0s3Q2Nm2B9zdBNrg4a8PG+Lm56sPBOvf6O7vnATd3PD19pQFDhoG/Pf+/4s2KANIsGAhDQfYtTPIsOEdefMcSpwI5wK/ixQzakSDgYCBBxo2ihzpBWFCDhFIqlxZxUIGCR6vHdGw7sKQjgSCsdypsQC7/wcyi0g4kMHBAQMAEEaIcCAkz6cOCVDLZwEJNwjyvmU4gAEDUahgDULYesCBTiNDI2TIAAEAPbfXLihc9yCsXXMQLhqweYQD0bLB3r6Vq1DCwLuIsW2I0NZCSiNelflVZhQChLJIDBxOrIvw3M+gQ4seTbq06dOoU6sOXfeLz2VBh1woq2GoBABD1x24fUQzZ0OeWacxEGG18ePIkytfXngzFwtVAXBwgOQBUwcS2kKwwM1C297OfwMy0KGC+fPnPYQf4/tfey9AIxTY3eW9+EAGEATYz59/gvVi2GePgFxIdYB39QE4UXDCEZJffxD+N5yC6BCohUVhWEgReeh1WP+BeoU8CKF/FH6hIYOptWaLhljIk2GJDYk44n4SOqjfjAHUeIaGHHroY4cg3sLiFRc48J0XQzok44w6CrJkhDAmmNmNOFbZJC1JVgFRN1KS9CSUIVI54pVk8ChmlWNGuUqWVDxQzZtdjvRlf2T+MSeNam5hJppW5pkKm3YAWtCdeIbZ54RT8oljnbEIGsV2CUkQnZ5+AkRojpXSQSijLyaqaJq4OArFBgcUh1CcIl3KKR+bZnrFnp+CqQQ/R0JgWDlEFICrFrRmoWuArjah6zrMoLqRqsHG0SqivZ0Z66om7TrUBioKQUC1V0SbxbXAggHdOo4ZqxGyhi5anGjYZgH/a6wkKjFUqcswRYBcD3QEALcAGGCYBBhcYJiubV3LQQHZHfHuY/eqU0C90H3nZgEcWFvvN/g+YAHABlwMscQDF9yEqE8w4424GZFro5UhTKDyyiuLkGwS67KLaRKXQdcUAA8YVYBXRjVzgDLMZJCMRz7ZBlcGTPFGRM3cOcVNUaVudRupG3AXcVn0/HzvgQREYAABMM1X19NJOwHyExpcHDHJGzpL58tFoPhZulZsyoAAeOeddwNwg+epzDNXd8ADQPE2nxBfIa4Md3zZ9IBhWmt9mTLdKAMU4fS5pYw8SGntwLmRZzCE549ZBgEHLiWkOQCTm933rEgh+XqFbrfL/2t5P344+zK153i33nrzLfvfMnO61VpXAXD46oorHxTVzFA+kNYXBXM8WW1pzfnqpf7EPPebFcWBX99o/f0SZzeBQc9msT2Ryer2HjivvSfwO/B4C8/2pYceEdk684nY8sy3Or9I4GvJaApQpNc8IvwvgVfb3FFWxx2PqON7WrNaxpjhNVKVb3pqSh8TLOCADUgFYURah2FUAj8stNCF9bsf/vTHhZixi1GkcgpCRDfAw5iva7RZ388iB8Ii5FAIO1zd9iQnAaM44IOjU4atjBKBCwBliFA836x2VwQLtONUWSDMCr0kv1VF4YWviiH+9nauBp0RQPxbFBc5IUL0Ff+AHyjpB6/mGA40VsGPf1TjGgXQABBQ4JCIROQHXGXDZ/FRE3VUwpYiskcWlnF3gKSC3QZJyAUM4JOgBKUCGAlH+fVvRY/MF2goZUk0mREKmZzCJgfZAE+GMpSjlGUpAVcoIaWSPb/ERizPeMkaCnKNtbwlLklJvBsG0xKRZEM03TFMWJaxjatJ1yyRaUtlDiCXUmjkp17JimmqwZznqGbIypgylrFMBIZMZCIXaYRtzrCbygTnGzODu9z9KEioHAQ6zaFOs5VRhsBLpje/GR57JhSft9QnLAEkt9PQrVHPvBdfWElGV2LyoJxUqDclyjsrITR4EF2mLi2VUW5IYKP/LsyoMwr6MZDSMqWibOgx77lQhq7UPRnFAOomFdNWnhKGrjzp3nD6SZLma6cP7alTPyZTWQw0bnpxn0RoygRVKTV/TPVpERyKUqkyE6hgMAmXalhVY3AVfTblplnrCdWyLnSqXW0rLK46hPmYcB1aVVIx6ZfUkIbVqWRd6lzDqddX8FUIYzRRY33x1lnFlad31alJDbvYfaL1CxpwQFbZalQ56umyUc0sXTd7085OFAkVNc1F95rKScamqB09ahoL21rVjrWuivWtZ+vZTnca17guC1UqEcgOJdBkXkLAyVnqOdleVBZmqLXrSDW7qK920rUhg6N3OUnI6jbisU8Y/wtRMoAUpTDFKdQtLZM+ylu5CncIiQUreF2XmfGG1LyMQC8ANmAUBBnsAGsTwla6krj45ta0hGWtfbe72u5y9r7h7S95/6tcMMgjA/MBkM6IYhPBxGUukU3VYONXX8xS+LcSdnE+z1pP/9ISwItA76+SclvEHcVoJhYGinGci0zGli4wjnFqX0yE/H4Xw/ztjY2RSeREoLdh96LOEYySL88dwDKY8duD5wuzeMrzkPRscnaDy2T8Ale/UKaqhjdMZdjuZRk6wYABIOCm6fYZkqlU6wF2JZRIqS438lDaWKsspBXX87DO8eqF21xSC/eW0lGuMZ3rPBOtzUbLV9kefv+hu7xKCDhtG0MCpAYthFUb2MFycvRYIZ1kS094xhVmkndFimvGznnTwQPQZZpxRT1/RR4cMExIvmYReSElYwB7hIC7NWZQZYbWam7xknudbVvLOKI0HuuUZ6ig+WAgdRzIytaowQ25HCVnPwPJgUhF1Bzz0Se2DWyMZN1kbLtZ29rl9r+9vW1w/1TTwA52EpD9xAzYDCnbI9XXJri8CgJR2nyk1sPgRNpqy6o3/q40wQNu8FqPadchz7CUE65wJHiFKQYgsAO0vD3ObW9581EIxscwDH0zJJMGSLmkLy1wkZ980kXPtLhZvjcKObHLB7LWBG1O8aYI9UAGqM3Ov9D/tSIh2OcGAbrQ1wxnTDuZ1yUf7tKZXl4lcCc6RllbzY+yvdB+HYhRd4SOTXggFKqL0SviN37HDnA2J/3sKVd6k8edUMAbQscEcEyxOh5rj8KM8EomuUpNHiGU71fOK2c7DWuBXplbAChgH5Tgl4H5kRs+7QPXNdJhr3KEM330WEolBKaBgQLUG7eV122/wTv0W9P+qZl//ebVvni2t92XAnU8llafr9bLnujHR/zn8/prluN+Fui11ZvmOG1oiJ34ZH+y2d+s/qSD3vbel76DUvmutXI0+BAGOfoLX/bDsx/ty/davVFcx1WAE5Bc0OcajAEG5fcM54dhxfdtAWh0/503exOoeLKBHLPlWKnEAaLDgPJnVdQXdPuXfP2Xff+XeO93D+i1QBx3fypmeddWgq53gheofXHGfZ/lBflGeTFoJdiEYtZ3dNh3gym4fXbEUoAgRiHYKOxkgCIwhBVYhDmVa0RofBe4ggOiexUkKReiQk24V+kHgFXYbTXYfihogmiYhTroD6XXPWAEg8cyhlJIJ54HZTiIaVpYD3tHLD1WN2EIHKSxgeFEhzR4fVhYhmZ4hRKoiALohqn0LZHnd8C3Cz3iIwDFYmpIhk0VaYaIh0eYg0l4BEc2iB1mIvOwEJVkXfXDRRFYcBP4iprniBRohxZIixi4DGZ2ZryoSP+BaCe/hGoJJodF1orGxH9rSIuyqHy4mIfu14az1lPSiFe0xYCtIVSp51jGeFrIyIliFXuI2IidaIVTmIjj6Gv6J42iyIEeNhBxuIq8sCzcuIl16B93uH70iIRbNIPqqIcY9QXzwA1aRoyhso0RdobeSFLLaIPNGIr+OIqP1o8PyY5eIA1TUQDwBY+WaJCaiJD1SCP36H/5uI4wA0dhNY2/6Afo9RGdworCVzefSGkLmYznuIjlKI7f+IjRKJHHdxN3BgAWMV1LsGNZkBexcwW9R4jMtwUuAoKUxZFINZIyGZMi6ZH6WJL8yJO42Fd5xxR5gi9ZQCo3k0JH+XcM+If/ZumS+deR4QiLykiVaWiVJJkZJqmVbOg8B3ABJjEQ0LYBlkEAEYMVEVMxF+OX0JZqAkMwR0IETJE5clEbO6MBRPkwESMXWfcAlikEFgMwD2MBIfGYAqGKiwYGOQNi1ZCNriCPB9mWs1iTtWiLVOiarwmStyibuVh9drmVQjAfEVA1XsljFkBvW/M4XKFEXOM1YJNAY0MUZVMECDEdXwZ18/E5TFEXVKNBWHNHqiMPXuQ1wQlEFsEN+TA4dOlhAYmaraCabMmIbimbM5mQ3MWazGibe8h6uUmfu4lgcZdBCXFxAEBCX7c6n9NqloE6WwFFkyMyh5aXQ1EXzPANh/Og/wDwObqhnbgioQPKOhAgF9bAD6qDEKKJXylZnmpJZvMol1PZjYnnjD0JjcN3n9Q4H5fBXlqTc82FM+3WPAQEAOJDPszzM0a5F8NmDaIjoRGqOt1DFxLaZVkElA6QAcTpod+wpLDmBQOjDiH6KiPqJFC5W1JZdO+5og75jBC5k7kZo83QL9EjHVindeuTD2xBQQi2QaUSc0haRERgQOvAFMYGoc0goRX0ETHRDoA6p16EdfMhpUxKolbKDdcykKRoAGchXVhZota2muzZmjmJfF8al/LJkPhZpi96puUmE2t6L43pHUWRF/TBRFRkReJ5pw00BFvxHdCjOkf6DVNUFv+DChu62kSl4i9lsRWKSqWj6RpeFBM0sxXuWCrvxagb+ZKBpKKHmKnzuamc+qk0ia31iZswuqV70IfrAKlGJJ4KxhVe8YFVqgvqGZUoCqZwaYSdepf7mI6keorw4ayZU08JYT5BBpRD9pTSqknx+pbUCorzqpuiOnj3ya3/CAYEdiCLOQS7twGn+q8MkmLs2qUwebApmrC2yaL0WqkR+a34ek4BSRlfdhnkKqICu5buqq3wyXk32Z7YKrIKW68le68J6AWuNrGthkdEEQyItq/HGo/1E4RzY00eC69N66nWCqoOu7D2abI92wVDAWI7yq8D8bPQurEoY4AH6CdhWq3/NaupiDWmLUq1+bKLvciLaRZQroErfoGe5cR+z2dQTxuLBRuyajuyX5uBx6GU5bRcvEEcdrsmePt9lrW3BguyN/u3OUuyLFhbAfkWaYm0api3NeW47tm3kQu51KizlUua4/eClQi2Z8i5XQW6Cum68Rm12zq6lLuFYAC0Pqi62sq6cOW5m1q2CPuuazsrSsscxnu8yJu8o6GxTBkBHIC7qVuMm8u42OW7r2u9sXu210q7sKW83vu94Hu8hDsF8HYgGZm50bq61NtM2iu11yu62Qub5ji19wEFGkAWxUGQjTa9ZAu7NCu/OJm28Fu/VnABHsgNjam/gce/TDvANtm+/7Mbv/ZYm/RLwEsgD9iBFKejwKS3uP2Lvf87wbEZusILuBaMBBrwANAbvQXJwOsEwg8MwDYrwCU8uSecBFgKWLkrvepbvN4TwyI8v+9bw37rwDcMBT3IwdM3vW47T54Iw+AouzMbwr5Dwdx7xEWQD/ugR0oMfov7kVU8wkMss2JqxFjcBALRkpqrvmBsP1b8xGY8m2EsxOCKDurgQTfaxYlQiuOrt2xstjKMtnBMxCRMxld5xvl5uV8INnVcN/3kIZkYsxAcwVQ8xwE8yIYcvJk8kYgcXXqBEWEEhqbGsdP6xxDov0BMm2IswapMx50MBw2oLKRMsNPbxiFJe8CLj/+EfMWvTG2T0K5eurtTHMUQPMxybMkzzMrILMi97AaxDMuzLEtfDMhBfMmV7MarTI6BvL2NbA7U0nOSNcoDK821TM2tbM2pvMzcrM3VnMzNjATD8kvP/AbA3LGm/LG7jMlSXMb5/M4Hpsg7LG3RXIjlfMpQfMzY7MpUnNDo7M9LIwHTMH6Jix8DTUwFjc+b7LRxnK37fMivzJJOSQn1XMrCbMtvfM23LK/97NAzoTbDI9IV3cAlbc7q7L76XMz8nNHD28yCRmjoGwkjTcv3rNErTczbbNPsfM7uzNJZjCBNqceIENTkPNS4jMpG3c7MvNApbcOvvGPv+NOQINUETdX/fHvQHN3RmozWnNzLfqG1v6el4gyzwSy7lJzODL3UV63UWZ3Kd73XTD0EEftqGgnUMf3CZP24RY3QW13Eif3XwBTXJoqpR43Udr3Yv2vVed3X6+zYZTDPzlzYfjzTBh3HuVyVOm3CnE2xWLpRlBq4Aj3OYy3aGK3WRH3aDbnRqb1w3eAANuFeY7muYQ3anXvYn2vWpQ21OO3Rr9wRH3G++GUTFcSj6NpgRysJYm3RxH3Zxo3ZcqzZlM3ZJgGYlFhoy+ljQtYckH2p6znZdZ3XNd3ein3SWi3fnO0SMDF5Lpc4GBuwMA3b2C3btU3bVW3WZz3ZxvzX+HYtaFma31EZ/yzr2non3K170QGe3KPd2AWO1ZvN2VJRDQ7w1mxaQtxStIrWZN0s1JG93hq+4fGdzZVN35lt2byMyOoFGPA8D1LEHRIL4ecl4b2b3WMs4GW90Tgbqu8cpD8J1Ydw3TJN1wd+3EOO4UVewb28GI0x3oCY3h+n4nrt1xm+4vD95V3+3TEO4whOqGipSSc+1Skuyez95NwN5beN4SwNHUIwHRM9Hj7euEB+0wZu0i7O1zK+5uIQH/NR4iwc4f7d5JMM59tN4FM+44hsIIIN1q8t1/YM4ANO2twt5t4d5rn90r+859Xb5yht5nLO2LZt5M0sfqhr6YqO6STt5ICu0O796f8H7umDntv1h7mDHdyLbtiaHuWrrt1ELrms3svSsMJw3d+yjuK0TtO4XusNXeaB7tgeqMbWTersC+ZhnurGLuXITuWv7IKnGdCx3uZz3ejUjtctbuvWDu9/ncS/funqnunRfuHFHuQWrsv7TuhQ4dltsCk+/MOhne+z3e8V/uf7FekADw6QAjYg/kcPL+xjQoDI9cGm/uLXLubvnesOn9ukYippfnBpwMfH2MOjgS1O9u1x3ukhn9rDoqyhzMjS9MhA4oqL28S+ON+o/vKQPu6SjsWSGC41z7xmwOQWz+7m/Oku/+jHjtsOraCqg+5lwu3NQuGbPuyI/e+n3vG6bub/fy2Moj4cWJ/U7/30G3/ru87x8h72YB/qVs8eZ+/zHd/yjs7pQS/1zSwQp0t+5hXUpQiW3T1eec/1xa33UU/n7zwfAK3k9THLBsDzPS/o5HX4CL/wYI75Qj7nXi/3IX1Okn+S/O7tnP/m7e7l4E7Dn5/aOZylWb4GBC8aEkD6fj7mZA73dw/0i9/62H6ecx8g9YPx72T7di/veJ/6LO7x097wQl/x2VANGcABaRz8GTLu4Z75W6/9xN75iS/ufN/4kfcA+F3vnY39pY/7ao/42e/97a/wyM3wc/nKFiAB08EUeY7v8L/9TA8EA+FQqCgAkEgDItB0OhMMwZRabSyI/1ljUsl8fqNV8TVL3HKXX7BUTCWXi0cuIK1uhtvTN/w89/8BAwUHCQsNDxETFRcZ0QggMg4eGgEN5CgZ6+zw8vb4Lrvs7tjyBDy1QOm8Nkk7seAG+kJFAzjbTs1SNVlLTV8//XbXenGHZDGRk5WXmZsZIZzRUqMrV9Vsx36B0ayHibVR54SfsLNhY3W7vV3Pj8fJW81hj1Vpy93Ac6n3+fv9/QlEIHAhmqV/f96N+nYOnTh1UOLJ25YkYa2IVvIZS0fL4sJ5G+1d1JMxTrCHCksVK3mQZUuXL+c8cHDgQIFJzAwiuUCAZ0+fBG4qq3hvJEN3Jzt6nDiLl9IyRzkS9f/VDqQoqSobOgzpNBxMr1/BNjMggabYSwY6VFC7dq2HaZSGipxKVatVuXOX1rPbC+/Tqk3Zfay7NyXJrNy2FqYblnFjx4MucIh0IAIiDQQ4EKx0FmmCtzp/hgY6+JpcrIeZluaLFSphxYIRJw6ct2LS2X5Nyr5lmN5j37+9EjjgQIIGRBsOZHDgQHMwzvYEiiYgAQQF69exf/i7brfR7fBW8/4OMfxiikhtd4d9Pqpp8bldq88LnH59fxoeQEMEYTgADgc22Iw9q0KYwMADDxTBMNT0Akw+2jq7i7XxUHoNwva40ie2+CTCjTTuOuzKvhFJjIYDm3gyxICa6GARgJ3/fJIguunSYostDwpEEEERqsPOxw9m5EmCGm1UC0cdd+zRx+uA/GnIItvKEUkDeVySySBphNJIKaes0koKmoyRSCiPnHICL60Ms6cntaygzC6VXFLNNce08U0k0ZQzuqBK7NPPRP47ACgHVGRxRTlgXBNL6RhtVDQZHY1UUkUnrbRRSC3N1MlFNa0U0041/RTUTCX47M9TUU2iAAt4WtEQDJIDQIMDLBDwoJz+wdUfXfvhlR9f9wE2WFNTLbbPAjboiVBDIjhAAwsksTVXYs1iSdiCqMUp22WuxdbYb1N9gLJmJTgEg0gcCFDaXbcVqt1kuq321neRiVdecPHtc4OZ/yzQj1t6MbH3X2sBhqvgRgR2t6WE823YqwsMGJbgieeleFqLL3ZY49+E2+cCPvv5mCWRDyL5H5P9QTlkkFfe2GXHLnDA35dprtnmm3FmSTiaysrZ55+BDlpoJB4owGijh05a6aWZbjoQDCJOAoNWAbmMgKgBmDozQT7GrLmpCcDgDwisFhsJrZsLBGKzs+aJbT8gMABrtAeBWm4D9AP77SQgvlszugex+m+3n6a67a0DuVvuwcP+w265zQb8kLS5gOABzPy9DHGnOU9EpgMkmJmaj2dKQtwImiUgGJ6dBeD05SjnogCeZZZ13Nbn2JmmiF9nThBIXJwVddz9IOsAov8pg12Q2XmOWPhmjcudddV7jz0J4DPIwPnbo5+DrAgKoD553wFhXVDbh+9eVdaPqB6RAiLY4G3gZ68dOeXI71z/QfjjWfV+dLc+DRzKDxDzD4tmYjnQBUIDEABexCKBAVhlIBgEIYvqEiiucgUCOS6K4AT/MKueZXCBgZgdB+QGjQ/GSnoSWBwASLjBP5CFA1xYIQVjQisuxDBxcpvJJG7oB7vNrlw8nJxkKCO/FlFwdnjrz3/UtT8pIuQAYrPAwRbRM9cNpwAO2BsXNAgAmsTNRYDYiQPk0DMt5i4DESDIGAlYCUG5SI3HmwMEHLAzJMCxjH+YXQZsskc7rhEJwgH/3yPEeAAymmomf3zjIO3IBWjVL2J8pNbpBJnJP1yAJo9c5CIswSLsRaBcBIzjFFFJkQPITQLaw9o+tGgAB0xmEjy7BAQi4LvvRYJYGOhiAaBRx0SWEX4RENsu+1i5+MVRmLYEgAUo2DNkEitZ+2pdM2nSvmQ1K0DTDMTuyFIubLLohP+pjDcF0aybjPMS4UQCOg0RmUjET2wQkIADmpWBT54ylahckfkiCctIlg5Wx7tb5HJpNsvx5HyDEA4GFckfQh0UDaK83EPlyD4YRrQ/FAUoABaKUUJgNIESpQPkKnqEkDb0D6UjYEk7ilJoVfJ4K/0fIDCJBJhOFKUv6iQS/2z6Pnpy4T+qg1bYYjWrWvUzlb482tH4AbHdEaRZHDBnMGYigRTJTSb580P8CPBDAFxQODJMggW0GolSGqCr1gOp3P6TgWMKqqzBkNvuTtrWdG7AmhEjawklqdXU5VV5gLjgBcdKV8Cajlb/OQJXCzs2sb5TsWZdnwwh61VCDFBxYhOX9iIxCehBi2VMNe0+dHe+c9HEAl9M7fF21lpBQGs4/4MAbfvlh7DSJHQAiO0XVyeH27JWdFzo2W8HQdsI3GS4tCrubtNVSNYC93q0VVdzc+sHawLTt9MVhHBwCFTcFndF+UPu+8wnB2sK5GzoiuJp4Rtf+c6XvvW1733xm/9f/e6Xv/31738BHGABD5jABTbwgRGcYAUvmMENdvCDIRxhCU+YwhW28IUxnGENb5jDHfbwh0H8sxSGmMQlDosI32tiFa+YH8arDFBLRTUIEGBV6iPq/zADUhpbIHobMJoExGaAsD0Abz4OH4uRDGH+WABa0YvEBhCrHAJEcIZVhFW5pExlgeyrMsKZSUDyuIEXJ5nMChbXA8K4olIKClbhQ+zq+GrlmkznfAbwcemEE73laNWtZfYzgCORPT6qbkVXm7PhvopPCh6qJwZQqgYi0d2oYcACzdLsnzHd3zbz5IT8iYCdz7ccInPgAbC6qXQPUEMYOmDUlxOUBpolaSRv2CSU1M30re2LnOjNioKfm53qKE2TCGjgP5TjpCLPptwGzjPWwomackuLa2n3l8gGaPIf0OqHWVl22t2usItPLcnYzdTb5Tb3udGdbnWvm93tdve74R1vec+b3vW2973xnW9975vf/fb3vwHejCAAADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Prevalence of hypertension in women according to age and race/ethnicity in the United States from the NHANES-III survey. Hypertension occurs earlier and more frequently in African-American women.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Burt VL, Whelton P, Roccella EJ, et al. Hypertension 1995; 25:305.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_63_2032=[""].join("\n");
var outline_f1_63_2032=null;
var title_f1_63_2033="Follicular cyst ultrasound";
var content_f1_63_2033=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F76189&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F76189&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Follicular ovarian cyst",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 327px; height: 246px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pelvic ultrasonography shows a follicular cyst. Follicular cysts are usually less than 10 cm in size and appear purely cystic.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jorge Londono, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_63_2033=[""].join("\n");
var outline_f1_63_2033=null;
var title_f1_63_2034="CT rupt corpus luteum cyst";
var content_f1_63_2034=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F72345&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F72345&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Adnexal mass",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 361px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Computed tomography. Arrow indicates poorly defined adnexal mass, which at exploration was ruptured corpus luteum cyst and clot.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_63_2034=[""].join("\n");
var outline_f1_63_2034=null;
var title_f1_63_2035="Renal pathology test: Pattern recognition";
var content_f1_63_2035=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Renal pathology test: Pattern recognition",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/63/2035/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/63/2035/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/63/2035/contributors\">",
"     Helmut G Rennke, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/63/2035/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/63/2035/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/63/2035/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/63/2035/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/63/2035/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 26, 1997.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     PATTERN RECOGNITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Click on the figure link following the question to bring up the unknown renal pathology picture; click on figure link following the answer to view the solution.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CASE 1",
"    </span>",
"    &nbsp;&mdash;&nbsp;Question: (",
"    <a class=\"graphic graphic_picture graphicRef73026 \" href=\"UTD.htm?23/20/23881\">",
"     picture 1",
"    </a>",
"    ). Answer: (",
"    <a class=\"graphic graphic_figure graphicRef53275 \" href=\"UTD.htm?22/17/22805\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CASE 2",
"    </span>",
"    &nbsp;&mdash;&nbsp;Question: (",
"    <a class=\"graphic graphic_picture graphicRef66036 \" href=\"UTD.htm?20/31/20985\">",
"     picture 2",
"    </a>",
"    ). Answer: (",
"    <a class=\"graphic graphic_picture graphicRef76847 \" href=\"UTD.htm?15/15/15605\">",
"     picture 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CASE 3",
"    </span>",
"    &nbsp;&mdash;&nbsp;Question: (",
"    <a class=\"graphic graphic_picture graphicRef52798 \" href=\"UTD.htm?20/30/20969\">",
"     picture 4",
"    </a>",
"    ). Answer: (",
"    <a class=\"graphic graphic_picture graphicRef63425 \" href=\"UTD.htm?13/60/14277\">",
"     picture 5",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CASE 4",
"    </span>",
"    &nbsp;&mdash;&nbsp;Question: (",
"    <a class=\"graphic graphic_picture graphicRef76258 \" href=\"UTD.htm?28/45/29401\">",
"     picture 6",
"    </a>",
"    ). Answer: (",
"    <a class=\"graphic graphic_picture graphicRef54303 \" href=\"UTD.htm?38/56/39813\">",
"     picture 7",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CASE 5",
"    </span>",
"    &nbsp;&mdash;&nbsp;Question: (",
"    <a class=\"graphic graphic_picture graphicRef67088 \" href=\"UTD.htm?13/29/13780\">",
"     picture 8",
"    </a>",
"    ). Answer: (",
"    <a class=\"graphic graphic_picture graphicRef77697 \" href=\"UTD.htm?16/52/17220\">",
"     picture 9",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CASE 6",
"    </span>",
"    &nbsp;&mdash;&nbsp;Question: (",
"    <a class=\"graphic graphic_picture graphicRef57731 \" href=\"UTD.htm?13/29/13786\">",
"     picture 10",
"    </a>",
"    ). Answer: (",
"    <a class=\"graphic graphic_picture graphicRef68429 \" href=\"UTD.htm?17/23/17783\">",
"     picture 11",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CASE 7",
"    </span>",
"    &nbsp;&mdash;&nbsp;Question: (",
"    <a class=\"graphic graphic_picture graphicRef79428 \" href=\"UTD.htm?31/60/32713\">",
"     picture 12",
"    </a>",
"    ). Answer: (",
"    <a class=\"graphic graphic_picture graphicRef55209 \" href=\"UTD.htm?37/37/38486\">",
"     picture 13",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     CASE 8",
"    </span>",
"    &nbsp;&mdash;&nbsp;Question: (",
"    <a class=\"graphic graphic_picture graphicRef67961 \" href=\"UTD.htm?27/10/27817\">",
"     picture 14",
"    </a>",
"    ). Answer: (",
"    <a class=\"graphic graphic_picture graphicRef82728 \" href=\"UTD.htm?34/24/35205\">",
"     picture 15",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     CASE 9",
"    </span>",
"    &nbsp;&mdash;&nbsp;Question: (",
"    <a class=\"graphic graphic_picture graphicRef58811 \" href=\"UTD.htm?19/7/19577\">",
"     picture 16",
"    </a>",
"    ). Answer: (",
"    <a class=\"graphic graphic_picture graphicRef73942 \" href=\"UTD.htm?11/8/11397\">",
"     picture 17",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     CASE 10",
"    </span>",
"    &nbsp;&mdash;&nbsp;Question: (",
"    <a class=\"graphic graphic_picture graphicRef52938 \" href=\"UTD.htm?14/22/14697\">",
"     picture 18",
"    </a>",
"    ). Answer: (",
"    <a class=\"graphic graphic_picture graphicRef63692 \" href=\"UTD.htm?42/12/43204\">",
"     picture 19",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     CASE 11",
"    </span>",
"    &nbsp;&mdash;&nbsp;Question: (",
"    <a class=\"graphic graphic_picture graphicRef76520 \" href=\"UTD.htm?9/51/10041\">",
"     picture 20",
"    </a>",
"    ). Answer: (",
"    <a class=\"graphic graphic_picture graphicRef50449 \" href=\"UTD.htm?21/53/22356\">",
"     picture 21",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     CASE 12",
"    </span>",
"    &nbsp;&mdash;&nbsp;Question: (",
"    <a class=\"graphic graphic_picture graphicRef62844 \" href=\"UTD.htm?5/15/5369\">",
"     picture 22",
"    </a>",
"    ). Answer: (",
"    <a class=\"graphic graphic_picture graphicRef77678 \" href=\"UTD.htm?7/60/8132\">",
"     picture 23",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     CASE 13",
"    </span>",
"    &nbsp;&mdash;&nbsp;Question: (",
"    <a class=\"graphic graphic_picture graphicRef57678 \" href=\"UTD.htm?37/63/38899\">",
"     picture 24",
"    </a>",
"    ). Answer: (",
"    <a class=\"graphic graphic_picture graphicRef68446 \" href=\"UTD.htm?43/14/44259\">",
"     picture 25",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     CASE 14",
"    </span>",
"    &nbsp;&mdash;&nbsp;Question: (",
"    <a class=\"graphic graphic_picture graphicRef77223 \" href=\"UTD.htm?31/9/31897\">",
"     picture 26",
"    </a>",
"    ). Answer: (",
"    <a class=\"graphic graphic_picture graphicRef55195 \" href=\"UTD.htm?4/24/4486\">",
"     picture 27",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     CASE 15",
"    </span>",
"    &nbsp;&mdash;&nbsp;Question: (",
"    <a class=\"graphic graphic_picture graphicRef68018 \" href=\"UTD.htm?7/42/7846\">",
"     picture 28",
"    </a>",
"    ). Answer: (",
"    <a class=\"graphic graphic_picture graphicRef78887 \" href=\"UTD.htm?9/44/9926\">",
"     picture 29",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     CASE 16",
"    </span>",
"    &nbsp;&mdash;&nbsp;Question: (",
"    <a class=\"graphic graphic_picture graphicRef58828 \" href=\"UTD.htm?20/24/20868\">",
"     picture 30",
"    </a>",
"    ). Answer: (",
"    <a class=\"graphic graphic_picture graphicRef69604 \" href=\"UTD.htm?27/32/28164\">",
"     picture 31",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     CASE 17",
"    </span>",
"    &nbsp;&mdash;&nbsp;Question: (",
"    <a class=\"graphic graphic_picture graphicRef82190 \" href=\"UTD.htm?1/46/1760\">",
"     picture 32",
"    </a>",
"    ). Answer: (",
"    <a class=\"graphic graphic_picture graphicRef60563 \" href=\"UTD.htm?3/2/3104\">",
"     picture 33",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     CASE 18",
"    </span>",
"    &nbsp;&mdash;&nbsp;Question: (",
"    <a class=\"graphic graphic_picture graphicRef73349 \" href=\"UTD.htm?22/27/22968\">",
"     picture 34",
"    </a>",
"    ). Answer: (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef51341 \" href=\"UTD.htm?26/22/26979\">",
"     image 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     CASE 19",
"    </span>",
"    &nbsp;&mdash;&nbsp;Question: (",
"    <a class=\"graphic graphic_picture graphicRef59983 \" href=\"UTD.htm?38/46/39651\">",
"     picture 35",
"    </a>",
"    ). Answer: (",
"    <a class=\"graphic graphic_picture graphicRef70750 \" href=\"UTD.htm?43/7/44147\">",
"     picture 36",
"    </a>",
"    ).",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7243 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-125.39.66.147-B9BF6B98CC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_63_2035=[""].join("\n");
var outline_f1_63_2035=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      PATTERN RECOGNITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CASE 1",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CASE 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CASE 3",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CASE 4",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CASE 5",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CASE 6",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CASE 7",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      CASE 8",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      CASE 9",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      CASE 10",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      CASE 11",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      CASE 12",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      CASE 13",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      CASE 14",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      CASE 15",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      CASE 16",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      CASE 17",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      CASE 18",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      CASE 19",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7243\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7243|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?26/22/26979\" title=\"diagnostic image 1\">",
"      Nephrology pattern 18 answer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7243|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/17/22805\" title=\"figure 1\">",
"      Nephrology pattern 1 answer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7243|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/20/23881\" title=\"picture 1\">",
"      Nephrology pattern 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?20/31/20985\" title=\"picture 2\">",
"      Nephrology pattern 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/15/15605\" title=\"picture 3\">",
"      Nephrology pattern 2 answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?20/30/20969\" title=\"picture 4\">",
"      Nephrology pattern 3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/60/14277\" title=\"picture 5\">",
"      Nephrology pattern 3 answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/45/29401\" title=\"picture 6\">",
"      Nephrology pattern 4",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/56/39813\" title=\"picture 7\">",
"      Nephrology pattern 4 answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/29/13780\" title=\"picture 8\">",
"      Nephrology pattern 5",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/52/17220\" title=\"picture 9\">",
"      Nephrology pattern 5 answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/29/13786\" title=\"picture 10\">",
"      Nephrology pattern 6",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/23/17783\" title=\"picture 11\">",
"      Nephrology pattern 6 answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/60/32713\" title=\"picture 12\">",
"      Nephrology pattern 7",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?37/37/38486\" title=\"picture 13\">",
"      Nephrology pattern 7 answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/10/27817\" title=\"picture 14\">",
"      Nephrology pattern 8",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/24/35205\" title=\"picture 15\">",
"      Nephrology pattern 8 answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/7/19577\" title=\"picture 16\">",
"      Nephrology pattern 9",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/8/11397\" title=\"picture 17\">",
"      Nephrology pattern 9 answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/22/14697\" title=\"picture 18\">",
"      Nephrology pattern 10",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/12/43204\" title=\"picture 19\">",
"      Nephrology pattern 10 answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/51/10041\" title=\"picture 20\">",
"      Nephrology pattern 11",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?21/53/22356\" title=\"picture 21\">",
"      Nephrology pattern 11 answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/15/5369\" title=\"picture 22\">",
"      Nephrology pattern 12",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/60/8132\" title=\"picture 23\">",
"      Nephrology pattern 12 answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?37/63/38899\" title=\"picture 24\">",
"      Nephrology pattern 13",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/14/44259\" title=\"picture 25\">",
"      Nephrology pattern 13 answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/9/31897\" title=\"picture 26\">",
"      Nephrology pattern 14",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/24/4486\" title=\"picture 27\">",
"      Nephrology pattern 14 answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/42/7846\" title=\"picture 28\">",
"      Nephrology pattern 15",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/44/9926\" title=\"picture 29\">",
"      Nephrology pattern 15 answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?20/24/20868\" title=\"picture 30\">",
"      Nephrology pattern 16",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/32/28164\" title=\"picture 31\">",
"      Nephrology pattern 16 answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/46/1760\" title=\"picture 32\">",
"      Nephrology pattern 17",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/2/3104\" title=\"picture 33\">",
"      Nephrology pattern 17 answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/27/22968\" title=\"picture 34\">",
"      Nephrology pattern 18",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/46/39651\" title=\"picture 35\">",
"      Nephrology pattern 19",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/7/44147\" title=\"picture 36\">",
"      Nephrology pattern 19 answer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_63_2036="Levobunolol: Pediatric drug information";
var content_f1_63_2036=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"13\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Levobunolol: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?27/55/28533?source=see_link\">",
"    see \"Levobunolol: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?29/30/30180?source=see_link\">",
"    see \"Levobunolol: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F187708\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Betagan&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F187709\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Levobunolol&reg;;",
"     </li>",
"     <li>",
"      Betagan&reg;;",
"     </li>",
"     <li>",
"      Novo-Levobunolol;",
"     </li>",
"     <li>",
"      PMS-Levobunolol;",
"     </li>",
"     <li>",
"      Ratio-Levobunolol;",
"     </li>",
"     <li>",
"      Sandoz-Levobunolol",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1059732\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Beta-Adrenergic Blocker, Ophthalmic",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1059727\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?27/55/28533?source=see_link\">",
"      see \"Levobunolol: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: 1-2 drops of 0.5% solution in eye(s) once daily or 1-2 drops of 0.25% solution twice daily; may increase to 1 drop of 0.5% solution twice daily",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F187695\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, ophthalmic, as hydrochloride [drops]: 0.25% (5 mL, 10 mL); 0.5% (5 mL, 10 mL, 15 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Betagan&reg;: 0.25% (5 mL [DSC], 10 mL [DSC]); 0.5% (2 mL [DSC], 5 mL, 10 mL, 15 mL) [contains benzalkonium chloride, sodium metabisulfite]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F187680\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1059735\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Intraocular: Apply drops into conjunctival sac of affected eye(s); avoid contacting bottle tip with skin; apply gentle pressure to lacrimal sac during and immediately following instillation (1-2 minutes) to decrease systemic absorption; see manufacturer's information regarding proper usage of C Cap (compliance cap)",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1059734\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     To lower intraocular pressure in chronic open-angle glaucoma or ocular hypertension",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F187745\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Levobunolol may be confused with levocabastine",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Betagan&reg; may be confused with Betadine&reg;, Betoptic&reg; S",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F187744\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Arrhythmia, bradycardia, cardiac arrest cerebral ischemia, cerebrovascular accident, chest pain, congestive heart failure, heart block, hypotension, palpitation, syncope",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Ataxia (transient), confusion, depression, dizziness, headache, lethargy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Alopecia, erythema, pruritus, rash, Stevens-Johnson syndrome, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hypoglycemia masked",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea, nausea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Impotence",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Myasthenia gravis exacerbation, paresthesia, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Blepharoconjunctivitis, blepharoptosis, conjunctivitis, corneal sensitivity decreased, diplopia, iridocyclitis, keratitis, ptosis, stinging/burning, visual disturbances",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Bronchospasm, dyspnea, nasal congestion, respiratory failure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Hypersensitivity",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1059739\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to levobunolol or any component; asthma, severe COPD, sinus bradycardia, second or third degree A-V block, cardiogenic shock",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1059726\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with CHF, diabetes mellitus, hyperthyroidism, myasthenia gravis",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1059725\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Contains metabisulfite which may cause allergic reactions in susceptible individuals; use only in combination with miotic for patients with angle closure glaucoma; products contain sulfites which may cause allergic reactions in susceptible individuals",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299587\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F187689\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha-/Beta-Agonists (Direct-Acting): Beta-Blockers may enhance the vasopressor effect of Alpha-/Beta-Agonists (Direct-Acting). Epinephrine used as a local anesthetic for dental procedures will not likely cause clinically relevant problems.  Management: Cardioselective beta-blockers and lower doses of epinephrine may confer a more limited risk. Patients who may require acute subcutaneous epinephrine (e.g., bee sting kits) should probably avoid beta blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Dipivefrin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anilidopiperidine Opioids: May enhance the bradycardic effect of Beta-Blockers. Anilidopiperidine Opioids may enhance the hypotensive effect of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta2-Agonists: Beta-Blockers (Nonselective) may diminish the bronchodilatory effect of Beta2-Agonists.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bupivacaine: Beta-Blockers may increase the serum concentration of Bupivacaine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cholinergic Agonists: Beta-Blockers may enhance the adverse/toxic effect of Cholinergic Agonists. Of particular concern are the potential for cardiac conduction abnormalities and bronchoconstriction.  Management: Administer these agents in combination with caution, and monitor for conduction disturbances.  Avoid methacholine with any beta blocker due to the potential for additive bronchoconstriction.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dronedarone: May enhance the bradycardic effect of Beta-Blockers. Dronedarone may increase the serum concentration of Beta-Blockers. This likely applies only to those agents that are metabolized by CYP2D6. Management: Use lower initial beta-blocker doses; adequate tolerance of the combination, based on ECG findings, should be confirmed prior to any increase in beta-blocker dose.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ergot Derivatives: Beta-Blockers may enhance the vasoconstricting effect of Ergot Derivatives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fingolimod: Beta-Blockers may enhance the bradycardic effect of Fingolimod.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Floctafenine: May enhance the adverse/toxic effect of Beta-Blockers.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypotensive Agents: May enhance the adverse/toxic effect of other Hypotensive Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lidocaine (Systemic): Beta-Blockers may increase the serum concentration of Lidocaine (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lidocaine (Topical): Beta-Blockers may increase the serum concentration of Lidocaine (Topical).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the orthostatic hypotensive effect of Orthostatic Hypotension Producing Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mepivacaine: Beta-Blockers may increase the serum concentration of Mepivacaine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methacholine: Beta-Blockers may enhance the adverse/toxic effect of Methacholine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Midodrine: Beta-Blockers may enhance the bradycardic effect of Midodrine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNIDine: May decrease the metabolism of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Reserpine: May enhance the hypotensive effect of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Theophylline Derivatives: Beta-Blockers (Nonselective) may diminish the bronchodilatory effect of Theophylline Derivatives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F187690\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F9951563\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have been observed in some animal reproduction studies. If ophthalmic agents are needed for the treatment of glaucoma during pregnancy, the minimum effective dose should be used in combination with punctual occlusion to decrease potential exposure to the fetus (Johnson,2001; Samples, 1988)",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1059731\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Intraocular pressure",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1059724\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     A nonselective beta-adrenergic blocking agent that lowers intraocular pressure by reducing aqueous humor production",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1059737\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Following ophthalmic instillation, decreases in intraocular pressure can be noted within 1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Maximum effect: Within 2-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Maximal effectiveness: 2-3 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: 1-7 days",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1059738\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: May be absorbed systemically and produce systemic side effects",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Extensively metabolized into several metabolites; primary metabolite (active) dihydrolevobunolol",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Not well defined",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12547 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-118.195.65.247-9CA6F9C4F1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_63_2036=[""].join("\n");
var outline_f1_63_2036=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187708\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187709\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059732\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059727\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187695\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187680\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059735\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059734\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187745\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187744\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059739\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059726\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059725\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299587\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187689\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187690\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9951563\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059731\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059724\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059737\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059738\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12547\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12547|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?27/55/28533?source=related_link\">",
"      Levobunolol: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?29/30/30180?source=related_link\">",
"      Levobunolol: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_63_2037="Pathogenesis and clinical manifestations of oropharyngeal dysphagia";
var content_f1_63_2037=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis and clinical manifestations of oropharyngeal dysphagia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/63/2037/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/63/2037/contributors\">",
"     Anthony J Lembo, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/63/2037/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/63/2037/contributors\">",
"     Nicholas J Talley, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/63/2037/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/63/2037/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/63/2037/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 12, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dysphagia can be classified as either oropharyngeal or esophageal. Oropharyngeal dysphagia, also called transfer dysphagia, arises from disease of the upper esophagus and pharynx, or from upper esophageal sphincter (UES) dysfunction (",
"    <a class=\"graphic graphic_table graphicRef52707 \" href=\"UTD.htm?16/45/17117\">",
"     table 1",
"    </a>",
"    ). Esophageal dysphagia arises within the body of the esophagus, and may be due to either mechanical causes or a motility disturbance. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/17/12569?source=see_link\">",
"     \"Evaluation of dysphagia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Initial evaluation of oropharyngeal and esophageal dysphagia differs, making their distinction important. In most cases, a comprehensive examination and a careful history are sufficient to guide appropriate evaluation.",
"   </p>",
"   <p>",
"    The physiology of normal swallowing and the pathogenesis and clinical manifestations of oropharyngeal dysphagia will be reviewed here. The American Gastroenterological Association (AGA) guideline for the management of oropharyngeal dysphagia [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2037/abstract/1\">",
"     1",
"    </a>",
"    ], as well as other AGA guidelines, can be accessed through the AGA web site at",
"    <a class=\"external\" href=\"file://www.gastro.org/practice/medical-position-statements\">",
"     www.gastro.org/practice/medical-position-statements",
"    </a>",
"    . Diagnosis and treatment are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/38/17000?source=see_link\">",
"     \"Diagnosis and treatment of oropharyngeal dysphagia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHYSIOLOGY OF SWALLOWING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal swallowing consists of three phases (oral preparatory, pharyngeal, and esophageal) that are usually performed effortlessly up to 600 times a day. Once swallowing has been initiated, it takes less than one second for a bolus to reach the esophagus (",
"    <a class=\"graphic graphic_figure graphicRef59163 \" href=\"UTD.htm?39/56/40845\">",
"     figure 1",
"    </a>",
"    ), and an additional 10 to 15 seconds to complete the swallow. This process involves more than 30 muscles. Therefore, precise timing and coordination during the oropharyngeal phase are crucial for normal swallowing.",
"   </p>",
"   <p>",
"    The swallowing centers within the central nervous system are represented bilaterally and are interdependent. The degree of representation within each hemisphere may be critical for determining recovery of swallowing function after a stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2037/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Oral preparatory phase",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the oral preparatory phase, the bolus is processed by mastication to an appropriate size, shape, and consistency to pass through the pharynx and esophagus.",
"   </p>",
"   <p>",
"    The tongue is a critical part of this phase, both for controlling the food so that proper chewing can occur and for directing the bolus to its proper position for swallowing. After chewing, the bolus is moved to the back of the tongue. The anterior portion of the tongue lifts up to the hard palate and retracts posteriorly forcing the bolus into the upper pharynx. Elevation of the posterior portion of the tongue by the mylohyoid muscles elevates the soft palate, thereby sealing the nasopharynx and preventing nasal aspiration.",
"   </p>",
"   <p>",
"    The oral preparatory phase is under voluntary control and involves use of cranial nerves V (trigeminal), VII (facial), and XII (hypoglossal).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Pharyngeal phase",
"    </span>",
"    &nbsp;&mdash;&nbsp;During the pharyngeal phase of swallowing, the bolus is advanced through the pharynx and into the esophagus by pharyngeal peristalsis. This occurs by advancement of the soft palate to the posterior nasopharyngeal wall, which narrows the upper pharynx, and contraction of the superior constrictor muscles. Simultaneously, the larynx and hyoid are pulled upward and forward, causing relaxation of the cricopharyngeus muscle, which makes up much of the upper esophageal sphincter (",
"    <a class=\"graphic graphic_figure graphicRef59163 \" href=\"UTD.htm?39/56/40845\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The pharyngeal phase, unlike the oral phase, is controlled reflexively and involves cranial nerves V (trigeminal), IX (glossopharyngeus), X (vagus), and XII (hypoglossal). During swallowing, respiration is inhibited centrally.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Esophageal phase",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the esophageal phase of swallowing, peristaltic contractions in the body of the esophagus combined with simultaneous relaxation of the lower esophageal sphincter propel the bolus into the stomach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PATHOGENESIS OF OROPHARYNGEAL DYSPHAGIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oropharyngeal dysphagia can arise from the oral preparatory or pharyngeal phase of swallowing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Disorders of the oral preparatory phase",
"    </span>",
"    &nbsp;&mdash;&nbsp;A normal oral preparatory phase requires food to be adequately chewed and presented for swallowing. Proper mastication, adequate salivary production for softening the consistency of the bolus, intact mucosa within the oropharynx, and neuromuscular coordination are all necessary features for the initial phase of swallowing to occur.",
"   </p>",
"   <p>",
"    A variety of disorders can disrupt normal completion of the oral preparatory phase:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Poor dentition may lead to inadequate mastication of the bolus.",
"     </li>",
"     <li>",
"      A decrease in salivary flow may occur in diseases such as Sj&ouml;gren's syndrome or from medications that reduce salivary flow, such as anticholinergics, antihistamines, and certain antihypertensive agents.",
"     </li>",
"     <li>",
"      Neurologic disorders such as stroke or Parkinson disease can result in weakness of the muscles of the face and lips, or a decrease in coordination.",
"     </li>",
"     <li>",
"      Disruption of the oropharyngeal mucosa from mucositis, aphthous ulcers, or herpetic lesions may inhibit normal processing of the bolus.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Disorders of the pharyngeal phase",
"    </span>",
"    &nbsp;&mdash;&nbsp;A normal pharyngeal phase requires neuromuscular coordination for propulsion of the bolus, an unobstructed lumen, and normal relaxation of the UES (",
"    <a class=\"graphic graphic_table graphicRef52707 \" href=\"UTD.htm?16/45/17117\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Neuromuscular discoordination can result from disorders which involve the central nervous system, such as stroke and motor neuron disease (amyotrophic lateral sclerosis), or the peripheral nervous system, such as Bell's palsy or myasthenia gravis [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2037/abstract/3\">",
"       3",
"      </a>",
"      ]. Oculopharyngeal muscular dystrophy is a hereditary disease transmitted in an autosomal dominant manner. The clinical symptoms are palpebral ptosis, oropharyngeal dysphagia, and proximal limb weakness.",
"     </li>",
"     <li>",
"      Obstructions within the oropharynx are most commonly due to malignancies. However, obstructing lesions can also be benign, such as cervical rings or webs. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/34/12838?source=see_link\">",
"       \"Esophageal webs and rings\"",
"      </a>",
"      .) Cervical osteophytes can also narrow the lumen and impede transit of the bolus.",
"     </li>",
"     <li>",
"      Poor compliance of the UES causes incomplete relaxation during swallowing. Patients with Parkinson disease, for example, frequently have incomplete relaxation of the UES and reduced UES opening [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2037/abstract/4\">",
"       4",
"      </a>",
"      ]. Similarly, patients with a cricopharyngeal bar likely have impaired opening of the UES due to decreased muscular compliance [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2037/abstract/5,6\">",
"       5,6",
"      </a>",
"      ]. While a cricopharyngeal bar is a common radiographic finding in patients undergoing dynamic pharyngeal radiography (5 to 19 percent), it is not known how often it accounts for the patient&rsquo;s dysphagia (eg, in one study with 24 patients with a cricopharyngeal bar, esophageal pathology that could account for the dysphagia was found in all but one patient) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2037/abstract/1,7\">",
"       1,7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The accompanying rise in hypopharyngeal pressure associated with UES dysfunction may result in development of a protrusion of hypopharyngeal mucosa between the oblique fibers of the inferior pharyngeal constrictor, and the transverse fibers of the cricopharyngeus. The resulting pharyngoesophageal (Zenker's) diverticulum, may also contribute to dysphagia [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2037/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/52/29512?source=see_link\">",
"     \"Zenker's diverticulum\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of oropharyngeal dysphagia is often made following neurologic injury, such as a stroke. Disorders which present more insidiously may be accompanied by a history of neurologic symptoms, aspiration, weight loss, or progressive dysphagia. Many patients will have made significant adjustments in their diet prior to seeking medical attention. In extreme cases, patients may sustain themselves entirely on a liquid diet before presenting to their physician.",
"   </p>",
"   <p>",
"    Patients with oropharyngeal dysphagia point toward the cervical region when describing their symptoms. Symptoms occur almost immediately after swallowing and are characterized by the feeling of an obstruction in the neck. Other common complaints include coughing, choking, drooling, and regurgitation when swallowing liquids or solid food. However, patients with neurologic disease or dementia may not be capable of accurately describing the location of symptoms.",
"   </p>",
"   <p>",
"    Oropharyngeal dysphagia may occasionally be confused with other disorders which can produce symptoms in the cervical region.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Because the interpretation of visceral innervation is imprecise, dysphagia related to distal esophageal disease, such as a peptic stricture, may sometimes be felt in the suprasternal notch. However, in contrast to oropharyngeal dysphagia, the symptoms associated with esophageal dysphagia do not occur immediately after swallowing.",
"     </li>",
"     <li>",
"      Patients with a globus sensation (sensation of a lump in the throat) can sometimes be confused as having oropharyngeal dysphagia. Careful questioning of such patients often reveals that the sensation is present independently of swallowing. However, a diagnostic test in patients presenting with globus is usually required for precise diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/19/21814?source=see_link\">",
"       \"Globus sensation\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?7/13/7378?source=see_link\">",
"       \"Patient information: Dysphagia (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H106303318\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Oropharyngeal dysphagia, also called transfer dysphagia, arises from disease of the upper esophagus and pharynx, or from upper esophageal sphincter (UES) dysfunction (",
"      <a class=\"graphic graphic_table graphicRef52707 \" href=\"UTD.htm?16/45/17117\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Normal swallowing consists of three phases (oral preparatory, pharyngeal, and esophageal). In the oral preparatory phase, the bolus is processed by mastication to an appropriate size, shape, and consistency to pass through the pharynx and esophagus. During the pharyngeal phase of swallowing, the bolus is advanced through the pharynx and into the esophagus by pharyngeal peristalsis. In the esophageal phase of swallowing, peristaltic contractions in the body of the esophagus combined with simultaneous relaxation of the lower esophageal sphincter propel the bolus into the stomach. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Physiology of swallowing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Oropharyngeal dysphagia can arise from the oral preparatory or pharyngeal phase of swallowing. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Pathogenesis of oropharyngeal dysphagia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A variety of disorders can disrupt normal completion of the oral preparatory phase (see",
"      <a class=\"local\" href=\"#H7\">",
"       'Disorders of the oral preparatory phase'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Poor dentition may lead to inadequate mastication of the bolus.",
"     </li>",
"     <li>",
"      A decrease in salivary flow may occur in diseases such as Sj&ouml;gren's syndrome or from medications that reduce salivary flow, such as anticholinergics, antihistamines, and certain antihypertensive agents.",
"     </li>",
"     <li>",
"      Neurologic disorders such as stroke or Parkinson disease can result in weakness of the muscles of the face and lips, or a decrease in coordination.",
"     </li>",
"     <li>",
"      Disruption of the oropharyngeal mucosa from mucositis, aphthous ulcers, or herpetic lesions may inhibit normal processing of the bolus.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A normal pharyngeal phase requires neuromuscular coordination for propulsion of the bolus, an unobstructed lumen, and normal relaxation of the UES. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Disorders of the pharyngeal phase'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Neuromuscular discoordination can result from disorders that involve the central nervous system, such as stroke and motor neuron disease (amyotrophic lateral sclerosis), or the peripheral nervous system, such as Bell's palsy or myasthenia gravis. Oculopharyngeal muscular dystrophy is a hereditary disease transmitted in an autosomal dominant manner. The clinical symptoms are palpebral ptosis, oropharyngeal dysphagia, and proximal limb weakness.",
"     </li>",
"     <li>",
"      Obstructions within the oropharynx are most commonly due to malignancies. However, obstructing lesions can also be benign, such as cervical rings or webs. Cervical osteophytes can also narrow the lumen and impede transit of the bolus. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/34/12838?source=see_link\">",
"       \"Esophageal webs and rings\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Poor compliance of the UES causes incomplete relaxation during swallowing. Patients with Parkinson disease, for example, frequently have incomplete relaxation of the UES and reduced UES opening.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with oropharyngeal dysphagia point toward the cervical region when describing their symptoms. Symptoms occur almost immediately after swallowing and are characterized by the feeling of an obstruction in the neck. Other common complaints include coughing, choking, drooling, and regurgitation when swallowing liquids or solid food. However, patients with neurologic disease or dementia may not be capable of accurately describing the location of symptoms. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2037/abstract/1\">",
"      Cook IJ, Kahrilas PJ. AGA technical review on management of oropharyngeal dysphagia. Gastroenterology 1999; 116:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2037/abstract/2\">",
"      Hamdy S, Aziz Q, Rothwell JC, et al. Recovery of swallowing after dysphagic stroke relates to functional reorganization in the intact motor cortex. Gastroenterology 1998; 115:1104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2037/abstract/3\">",
"      Rothstein RD. A systematic approach to the patient with dysphagia. Hosp Pract (Minneap) 1997; 32:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2037/abstract/4\">",
"      Ali GN, Wallace KL, Schwartz R, et al. Mechanisms of oral-pharyngeal dysphagia in patients with Parkinson's disease. Gastroenterology 1996; 110:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2037/abstract/5\">",
"      Dantas RO, Cook IJ, Dodds WJ, et al. Biomechanics of cricopharyngeal bars. Gastroenterology 1990; 99:1269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2037/abstract/6\">",
"      Ali GN, Wallace KL, Laundl TM, et al. Predictors of outcome following cricopharyngeal disruption for pharyngeal dysphagia. Dysphagia 1997; 12:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2037/abstract/7\">",
"      Jones B, Ravich WJ, Donner MW, et al. Pharyngoesophageal interrelationships: observations and working concepts. Gastrointest Radiol 1985; 10:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2037/abstract/8\">",
"      Watemberg S, Landau O, Avrahami R. Zenker's diverticulum: reappraisal. Am J Gastroenterol 1996; 91:1494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2037/abstract/9\">",
"      Cook IJ, Gabb M, Panagopoulos V, et al. Pharyngeal (Zenker's) diverticulum is a disorder of upper esophageal sphincter opening. Gastroenterology 1992; 103:1229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2037/abstract/10\">",
"      Cook IJ, Blumbergs P, Cash K, et al. Structural abnormalities of the cricopharyngeus muscle in patients with pharyngeal (Zenker's) diverticulum. J Gastroenterol Hepatol 1992; 7:556.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2277 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-9CEA1CDAAA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_63_2037=[""].join("\n");
var outline_f1_63_2037=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H106303318\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHYSIOLOGY OF SWALLOWING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Oral preparatory phase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Pharyngeal phase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Esophageal phase",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PATHOGENESIS OF OROPHARYNGEAL DYSPHAGIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Disorders of the oral preparatory phase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Disorders of the pharyngeal phase",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H106303318\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2277\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2277|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/56/40845\" title=\"figure 1\">",
"      Pharyngeal swallow timeline",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2277|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/45/17117\" title=\"table 1\">",
"      Causes oropharyngeal dysphagia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/38/17000?source=related_link\">",
"      Diagnosis and treatment of oropharyngeal dysphagia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/34/12838?source=related_link\">",
"      Esophageal webs and rings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/17/12569?source=related_link\">",
"      Evaluation of dysphagia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/19/21814?source=related_link\">",
"      Globus sensation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?7/13/7378?source=related_link\">",
"      Patient information: Dysphagia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/52/29512?source=related_link\">",
"      Zenker's diverticulum",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_63_2038="Prenatal ultrasound images of umbilical cord insertion sites";
var content_f1_63_2038=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F55337&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F55337&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Prenatal ultrasound images of umbilical cord insertion sites",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 316px; height: 514px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAICATwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3r4n+P9K+HOg2+r63b3s9tPdLaKtmiM4dkdgTuZRjCHv6V5sf2oPBypvOkeJNvr5Fv/8AHqi/bR4+F+k5GR/bUX/oies/V7Xw94a+Cvge70rwR4Z1bxVrNrp9raR3emxSefNJErO7nAJ4zklhywJNAGiP2pfBZGRpPiQg/wDTvB/8epf+GpfBef8AkE+JP+/EH/x6ub8aweFPEP7MF14q03wtoGmasVt0mazsI4ngmF1GkgUgblB54zna3U18uI6CQEoSAaAPsgftReDCQBpHiTJOP9Rb/wDx6pof2mvCMzYj0fxGT/1yth/Oevj5LGaZXe0UO2eRnoDTpLWe15mhdZVGeTxigD7MP7Qvh7bu/wCEf8SYIyCI7Xp/3/qAftI+GCzL/YXiUMpwQYbYH8vPr5NtdXlkiTaykDqgbBP41et9YXzC7shTIDSSL88f+znuD60AfUx/aN8MiQIdC8SBzwAYrYf+16dJ+0V4bjYrJoHiVSG2/NFbDn/v/Xye2oxm9aRUAilOfv8AIxWr/bgm014pQ7xA9GXk/Q0AfT7/ALQnh5JNkmg+Ikbj7y2ijn3M9bFh8YLLUCosfDWu3BboI5rBifw+09favkmB4mgktzHvTZvXzZRuX2FV47yWGG3ubJ2tCgCZ3bSxoA+yrv4mPZ7ftXgvxTCGGQZBZqP1uKrw/FmKeJpIvCHigovXizH6faK+W4viF4mjtbeG51e8u7TzM+VcDd8v1rooviZLcttk820UdWRs7iOxHYUAe8/8Lls9pY+EvFQAO0kx2o5/8CKrXHx10i3l8ubw14lV/wC7stCf0uK8nsPGGi6lbRxzl7eRyQ7yyttkXtwPet/S7KG7RILS6tZrbHmhgw3q/wCPJoA7ZPj1ozyiJPDfiZpCMhRHa5x9PPqWP446VJu2eGfErAcEhbTH/pRXleqQw3F5JJLL5U0IwpiTG8+9VbWC4GxxLGsQzJGSflJ7gj3oA9i/4XXpv/QseJM+n+h5/L7RV2L4rwysFTwp4i3ehexB+vNz0968TSK4nfzBC27e0hTPMX+77GiC6uIPLe7muSWbO0NhlHbn0oA9w/4Wiv2jyP8AhEPEnmEZA3WOG+h+04P4Van+IVxAsDSeC/EoWb7hD2JH44uePxxXjL6rczxw7pC6QuXDD5Tn0+tMh124nubm3truYwP91ZJMKnH60Aeuy/FRIpWjfwh4mDqu4j/Qun/gTU6/El3s47tfB3iU28j+Wrh7H73of9J4/GvKdK8YahpLSxW72mWARppgZCSRgYq3beIJYo0haT5JVEdxBGuzzP8AaHpQB6zF401CVSYvBHiRwCAds2nnn/wKpsnje9jnEL+CvEQk2lsefp/A9z9q4+lcDH4mC3NvYO1zCtsRLEHPDezHuMdKuz+JVvL261Czt44rwrkRT/MhUcEn3oA7eLxdqcsayReB/Ebo3RhcacQf/JqqUvxBuIr9bOTwZ4kW5ZxGF82w5YjIGftWM4rCtviD5MAjhaKRSixqLaD5IX757/nVjRfEZnLX2pywRTQSfu7Z03SSE8b/APZ47UAbj+N76NpxJ4K8Rp5PMhebT1A4z1N1zWc3xRCWxnfwf4mSMIJPnNkp2k4BwbnPP0rWu9Sn1MLDpunRXMcygEXjgJgc52dcZ70moaCI7S6vUkU6msJXauHEa91UHoPSgDJuPimtvBFNL4Q8SqkrbE+ayJJ+guc1ch+INzM0ix+C/EuY2CuDJYLtJ6Zzc8VhX8Vt4fSwVL2OTUppd8VvMysFyPvuewFU2S3tYpL9tRiu4biY/aWjBw79kUHqp6GgChrP7SvhXRdVu9N1PQ/EsF7ayGKaMw27bWHuJiCPQgkHtVP/AIaq8Ef9ArxL/wCA8H/x6vLfjL4Xu/Ea3muRQ7dQtEGIY4SBJCDzyeyDp7V8/v7EkZPNOwH2l/w1V4I/6BXiT/wHg/8Aj1H/AA1V4I/6BXiT/wAB4P8A49XxZRRYR9p/8NVeCP8AoFeJP/AeD/49R/w1V4I/6BXiT/wHg/8Aj1fFlFFgPuLw9+0p4P13X9M0i003xAlzqF1FaRNLBCEV5HCgsRKTjJGcA17fX5sfCj/kqXg3/sNWX/o9K/SehjPBP2zSo+GWkFxlf7Ziz/34nrmdI8YfCHVdE8Ay+MNcluLvw/pMVqdMmsJpbXzTCqOXXySHIK8ENj5Qea6X9tAZ+GGkg/8AQZi/9ET18a+obkCkB9GeP/FHwysvhN4x0HwNrt1PLrN5Fex6e9pLHFC/nxM6xZiUIu1OhJ+6AK+cMMq9T7Y9KVSDnccY6ZpygMQQx3Dse9AE9vcTJ80ciq459DWtD4juQ0fnKswXhhIv3qxXzwSuPelk2lVKMee1AHQzDTrzdI6m2djkIOmf8Kz9qrcHLFipONvOR6VnxTGFgQuSRjntU63QMm6MlZB1Xpu+lAFsXIlkIK7uPkVkA+b1NPuLiWRIwQOMAYbBB71Tjfzi3lqqN33UFsMFYYJ+/t/iPqPSgC5I5Z8QqYyMbieae8zyZ3IFiHHzcge9U2njhAZGcS9u4/GoceYzSDe6kZbn5RQBc+0s64hlaSMDbhxkAewp9vuDOqyHY5++W5PsahgUuqCIlWXq2eGq3ZxJ+7DRiZ5G+Ttn2oA0Uj2FIoJgUxmN34Deuakh1aWWUgO+8YQNGxAU+vH9aiuQF8tZYkijTO3aCfm9D7VYtIVuEljURRQYGWUlQfrQBo2ev6rBaZWd5CGLtv8AnUnpnn9K37bxHMQjSRRfaCuXVo8Y+vYGuJiC21yBb4KD5ljduGx3HrWiSEt0cuWMnOSf9af9o9hQB1j+JwsI8nY74y86nt3StKLxBDGFlkTzpGjzJBN90Htt9a4q0uL2IyzRxQpmNo2h8oFVBHX6+9XLS2njW2WQoA6cb+ifj60AdPc6xZRzQh8FwMgI33M9sUkmpRzFRDGR8hYAcNk8Z+lcw9nIko+0PCjj50kXkSCoIL2YBiskYVwV4PQZ6+tAHXQ3CiKHeIgrjaAeWyKv6eAsSpK2yU5KNnc3/wBauOjlMaTR+U4YLtSQA7SD1I96fZzSS27SLPFbQrwGL5YH3oA7yWdJbeLZJM0sRzIJcZkHoKrjMytdKJY7YjKIT19q5my1OWa2ZI7qHy0yWcr82fapoNTuHSG0E63Fy4OVQ4EKjnLHvn0oA6GKdYreVbeVIxMP30rHA2+igdDUUmrz6ekayFXhV97SMc7h2weorkr6+urEbJHgkmuBlkXkIPWpJdSjTymMckgaMKN56n6UAemSeNEt2hGlrdahdFOWUkFcjt9Klt/Ft9pEcrapKxnnhw21juZQeC3qecV5xDq87xI3mlHQFcIMAD6ilmvHMn2i5vY5ZQQgz0U9h9KAPQ4PEEE2jXNzqVorSEbUeUgtjP8AKp/CFtN4i1K0uLPzWmg3MnIWG3AP3iDxivMJEuNRuIkSVI4S+PLZsAfj3rWGv3VpLFbW7/Z7ZW8vMGcN9aAPV/HskN1a3p1jWLa8khj2w21uhw8noW/u+or5Y+JvhV9MmXV7Kx+yaXdPsMK5YW8oAJXPTB6j8u1exWOoWst60srmSOFlDl+ARjoK6XVvFGmXfg7VPDeo6Z9n0W4iIAyd4BIIkz1LBgCPpTA+PKK1vE2ly6Rq01pKWeMHfDKVx5sZ+6+PcVlEYxTEJRRRQB1Xwo/5Kl4N/wCw1Zf+j0r9J6/Nj4Uf8lS8G/8AYasv/R6V+k9JjPCf2xEST4caMshAQ6zHkn/r3uK+Nmtj5zCE7n9DX2J+2d/yTHSOM/8AE6i/9ET18eBWCp5gY9cFf60gIZI2X5So4PUHrQI5HA2qOuBk1KsJkIMIkIH3hkc1PMY5IVWM+X7N1BoAgSUwyYdt69Mehpy3KFGaRVZOgHdajmHlueoJ5BAyKJBEwVwcOR8wHSgCPYhHDt60+NcAEHI/vGm7eAOPcjpikIwSqtwRyPWgB6uwDBCpHrRI+WCHtzuBq+s73MaxyCJSq4UFQM1ntGVLKRwOf/1UALI5KheWDevakSWS3YGEKOOR1BqEKM/eJIOcelHzDftOFPUHvQBajuJCNw3bh37Cr9hdpjy5Aqq33mb+H6elZStkqePm6BamQ7SRv8s+h7mgDp9xYCaH5XTldx3IwovLtZ28yWNUdkwYk+6TXPxPMIDiVt2c+Wx/UVowvC0ag4imPWXrmgC/HchYFYAwRKMFdoJb6VauJ3uJLdlESKyBZJFBBI9h0qijGQJEswm5JLkBePxqeVUtfLuGk8yI8DJwV9sUAaVtd28MuyeczFzgNnBxVi5ZXvIo0aUwNn5iBx9KwGuftd0NkZeEcAxr/WtaPTrmS2d7bzY0PBLLkD60AXJbpot4KLFCrAAu24kmi6lt0uLdbUQpIAWkZhhW+lP0rw/9s8tZYnAP8Yzhj7VsxaBHuKKyNHGf3jvg7SO1AHPPPAVbElyZSeXLEqo+lV/JjhnuXWGSUpg5ZsLz3rq7jRSbxfscUoYjcylPlC9yKY3h2T7Q/wBmgYxcFtzc7R1oA5dEkiWRIrvfKSGYKMDPoWqedrwPDM+0jOCkA+8K7O90BrloRbWTRsFACBO3ualbwTrbWnmwKIQuCpncKcDrxQBxUwBnMssSWjngSE7mK+uKjkkhaykad5HeRtiAjHH94egrqLTw7qUo3xBLoxAkybc4+hPWsTVNKe2Mr/vcN2cY5oAxIrlrS6Xy5WeI/IVQ5P5VYdUW4dvMkjjjPzTSLlufUelQmzSFWkL4kHBwajRHa0LTTOI3B3RA8t9c0AbNrem5hTdMZgh2qB8ob3rQ0+5to0d7uViu7CqD1rktKwEElt+6YZjVJDkAf3iK0w8qKq3QjlblFAAAPuKAOvlu4Y33QuyRZB2lc7eP51S1PVHlvo5bnfPA2AplXapI6cDmsb7YlpB5asJEY/OWPy5HOBUi6nNcyRuQELf+O4oAra/YnxDYPHcFIb+1y9u8i8uoGWRj2H933ry2QENjBBHGCOR9fevV7uO2hvfNV5ZpvvOzthQfQD9a5Pxro6xkapa5eCRsTMTjLn+IDsKaA5GilIwcUlMR1Xwo/wCSpeDf+w1Zf+j0r9J6/Nj4Uf8AJUvBv/Yasv8A0elfpPSYzwb9ssgfDPSCwBA1mPr/ANe89fIRtJTaGeMgIfvKp5FfYv7XcEtz8P8ARYYFDSNrKYB/69rg18gS2VxDEUmgk2jPzYODSAhsykZ2unOOo5onjhDrCshLn+9TreNFRRBJGXJwQ3bNTS+cZEhd4WPqw4/A0AUrtFjl5OWA7c1Eo3wDMYdc8EcEfhVq5JQALDiRc/OvOakto1DlhKfMccNjHPpQBV8khVEm3b/telOSGMuRKW3EZQD7v41ZuoZNi8F5AfXj8arSSbSNwMbL97kc0APkmgjtzCYVLHo+cFfpVQJEUBJcOp/SpGKzOFUnd2JqDeysQwzzg455oAbLgOdrDnqwpqqGGCx46YpxU4JK89sDihFMn3cfhQA4YHCgZbv3qWGR4o2WQbkPJGf0pBCVwWAHb61PHCsiAJu39xQAgdwu4LtVuh6mnhCMHzVJA6d6mgspSeGLL1PsKv6d4flvrxCpVUkYKmT940AZrK6qFX5nZvlUdBXRaJ4du9TKRJFvmk+VQuTt+vp9a7fw34CludQjhktHKFvLMyYYIfWvTdL02z0S/itHI1J0bbGIE2sx9DQByOmfC46ZaB9UfCMuSiNjYfUketaLabocP2e3NzNCvPmrywx716Jqi39zeR2cKLa2p2tNbTsBtPXGe5rlNVMUeuztBZqGyE3r9wY7e9AGfEywCKSNgttbndDFs+Vhn7xPUUarexx3u/7Nb7JVyzxKGB+o9aqa9eandXKuXFqdu12hj6oPQGs/SYreIrdalNKywv0B2mRPUA96ANSfU7SeyQPcr5LjYzRjBQDtioJ9b0+ztvKshJcWw3K9wi43ceh6VZvrWzvZVewtJkdyDCvCqw9WqvqnheV45zfmOxcFWilSQFAO6ke9AF3T/EWlslsZHlxHyA8wGfTin3mp2t6JpZVMBIOwhi6sD65OK4650eO3v3je2tdkgwsqSZH1FRCwkTzLeMJPGowjJISDj2oA7SDW5oRBBuR4Su0IkeML+HegXOiSyPFf2Qu7lz8qlyqr9T2rzeO/vLCWOS6lRQTsWME5z+FWJNUEknlpvixjPmc5P1oA6nXND024YtHZ/ZyThIk+ZcjvurjvEXh17ABljkkiX51bv9K67R9bitrRWlb7Qd5Bt1OCe3WtfU4LeS1W4+1q0jglI8HYo9PrQB4bMjXaqNnl7fvBf4vTNOa8MESxvIplBO1thPlj0HrW1rlisly/mNHbgknKtyx9qxiHEQjiJbacluhNABCzyzLLDmVAvzheAPbFOinS3HnvnzmYliW3bR6AVTlu+HRC/X5go6Gl+zpboZLtHwRlOPu+5oA6rQtNe5tJL++lCozbkQ4LuR0+gqrfTWHkAMgkgZ9pQDKse5P0qtaaotvalkmBKpyGGKy5dVF1aiGOMRwpzk9yetAHLavYNYXskW7fHyY3HRhVEjFdZfpHcWC2pi+eNSUkzjafT8a5Rs5ORgjr7U0wOp+FH/JUvBv/AGGrL/0elfpPX5sfCj/kqXg3/sNWX/o9K/SehgeQftMTJb+GfDcshIQa2uSO2bW5Feb+DPE+kJqzWep3GnW4mIHmTQBom9z6V3X7WbbPAuhNjONaTj/t2uK+Y4XhxsHnGIHOByB7UgPrjxF4D8AX+lwXur6bYQmcBRf2IKoCejbl4APqeK+cfi98NbnwlqguLW4S/wBMdN0U8YyyD/aHT8qTw54q1Pw6JIdIuJ2tZQS9uwzE3sVNdNp3iY69pE9m8aLK3LRy5wx749KAPDYArwTM7L5m7crZx+dTwk3UhR3RJQAwyOCfauu8ZaBZ6dfqlqSVlXfJbSABlz0Knoa4+cGERxneMnAQcH86AHqkks5jCojEYfJqP7OrNIkuyMIOGC5zTGy0hDpvf+IKOR9PWryW4+wM82YlB+VyePoaAMaaLbt3vxn7xTGaqSQeVnaCRnO8Ditm9MxjA+V16BwapeThfmcuScY3UAU08v5iHO4iiONwAWA299pqdbcFy0g8rHAGM5pbe2MkrpsVgOgBxQBEApjAUs3zZ57irtrFHLgf6vb0H/16ZMOqqSGXqpHT6eta2j4WNZWiWQkYbecCgDS8MaPd3koiQOSxyV4wV+texeBvCEt6VX7KYoom2hlXc6eprO+GXg658QXwFmI5IRHvO5iFUfUd/avoa3gs/CWlRWduW+1Mu1/JOfmx1IPQUAc1aeF7mxEbTavcQllw5MOAU/2cDk4qpB4n0ewuruCeyaK3ETQxyMoaQknl/UVh+MPFErebcW+pXrwSN8sQbPlkcMR7ZrLs9Z2r+8NvcCSP5vPxuI96ALFvrMMt5FZwQmSyVspKT8zfU1Y1vVmkcJa6bGqIdzEg5PqRWSkVvbXFtFL5KW7Eyr5D8g+h9BUXinUXvUkk0Wd90BAUuucnvjHWgCe9k0ueyE6/aI55DgqvJA9Pas1k0uNIlvrKWXedsJlf7p/DvV/wp4am1e2vp4reWeWOEzOd5QO309apT+H71NOgleVE3sWjhd8OG+tAGDILuw1hxFP5MYIwrE4wewrQeOS41GNhGBvGCZZMq49cVI5eLclyhlkcbTLK2QhHbmqkli+p3MJhkAkUBepCn8KAFktp9Oa1hFtBPI+QvkjcWB/lUs9pqukyy/6IsLqPMSKTAbbjmtPQdNmttYnWG0kkvo1ypaXaI/f3osFSXXprnxRO16Iz+8CqQQR0xQBj6ppN3cQwzWlvZJZsoZ5ABvDnsM965nUtPka7ZEmLKODFty+fwr0bUF07ULq4uTJJFpsPzRQlDkt68VkBp4oftEdpEih8JIFw5P8AWgDhYHnsXcTxz7IR8vGDk9q6fSryS4tvsNqki3LP5rtKuCOO3oK6T7JbaiHW7AS58vJLY2Fj61zOp2V5pdll0l+zMSFO773Pr6UAYeoyKWcRwbwM7nk5OfauQuBPPIVaVYxzgnrXcSy+bCoaVVic7Qm3lfxrj9TyJZIjGHQnhlHX8aAM+32xmQQyZduCMdTVeeVQd0krzOBgqScZqUytbg+UmXJx2+WluY1nLsr4ZR8y46UAZqg3jBGZFJ5wOAo9KbHI6sYWw6ocgKMmmeXEqFwGLKcEk4q5EZFiDKVCA8hepoAmM7Xbxh1CRIcsB/jVHxDbwzRi6teqYSQgYDn1FLcSuh2q6CNvmZQOfxpURjGdw2oeAP8A61AFj4U/8lT8G/8AYasv/R6V+k9fnH8OrYW/xZ8HeXzE2tWW0/8AbdK/RymwPIP2l7E6l4a8NWayrEZtbVQ7jIB+y3PWvBfF/gLXPC1lHcXaIbN+VmtvnQ+mT2r6B/aIm+zaL4Wm3bfL1xWz9LW5rnPDnijQvHUL6TqWpwWF3b/NBFMQscw75zwf580gPnwq6CGcyCQtg7s4z+HrW7beRHJDL5rpk/MVXJHsRW98S/C8GjahI8F1axnPyRxHcv1BFc7ZRXTCO4kRXVCN37zbvFAF7xElhdwSxQRRr5Y3JOQTuOORntXnYtgskkEZVXILlZGyp/GvSNXLtpUq6aEubZ/9ZBI4V09x64ry6dWhn8l2kCl8klQQKAHRFzGkflBUU/Md+Sv41Ddhx85kPkngAN1PtVgoyNcCxCyKR85U4A98VmNcuYTG6iYLnacYKmgBznby0YXHACHJP1FRq3lMCRsGchjUkczIq3CSqXUYcBetQylJD5qRvtPv3oAGlAdiQ7hhnOeKWKPzJUcIzD+6H2k1Hbq+XztbnlQasJGkgJ2FpweATgYoAsQeTHcL8jBuxkOa9V+Fnh2XxBrtpHaQLFbTSbZn2bhx1OO1cBo1tNfXMNvY27PcMcCNUySfrX2P8KdLh8KeHom1ZGsbuRQHjmjVefUMPWgDcu/7L8CaIINGtLaO5f7kKggykdScc15T4m8XXLxzf2ha+RcZOXRz8wPqBXSeKPEmnz3U2pIkwvYCVhf7y4HYivF9R1TUNTv7h2uYY2LEiKQEFhQB09rqtjeKtq5Qw8ETuMbPYkdqpTwwHxA0ZaKSA8JJbjIPtz2qjo2qJY3E4W3toJdygSSfN5g7qF/rWnJqtnfTAPdQ2y5yPLg+6fTNAGpfXbJo7H+zbd5YQY2aFCW56EjpVLT/ABBZ2mnpuheKbBCoY+HbuTjpWdALuBri4ttTDCNT+5wWDr6mup8F+HdSvLEava2dnJEEJMkjfcx7HvQAzwtda7cr5VtJ9minJ5ZsLn6daItNksZtTmmuxLeWx+TeN6H3UetbOpWsunRmW3lhurqVNzbPkWLPYVxduNQneWKD96xGXYNlwo6nNAGjHeIXU3sKBpFy73CZC++3/Cm22oW9pAYIoUulL5ZgcEenNaZktp4YmXZMqoNyk5lx3C+9Zt5c2NvaTySJGhjXdBGfvkf7fvQBVS2vby7kisJNkbZkMbt8x+rVZsi7wl76WCF1P7zY+SoH9761T0aDTZo3knu7uS42hhHa859mbtXSw2sF7p7b9Nt4LUqVJDDzGP8AtHvQBlteJcSeVqFzGtnKufIiTDY/vZ9K4u8uRLqSwWM179nRzhpUyo+lbepB7YTKAnlECJQOHRPSiHUNN06GK3ljuJJR8yncNgHue9AEOkrbTXzi5ldFU7mdPmJ/CrNzfoJvstsxntV4E0gGee22rVrpEF7BNPBfhbWQjetum1mY9AGPQVlajZ6bp0rRytJFdk4V1O8j/eNAGfLHHp9zJbRIFinOcMu9gevXtXI6zIX8yIRCLaTjA6+9bFxeSx6mI1u0YBsgg5LfWqniV7CRDLblhIfvN0Ge/FAHCXBZcEKEYN1IyTVeRlkmP7x3Zjy2cD6Cpr4yiQLhlLDALDg+9VJdiMFUgbByAe/rQA5IvLJyVKg8qTk1C7uJcxnAPIyOBUaOBN5gPmOe3QfjT2umckvIpXsAMUANYuGErDIDcgdWPrUrXXnzKEjO7tgcmoUHAPnDe33VA5NTfbPLGy1AM3RnA6UAdF8OfNPxN8JLMoG3WbJgBzj/AEhBX6I1+efw0eRfH/hJCqqH1uxLEnJP+kJX6GUAeSftH2M2peHfDdnbOEml1nCsex+yXR/pXgHibwPr/h9LWLXdLCwz/dniXd+GR3r6O+Oevx+GLPwnq81utzHb60d0THAYNZXSfpuz+FeQeIPi2+oSIdHdyIwSkVyu8D1APpQBTtEtG8M/ZIbfzJYsBZ2GHj9mzwR7isnWoUt7NSLiOO4Qbn2r8rr6E1iX2qaprclzdGSGNnx5lsp2jHsKpXekx3BjS6uZ7Yyj5EALKR6ZoAp6lfy32xElWSNfmjeNsFfUZ61kIGmNwWjZYgPmL88+uRWtP4RvbaN5LcxuoHEQyrfXNVI4rq3Pl29hJ5jLiUK25WoAx72ya02tHOJEYfN2IHrVWSNXRmjkfyxw1WdSs72GTdew3KRsfkOzP51YW0ju4VDZDoBwBgGgDOmYtEnlIpj6ZA5/GiaHbBlZST/cHWtSx0y4nR1iCRKOgOf1q7ZeG5pvknm8oy5AAj4HuDQBzMCNbukjwKUJ5561p2ZLXOESNlf5fmPOa9J8P/AfW9dsmfT9StcD5mglOGz2x7VteG/gL4usrxLu8srRzG+VQ3Az/gaAL/wS8I29tPFe3d1Ms4YuEiiyevvXrnjTxU7rPpoZXtBjfKo/eeuCOlOvtH1mKWyWAxWlx5W3LY2lu4BFc5fW7KLm3WKS4v3zvmUZQn15oA8213WGmmuvseovDEGClXUYY/h0p2j29hBbE3ssUgmGPNcEt+HpWdeWNpYa2U8S30EW0En+HOe3Hetcan4U02ZZ7bVN1sE3GH77N/hQAiW9pfX0hdrW4khwIwOAw+prpPCen6bqs+oxG0MN0g/d7WGxSP5060HhzWdDa6SN/tROYoZOGYGq2naXdwWEvkwXcEOdsir1LDuDQBtRW9us4uRNGjwYDosYHPoR3pb+4tIdPe0N3IY5pPNMUI6t/dAHSsLSbgGGW0igcusmZHnG/Hua0Ul0+zuDNYxR31z12QRkHd680AV7+DU5rVLk2G23B2hEf5iPUiqljcTQSCOOB4ZCeZZEwuPTitmzvmuYpbdp0trh8tLDuy+P9n0NY0mlazax3M8VqZIWOPMll+Ye+KAG6x9pigbyJ7V4i+WSJsNnvg9RxWYsEGpyPa2dlI8kpypYkgZ9+9aUtnHFCk98rxRqfmlgIJyfU1cj1S2s9Ne0jlne0U5iEMYV/wAT1NAGJoUcmha4tnNNsRMNIkcPDH0Jrb8eX80iQXNwYLRQMxpt2lh9BXH3HxE13w3p11baZHCYp2zulj3yKe2KoWdzqvinT55NUaZiTvMhXaffANAEXinVrq8a2guLgpDIvMpjGR+NZlm9tEWjmnMxTrIxzj6Ve1nSLyXToP7Q2rbDj5DhiO39K5eGxY3i28Fi8nZFdup9TQB2ulajJc6hGh/c20Q+Tyz8zD1IrqbyewlsGuLPT2igBwzTL8zt/OvObOxm0a6M8mo263OeI/U+gq3N4j1Z1dH8uSKT5ePWgDN1CIfa3a3ARg3JU4Jqnp8ym6lthF5gyTuJztP1p50/zrhZp45lBbG1DyT71uanaR2MKvB9njcLkInzOaAOD1lIlkk3TOpBxhuv4VixSZ++qD0Pr9a6G/sgsQluEcO5LF5Rg/lWatj5suxQAD+tAGTn5juG5Sf4eKQqoyTndjgCtO/s/szCMcY7VnSM8RYDaN3OetACCUrIAhCKPvEdaS4aTK42oCflXufc1GE+YHdwTyamnjU854P60AdH8MCP+Fl+Dx8zkazZZY9B/pCcCv0ar86fhdEy/ETwix4X+2rHAPU/6QlfotQB47+07Ctx4U8PRO2xW1lRuxnH+i3NeA+HkhQ3SXYgcofldl6D1Fe+ftQu8fhLw60Qy41pMDOM/wCi3NeJwNBJbmGeJp5ifmRV8tk/HvQBShCy3yRXtzGlo+cSIo+cf0NddpcdnC/k2+yWUR/ujIQAR/jXJz/ZFYwTWlxFddvlyGHbBrI+1SBzGpyqnjIIKn60AejOY7+zSHU7N0kSXkq+MZ7+4qjDpGjw3TmxvbmGVckROMqcdSDXKwatdh1Mkjeco4G3dxXXaXeT6pBbrHIglQnD+VgL9aANEaRNrDIttdpJbvxJG0eNv+fWrmmfC+2e2mxb3jzjJjjUgrL+PasuXwv4qYjytMa9A+ZZrOUq31xU1t408eeFZEjk0+/ij+6omsyyt+IoAmPhfSrd/smq6PPaufm8qUFWOP7rdCKZd+G9MaxMsLSqudkcChhz6bjSXfx31G5jey1Cx0yZzxiaFgV/D1rGk+IWo3DBons2hHBtGQlB7565oA1bttY0O3hkgj8ksQDIZidg7ZIpbX4hXGmhXk1C5uZEbkqx/EZ9K0dD+KNxDpbW1xpGlX0Z+Vm3bHCn2Nc/qsWjahI93BINOU9QoyC1AE2vfGe+IheKN0WJt6AnJB7EZrj/ABL8XvEutTIX1BYgq/KVUD+VXdW8N+FJLff/AG/Jc3bKMFkwFqrYeB9MdRI85uVbgBHC4FAHD3eoTalcO+oy/apJOu7k5q5oei6jcyGW3VI0AyQRnj6V1A0Cwtb+aS3t40SP5NgfcW966TTNah0SZZNPtLGXbgbJgflPqaAOMvdTv9LZXtbpjKByXTG3Fbml/EnxTdKbSS93QOMMIkHJ9f8A69bx8Y6df3gh1/SLFwZAzeWu3d6c10viLUdC1TT4E0XQ7PTPKHDsoDn8v60AYvh7Um/tOM6Za3F1dkfvExw3vk8V2S6leNCbCPSi97KSTJBjjP8ACWFYWg6bCY5bqHUmVyhXZvABNbPhqaz0vS5beWO9OpSH909sflB96AN+28DWGkWDap4kurdGdeImjwUPoGzkml8NW4uLS9SyWK6s5h5aNHjfGPQlj1riPEEWu3LtP4miuLi2A2hZZOo/Cs9XdreO009z9nc5+zxbgB/vNQBteMfAup6RbG4MkiaSzhfLLBiCe7V1+iWHhqHwRJdyww2l4qGMXM/zsWHdR6GsC+09LnS0a81m7JiA/wBHjPmLx2/CuU82bUJMac0sk27GZlxtx6DpQBoeGtS0zS9Sm1a60l79xkJ5pCop9cHNbF94zj1sPJdWtj5canbFAmSCfU964bW1udPsiupXBnuuojztH5d64U+JriC7lWxRoD0kdUzu9qANLUb6fV9SFiY/Jt0JG9M5HPfNdLp/gOzvJ/Jm12G3jWLzDIJdpH1Nc14c1a2OpiKaKS4DjJzwd3+9XoFj8P8AVfFSvcaVaizVARvlkBR/YetAHEWugaNBqUqzXb3ckefkQ7gQOmD71oW9hHNGkNhZFSX3OW6L6DmrN34X1LwvM6XqMLwnpEvAA962NIv4YoTKZjJL/dZf4qAM8+HdTtrlXnlt4I3PysDuzW9pvgfWdU09k0KwjihYnfezMuW9duea1LfXbBrR5b+zAmUbYyxyCfoK43UfifdWFkdJildLVmJwpIx7Z60Ac/4v8NWXhx9+sakl3cDgQq24fSvNtUujBMZoUFuH+6rHkCrviq7a/vWui7yZ+5niuXvFLSlpidx6AnNACvcyyzAuxeRu56VA4/eFSuW780SkI4+VunAHekaNmIOQgoAlkRY4w8iZ/uoDzUQ2ggnlv7v92o2JP3M5/vZ606CJiGKkbT1JoA6n4Yru+JnhCRn5/tmywuf+nhK/Rmvzl+GkJi+J3g7cyknWrLgHp+/Sv0aoA8U/auVW8EaCHcIDrSfMTjB+zXGP1r53Sd7YoJ7pXVuCwOQx9yOlfQP7Xchi+H+iOqqxGsx/K3Q/6PcV8krI5uiYmwjfwjpQB6201rp9nDKbmOWNhlhuO4fQ1iah/o0y3MLzvaz/ADgvHnb+JrP8Ja+bS3Ec8CuUfKtkMR7Fe9e06fpM3ivRVWBLBxKoPlRvtY/gehoA8flErbTLh1GGVouGH1qezmaxDTWt1cx3PUlnwMf1rZ8TeErvw9JIJnaKTdgRNliR7e1crdxSly1woB6bVHAoA7nRPjD4l0aCSzlit72zfgO4Kyr7qR0P1ruNK+ON6LNF+zRyuO9y4yfqVrwVJmVtscRL+mCd9IYI/NZ3DWwYYKupADetAH0LffEfSNUhY6p4d0gyEEtI4Dkn2OM1522oaL9pkf8Asy2tQ75Bjctu9jXI2EEl5KjAK7Q4DMJCm4euK6CSxFvdxXFs7JbuvziXadxoA9ZsLXwnrHhoW8Gi2635AJdHG8n1BrC1zwBdC3KWl81rAyZVZlJ/pSeCbjQbbUoZfEGpAR5DQyQMFWFu27Hb2r3K+mh1vSduma9a7CMmRdkgYeh56UAfGfiTw5q+nXGPJNyEG3fb52kfQ1ykWs6npNy3lPNEw/5ZODjFfWevWo0ph/bNvbBF5R4W+/8ATNcRrek6FdWrz3lsAJDmKT72B74oA8w0vxhfapaCF/IQjggIBke5rXsjfTtI00yxwkYLSIq59vetn+zPBr2awadF9n1GI5kl5w3+FZ95pymNvtUkMsRO5HV8kUAQ3GmWUwBtZmuivzM2cBW+ldj4FtIr658jU4xc5XbtjPy49CB1NZOn29pZqFmEpgIDFTIAsvt65rofBuqW1l4oE+gaeLOLZgtctuRWx6jpQB0mreCBoHh+bUDbRuT91Qdvlg+ue/tWR5U81rChLLGi5OG2lvqRzXZ3esadrMiR3Gowtc7MvCdzRufbPGRXn11qcEWuSR3GZQM7RAeOPXHegDXl1ma401rAmVrdBhYol5H/AAI9a1fBXhm/1Cxup7e6kskA2q86BtoA9KobJjpyPpsRmVm3lTHgqfTNSyp4lezkljdbSMj5kS5w7fhQAmmWNhbTG50i7a91VG23DSsI4yg67Qe+a5PWtRRLmc2hCzPITM7HgD0XHFMvbWZrhbnUpIcMQqB3y2fTavejXp/Lt0ja2FsAPvuAu38KAOaZZdUmKzxFmZv9cjbsD0qDXpW0xVhtobcuy4Py5J/Ormn7reSSf7RNcLyflG1MeuBWLqHiGx1C5aBrPDLwJSTk+9ADfBWkXGqaomEYMWyURM19Q6rqE/hLwjbxJJFEFUbSvLj8OlfOfh+5ubKOS7tZ4rSKLgEg7nPtUHinxvf3NksTzSTzN13HhRQB3niLxcuvja9w00gHJVNgPuf8KpWltYQwpci7UOFyyY/pXlunX5vZ1jklVT/Hjha9Q0i10aDS5n8/zropkFThF49TQBw+v61DLqjoXkiOcAQ8k/hXE6pDcfajLI3zdQrHk/UV18mi6rBfyXx03y7eQ5Ep+bvTJdGF5fmaaIxKBlTuyGPvQByVnc7yR5bPc4wBt3Ae1ULrTnhuPNv1Clm+VO+fpXpb6EdIt3vInESsuSWAP5V55dyvPNLLds7sScORyB9KAK19ZvHCZAEC47nmspc4y68HjNXbtYmiLlpGLcfP/hWYxKjZvBx6d6AHM6gbYwCB3NRbjuOW49qc+NpG7nHQUmFjX5x83tQB03wuC/8ACzvCG0E/8TmyyT2/0hK/R2vzk+Fpx8SvCABJzrVlxj/p4Sv0boA8K/bCYL8OtGLbsDWY/u9f+Pe4r5F8yW2n82KROeqyD7v4V9bftlf8k00fBI/4nUXI/wCveevkJmIYea6OFHDdzQBpXVzHGsNy9usVx2eL7p9/Y1o6L4o1HT51m0/UH3FsgF8Mp7jPYVz6urbQTIsGfmA5zVnYtqpeExyw9RxytAHsOm/FFI7hG1K2drsjZLLI4kV1/pWzp2o6BeypJbtaR7m3EPJg/ka8Ct0muZZJY0XzAOVJwMUkk85yAm5V67hwPyoA+h9d0PRJ7pJ13xbxkS2sobH1rmrzU7O2SWG4uhMIT8rsocEe4ryu3udRhjLLeG2OPlUPlTVR7y4vJColJP8Ay0IoA9MbxPp4hkSKGMSEZVo+Nv1rj9V8TgwCKH55VY5DfNgfWuYM88cyhW3KDjpgn60/7UwuCZbdFHcp0/GgC4l0xkErgq7nI8s5B/Cuk0XxfeaPeobWaZEbCtHkYIrkcFw0lpsIB5jJxmopypTOAGB4+bpQB9Z6F4ilvtIhQm5mEgwFl2uv0BrF8SXMuh3K3EtrIxkIAVVyuT7V4/4D1+4tCgublXjB/dwSkqP0r2SSVNfsUAvYI1QZMajLfhmgDi9Y1Kaa4Zlhjtnj5lQqF8zPoayw0VxH5UVupJPzKzFNx/rV7xLp6zTzQLcxu0HILkqW+ornTclZEDXExZPvSooCqPbNAHZaJb3MSYFl5sbfLskfIH410ml6PD5MslzbXMLqcrFASsf/ANeuU0TxHdwRTNHc+dbcZEuMADvx3r0DR0uNc0d7mCS2W2ZeHE/T8KAKDWawpslicRZ3h0be4PpgVZj1aSxlij0+O2SRxhmkj2OT7561VnvH05Ud5ijLxG8ZDb/rVK0mv7i4luZVtpVByXLD5h7+lAD9SvtTspHlkvJZ5ZGx+75VD7YqCK61O6mjtb+4aWRxui3rjA9atX+sX7/Zkt7i3trdWy0UcWWP41PLq9swjMKR/aAT87Kfk9zQBl+TeafqC4UArzvmHygnvWpb2cl5PNdXUMU6YxJPPKAh91rCvL0STeSdRMs0gJckDCj2qx/aONMNrHpc020cuy/Jj6etAFHXPE+lW6SWOlW5jYcGUMDn6Vg6JpKX2pgsiyNkFjjAXPrXTW2n+H7cfaU0hZZDz5lzJsOfYCud1TxLJBcmK1t9hLbV8lev+8e4oA2Na0iKeaO2SeE7D8qLxj61yWvRTWDm3Nstx5g4YDAFbWkRPq2o2jXci28aNje3RjVjxyum2EjNJrCz3CD5IoOMUAcOPDd7CEnt1DLnc0ZOCPpXdaTb6n/ZyySQCRFwRmIkL9T3rn9B1u9umSK2jigj43u5yW/E10msaw9jYfZjqlzIG5CW/Q8dM0Aaf9uPbOo1i+aaHbmK3Rdu0e9c9qfisTW0lvY29vAhbOHPzD3rl86teEyJ5YCjCfaWy4p1p4dnlDXepXCgHkhjj8qAM3WNaluYGSW+ldQeY0HFURK88LW5iG5uQxOMCtoGzhBS3gDOM8kcVzGrTyySsS6whv4YxyaAM+9/cuQ8qySjggDp7VRLAfMRyecVLLGgxsUlh/E3WoMMTg4xQAm4g56Z5pd7ZwwwvbPWkDBflIIpsnL9R+NAHU/C0k/E/wAH84A1qy4/7bpX6P1+cHwsGPid4P6Z/tmy6f8AXdK/R+gDwb9sltnw10dsbsa1Fx6/uJ6+RBJI7hreIrGRyAuQPxr69/bFQyfDfRlDBCdaj+Y9v9HuK+RUlNsygM8ik4O1aAFt280guACrYBQfzqW4gBuQF2NuGMqcA+1JHHcKSti6lTyytwRUDWXzEl9rHqeuDQA8h0IaJWjkU/xfdApr3aJu8uV0d1w7fwNTXilkiIVzIBxw/wDSgWsiQFXCu2MhfQUAJCiSP+7/AHikZGDgClRXjY+UQx7ksM1HHDIYMFVKjnHSmwQiR2JAUr2PegCWQoOMsCTkn0+lQlZWJB5HbNSzq5jCNFGFHRkNFqpZGfzwCOArDrQBDPG8O1sKwYdjgihxEyA+dz7jpSyo4lBOGPQEDNV9pZiS2CTgqRigB8E7xTArIfZgea7/AML3yuFaWWUzdRJuJIrzsqhc4H5itTRbyC2O2aSWKNuCQcA0AezS6jb6npnlwSOl4h+ZvLxu+prkpIirXCcqS25kDAkn2FS6LeWMYRopRcRMOck1eaKwu7rzLF3Vh94Ywx+maAM3T7y0Hl29ojRsMiQOOfqfavUfDlnGNHWO2DXSsnPlkhfxri30m3ecGCX5+C+/gn616T4X8U32j2Js/wCz7Wa1IwkiqCR9aAOBuoYmnkhuwVhVsKxc7UPcZrds9QtlhNlFasyH7pj6N7knrS3eo6hNfXCwWbZc7ljEK+X+OaovHcOQXgt7eduCMEHH0oAuXVwrObaOVkZl2qOMn8ayG0qDTt7tfSBn++omDZPpWvp0+lBWVgzXKDGXGAD/AFqlaxjWNS+yXV/b2xU7lwiqMen1oAZoduj3MzCz/esu1ONxx6j3pbWC7tZTY311dw25yTvO3I9BWpPdT6VfC3tdUy23BZYsbR7U46nZ2ga51V21W5I+QTnAX8BQBxWqXyabaTLaeZIS3Dyru2j0zWdo811eb2EaLGT/AK1znn2rb1gXmvXbYs0+zn7qodigemO9NayvtNMUMkcVvaNhSQvH1oAxpIpWldLwzSLuzGIl/wA4q1HbWnlyC4iaMqvLSL8w9q6yy0u3uE8q3maUjqVb5qyNX8NCdpDe3kMAT5Rum3M31FAHIGUo7pbRtIg5XHHHrVE6sVlJR2Lr/CBwK37yxGnwTfZZvMDDG5uuPauZtbNVmkeFHZcfNnuaAGXGpzG7EgZpJT/dPP5Vrww6jqS7p52ATjy+tQ2CQWlw29Y5JXGcZxj8auTai2nWzlDgHoY04P1oAbd2Er3EcKyFBjJVBwPcmo5tFggglZoCzPyZpTtA9hWTHrl07+ZGWJzyx4xU8+sqYjvJmmPV3bd+Q6CgDm7mMRzu+4ADPHrVIndzxk1evHM7lsqXPTNZ5G3IJGaAGuRjGRTVwDg4NBjVvWjHAC/nQB1Xwtbd8TvB/AA/tqy/9HpX6P1+b/wqC/8ACzPB/wDe/tqy/wDR6V+kFAHgv7ZQLfDPSAvX+2ov/RE9fIKNKyMrOQRgAnqPpX2B+2QcfDbRyQT/AMTqL/0nnr5DnkLbSox9DyKAJJWlkjSOZjuUfeAwahxswyt5kI4YBuauoszxKzzMRnuKZLZl2Yx4DY5GOv0oApxyhpNsWUT1x1qyvlFyVSTzOmQcgio0h2qwUjcP4Mc06FG2Bt6BvQ8EUANmPG2M5HoRginM+FUEAnpuBK4pzSbxgTBmHHPanRiSDdtZSCM4I3UAQ3duoRWhLZ75bOabBEqgOztk9FNSOyliXZ1P+yc5qSNXZwsSsQD3FAEXlTOWwRGQeqdaja2abLFwWXua1tu3llII+9uHBqs09mJCyhgem1R/jQBmrZjAG9ue+OlRvbFWIizKB1PYVpQSxTRuTCpUZwwfFQiW3jb5Qqg9dp6mgDQ0jV7uygCQABB3Cg10uhatbAvO0TiTqxDZz+B6VwjXm12EcjID/CBS2d9JCzPAp+bjLHk0AeinVIZpJGaOYEn70mP0xWhpmoXEtntSQxRnrnIOPavPtP1CWKUST8uT3XcRXb2FpFqYjkN28hHI2jaq0Adfp+sPParFFfWsTx9GlUyOa0rK7lvLzciNMgABc/Jz/SuIudOht5dxNxFj+PcADVyG/juAkXnwqg4PZmoA1b6O3/taWaUR2vp5h8wCpNPuI7KctFCJjMeZI4wc/QdqgsoEeZlM6Rj+HcQw/I06e8uNMuEhtLyIl+NwTgH3oA0hqEmmzGZ104y9UEx3ED3HrWNq2sS3FwPtDiRH5BijCqPpU92dPEkZuBa310TlnjDYB9zVPxFFDPCj27hduPlQcfhQBSluriHbInmNCfRsEmqLG/eV5bma5aNuAH5C+9XnhDW0bm0ldVAYOH/pTVnvZ0BFvOYF6hxnj6UAXNIgn82M2ylt/Bk3BSfbFbN74cjFqs9zPJuYjEaKG/XrWdp0UdvMkrSiJm+6JPur+VdVbwRtDJIxkllIyJsFIwPagDhvFunLHAqB98hHEMY5HtXF2tnNukS4heEDlEGc/ia9B8U6s+nxmOMW/wBpIyrRHd+Zrzy91Wd5d5n2PnoOcfjQAnkm3kzK8YzwVHzEfjWfr2qTvIEG0RKPuqasXaYtSDMoXG488muakAeNhEVIJ++x5oAGuMrtwfm5yDUKu2WVeg70IQrDJ9s03dgnJxk4oAecBSQAW9TTeB8xOTTckOMDdmlDgE/LyKAB5Gc4AAFNTBPP5gUMFblicH0pVXLZQEAd/WgDpvhY5b4oeDwOg1qy/wDR6V+kFfnN8LoW/wCFl+EnwSBrNlk46f6RHX6M0AeD/tj5/wCFbaPjr/bUf/pPcV8jq8VyAI4+nUdxX1v+2ScfDTSCP+gzH/6Tz18nWbwtEdrCGT1bnNACx3MkP7tGWSLujGrlvcs6lJkAP8J7gelQAwOu54tzKfvJwKsxwCVgPMSUEZCnqKAIY1DsVdjnOAcYxVv+yURS0jnJ6NtzV3SLdJJCz27qqnDcZ/8A1122laXbamscSBnHRlKkED1oA4BPDEs77oszADJ2rg1F/Zixy+VGZCD947Dla+hND8C6N5sTSahhWXA2MRsP+1612Nr4D0bTnkuX1Eedt/498K+78+aAPlpfDrrFsMMrB1ysoQ4zRpvhm8iuhujk2S/LvfgA19OeRb3MqR2DBmiPIdAg/EVeMYiQpqFhYyWy8kuvX3oA+aW8G6ysqpb73yeMNkVHqPws8VhRPJYQCM9/NDV9CXc+jNMHg8u2QfwISVP4VzOqTTtfGaBhHZKescpUY9we9AHiUvw61NbVpJpUjwMmMLzXP3HhyZGKQSrO46xqhBWvojVNRhW2zawFpQOP3gyw9a5jUp4JIl8m3HmsMtkDcD9aAPC3sLmMMxiYbTg/IahKyI2QjLj26V6tfFrUgSRswbosfzZ+tVZTDMjNNYgOncrjNAHnH2rk+ZuyP9k1pabq32OUfvDxjav/ANau2i1SaKJUt9AtZFJwzSL2qlr8UckizRaRbuxHzCPIxQAy01V7xg9/tdR92QnaF/CriiC9+SEw5XkT5HGfYVyN3JEsgjksvIzwBnP5ikiuFgZtqwqF6MGwaAOt+z38TJJaTyS7P70QOT/hQ8uqKxe78tUPUscfoKyrHxSyoq+WzjGPkBzWsLmO9hxczC13jgydaADTb++nlkCKvkrwcsBurVXUrm3uUd2WJM8BkyPwrKs/DLQky2+oR4PIORg1JPBqcd0skc0U5HA3gbRQB2y6hNJZM0sqPG3JCxquPrSWRtrqFUk1Dy1zzxgH2riL+61KJ0jvHtZUPRl4A9jWhp8UE4Vrq5uGkH3IbRM4/GgDttYsrfSbNbjdEkRHyIz7mb3rn0u7rVw0dhLNPKRzhjtjHtTWsbi5G37DcGMf89lLN/hVqxE2lxiNY5rON+xwNxoAy73w+ljbu97cqjf7bgkn6VymsSWYlj3/AOksDwqLtB+tdRrNzG8rs8McjkYLSE81xl3FJIZJcQxqflBDcflQBjaxdvcS7FSKKIcbV6/jWQFO8gkADpViZSrt8yEA9VPWqkvzkcdKAFKx4O2mjaScKTikbAYACl384FADQMyZzwKMqxKgfjQynd8xwDSggAkYA9TQAYZSB1X27VraXGr4/wBHMh9SMCsyHLkbW+pxW3ZTjyznc7jgelAHofw/hdPEXh13RDnWtPGQMbf9Ki/OvuWvgnwBeSt418LQusoU6xYcv0/4+Y+lfe1AHjX7Uek3Gu+D/D+nWQjNxNrK7RIcL8trcscn6A18v6j4GuNOzHeJskPccj8K+vvjVobeI4vCOlRz+Q0+tHEnptsrtv8A2XH41wmqfCrY6R3F1O00Y35LfK3sM0AfPOleDr+8kYW0iBE5+c4LD6VsWvhGUqW2LG6cs/Qn2xXqj+DpI57i8aCQCAbS8Lf09aqr5MtqkCQLGXb/AFk0bBm+rUAYei6FdlI0tofMfgnb1211Wn6Uumyub2QqvY9GB9DW1b2dzYRRmC8itpMfLINrDNXdQaZ4431ryJZSuPtMCDke+OKAMHTdPOs3NxDZ3cNuy8/Odob3+tbFvYa3pdpvMgvo1+UjcCVH8zVizjuUVJILKxuoFHAEZDEepxV6zlvJWfyNLezHU7CwU0AUo2mgMUtzbPb7z8rqCD+Iq/da1A9s0cTRy3RPzJKeMetV7rWbyedPJRjNHxyN8Y/3u9U5pdOErXNylqspGD5RJyff2oAla5jjiMK2VlLMR26L9KwtbD3Fkbf9y5PHlbQD/Kr0ZlG97aG2kHVNr7c/nXLazr+okPHfWksPZSOf1oArR6YLaX5omRW/uctWZq85tXYQSZJ4xjLL+lSnUzJaIkVyjOOofgrWRqF3deYjyyRsp6bPvE+poAhtpIrd5RfQzyyyj5QDtBrPuSoO6aH5lOVWNsnHvT9U1Jp1aCeGVHQZVzwD9Ko2WoWjqCEnM2cM4jyF9zQBoxyCWMSqLiE/h0qa/vjJZeWDsxxvwAT71Qmube2l865mbcOgVgM1f0a0t9X3uYrWEnn9+S2f6UAZkGkW8xEl7dQvER65YmrunRafaqyvo0EwJ/1sjYyKVbBhdSputF2nCtGNoP51FdW/7zZeStKP4VDhQT+FAGnqfilraxFrpGh2Cgjbvdc/rXDS3l7K3761hIzlimSPwFd1p0ccMYW6tULY2gmQED/69XpNLX7OWU2iRMMgsecemBQB5vPPbN5YhyjDsQR9eKvwXoCrBHFknqV70utaEY5g9rmZif7xArLktb+BldonVwcHaCT+AoA7CztbBIXkvFAkYZUSN3rpPB8wjWWW0026urhfkxDgKw9a4rSrLUpgs7WguWU/8tjtUe9bU2peJkQx2clvaJjBFuelAHf3N5rjKzXK2en26rnyZpV3V5x4p8VwLMTLeKZx2gO5BXLXlldX98y3+rCeToyBzk1zmp2cMNw8UXyqnUgZ5oA1tX8VvfoyQ/eI4LCuda7l8oqyk5PWrqR2EVsrXUsnmY+QRiqryW0Y+WJ29N1AFMsQw55PqabIH3HBGPSngh2JI2N2wOlTIp5xE0h/vdKAKg3gkEc0g3Bsk/8A16tkLgjazy/3R2FOgtWlddwRGz0zQBV2AkFydvpipEjUuBLlU9a3hogkjxHKHfrhRU8Gl/ZnzPDvYjAXGc0AY0cZWQsE3KeIx6mt3T7Z22pIjB25EaDp9aS4iFjy6RwBhgYbc1JY3zqJEt45SXOC7HB/CgDpPBswb4g+FYtoBTWbEcHP/LzHX3rXwT4HUr4+8LKLfZjWbAsxPb7THX3tQB558YZktz4OlklaFV1o/vFYgr/oN3zkVyuqaprEsaG4vYri0RiYpHIz/wACIrpvjUyLD4RMgDJ/bJyCM/8ALld1ieHrPT7d5JrRrc7ssY3Gf0PFAGbpeszab5l3d2dpLFn5pIZj/wCg1JJqNjerL+6AZjlJGYBRntgcUmu3NhiRX0+KMj5h5aZRzVPTLfTrtHKJ9l9YSpAY+tAFiKJ5pfJu4LWeFh8siHlfetLTtHj+a1W88yM8SRovUex9axzFGQLeLTQSeFaKQBj+Bq3p+kJE+1547Rycr5z4b+dAFtf7F02RoINT1CzkQkBZYyA3tSprl3DFvsvPlderBc7h7g07XNH1U28bSzpPEvKOcNj3zVYX7RPDD9iFyeAZIZcEH6UATy3UGp3CzTo9jdDBE0S7T9CD1q5FGkkcgW8hmnYZLz2+0H8qXVNY094Eil3G4UblMiZZfqaxrXWdqsIp/tR7KEIx+NAEWp6L51pzJpjMhJZYpGTk1yGprdWTBWt4xH/eMu/+dbuuTSzSo00v2ZDz5aqCTXKaiiNO/wBm1CWVm4EczEBaAKkrRlZGS0szIeu7qaxbuKwb5p7R0lHV42OFrRktb+53rKYIj/sNurkdVtry0vjHCtwo7uMkUASzHySQ06i06hsZP41dj1JEUR2SechHzmaLb+RFYUlpfSr+78sE9XJyfrirdpG0R/4mBkYjj938ufwoA2De2MCgIYWlbnYITJg/WqH2lXn/AHfn2+TyWTZ+I9q2La5KRAWUCxq3V3xyfWqes217BG0st2txnnDRjgUAZ5kX7Xi7ki2nhZWO7P5dK1kuY/IKqlkyL0krEhnuBAzHTS0WOXCDFMhsbmWIMk0EcRPzBlGQPagDTEIvGCyQPKB90xnGDV+HTZ/KKbblI/d6y7U21pMEtdSlidR/FgrV2TU7iW9CQywugAG/ouaAKqmLTbhvkclu4BeidY5ZhK80obH8DYP5VqRzXuGNxOZEP8EYAWqb3LAn7LGqkfxEZoAzZDLNIIkkvVU8ZNR31qY4fKa4lKngqCQTVua9uY3AknhUNznZk1SvLqx85QzXUsp/ii4X9aAIINKQR5jxFnjJB3GsC/0mKF2kF2N3spNdR9uLR7LQNID0BGST/tVXuozaoJLqReQMRxrnFAHLjarqqkMx65GKq3saLNiINI3piumtbS1kZ5VKtKejzfw/hULadcSTkJOkinqI0wPxNAHMw2rSvslJjBPAUfzq5PYSqoEeBGRzg81pahopXmKYB8ZIzWZJbXax4EiocY55JFAEFjAEkIZ8DOAoHzGtG2gtLOTfJIJZSeI+pH1rLRLlGUIVX1Y9asvbyxL+6lZpDySowBQBrwahcplYZoUlY/3eFFR3kyQlW+0tM5/iUE5PsKi05lt1Anhwf9rk5rTS3m1D5DKIQOgRMGgChdWzi1EzuUY8hcZJFU7YSRSxSm3G4HKlm4Hua1rizktDgSMxx96XgD6VnXby22G3CUtyWYcfQUAdX4SnR/iH4Q8tOG1mxywPAP2iPrX3pX59fD15ZfiF4TZ5CV/tmxwuMf8ALxHX6C0AeZ/HOJJ7PwnHLJ5SNrWC/p/oV1XDLFPaySrBfORjgyJx9B7V23x4kSLT/CjyRGZRrXKAZz/od1XHSXZ1DbGtstscYVehNAESzwzRkTTmCYdWjX5az11PXFu0t1ltr2Mn5GJCt+ZpbjTpluh5d7LC69YTjDVpxt9n2i1VLh2GCJE4U/WgBz2lzcPHPqVtmeP+HJXA9mFdt4b0/Sb3GLcPKFy0bgP+RNc3Y3Oo3sP2e6WG1B7qwwR+NOeO9sB52nX0LydugYUAdO9rJY6nJFApFmF3NGFO4D2rD8Q6no4jMJtjFIwI8x4ymPqa0LDXda8hFuI0vWYZIYhSPx71jeIL25vkNvNawvGfvxySDgUAYtnfSoD5d3Fcw4xtyGx9c9atHxLNAghmS2ER4/dx4IrDvrPTQyiOBrd05LBiyn29qe1hZ6hDG8rovPyhSxXj6UAXb/UtNMR85UYDkiQcmua1CW1vNzCBY0H3PLbBNO1q1zKQJbSWED5UkyrfmawpgY5FjmhiCDnMb5oAp3lxaMvkyTXMUrfKCny7fxqjc4toAZL2SOT+D5t4ZfU1qXLWZD4juDkcsG4rEe2ilQ+XKWGckMuaAM6/MV3F87P5g53odtFpILvy1eZY2jOT5pPIp1wlvD88cJWccYOQhFZ81xcSXaj7JCsg6Mj5oA6y7RruMJbTREqBymRg1jSG8Ny0Un2mTbgEs/3qs3H2mWKNJYQTjko2ymCCG3QCSaVWY4++OPxoAm+2rDF5Vr9pgI+8Sm4CqKRG7kaaQLJF03EdT34rbaysksebvk8kk7qzdKthbXDeRcKEPTdwPyoALmWyVERVdGHQKuNx9DWtp1hfsokFjAiY+UzSAfpWdqFu5mEhvBI46JwBRHqFzD/x9WjTRjoS/AoAs3qawSw862hjzzlt2R7AUG6nggAEUcuP4WwAaY+qC9Ro4hHGMdgQ35msuMWNtOzXE8jYPU8mgDQk1N5sRz6fFFjkbMVKAGiB+ykh+vy1C9zpMkQeAXLS+pTH86ZDqMUkZjk3RBe7ODn8qAC6votNiYRk+Z/zzRM1nyXlzcrlbU7Tz84xUk1rcXLf6Kr+X3kXjP4mno12bUwW9vIz/dLMMjFAGKczXfyIplzhU28ZrpI9O1BbJTfTwxp/DGgxWSkMli2cSyXHYIv6A1bie4a5CXYLsR3bJHtQBm6pcJ5xhRd7ngCBc5+prLnSO2JMpaSbqUx8q+xrp9SZ0BjtljhUD58Lg/nXPXLwNbnc+c8BiepoAw5rlZrjMkgZhwEXgLWzZXNpHbeZgDHpyc1hxCJ3I8vaQcbupP0pzfISJH2c8KB1oA2JZGviGigXb2eTgD3qa3vWsVP2YmSU8NITx+FZdjJI21QRtzjBrSuJhvigWMKGOC4HAoAkN0Z2DXE6GTplzwPoKqaqvmwK4V2jU/e+7n6VcubNLWBZYFM1xjqRgLWLeXF1cP8Av3AVeD6UAbvw1Un4heE2Odo1mxwSeT/pEdfoXX59/DmVW8eeE1wMjWbHnGOftMdfoJQB5t8bIEubfwlDJL5KtrJy/p/oV3/+quLvITYROkZicY6SjOa9B+Lukahq1joDaXplxqRs9T+0TQW8sUb7Ps1xHuBkdF4aRO+a811HQ/HUyBIfC2rOin5RPcWPH4i4oA5x76aSb/S1RIM4VVJJ/wD11Z0+SZdQ32WqSxHGAki4X/8AXW7H4a8TtADP4L1cXPcpdWJUn8biqf8AwinixrhZJfBF+4U5BN1ZA/pcUAa0Om3NyFnu5hM+Pm24xVWTTWN9v/1QP8KIxSQe59asRaF4lQZXwVrUb55K3tkQfwNzW7HP4whg8qDwTqqccMbixYj/AMmaAKE9pbC3zDEttMR8r+cQAfoapW+nq4Mk9y3mLy6Bwyyf4VNdaT4svQxu/DPiCR+wM2nkf+lNZr+GPE802ZvBGpgL914rqyRh/wCTNAEN1eT78oPKjXoXGF/Ksa61+9FwIUvbKFjkny48git5vBuvB/MTwr4leT0kvLEj/wBKaiufCniufhvB2rAYxlbmwB/9KKAOLvpJr+Ro2v4C5IxmQLmmJpkaQFJmVypJDRyA8+9dKPAXipZM/wDCH6m6k5O+4sCf/R9Ubv4d+NFlMmneFdTjJ/he7stv/o+gDkpA0rE+ZLJFH/AFwp/Gq6zDaDuSFAekbZ/OupPw7+JT5DaFqKIf4EubLH/o+q5+E/jd8k+GtSic9XjubLJ/8j0Ac/e6Xa3KCSO6k3lfwrDurKOKdVlnZJR1wThvpXbL8J/iHGWWPQtR8s9N1zZbvz+0Uz/hUnjw5Mvha9mbtuvbMf8AtagDnjBtUZS8YdvlyprP1K20vbISipcINx3g5H5V26/Czx/NGEufCuoIg6pHqdqQfzmqvL8J/iAJi1v4MG0fdMl1alvxPn0AcTbxrLZrLeyYtz93Yx/lV61l0uALHGJZ265Y9K6lvhL49meN7jwhMSnGEu7RRj/v/Vr/AIVJ4u8kKng69jcc5F5Zn/2vQByVwzy4WC1Yt2ZeStMstK1s3RcTMkZ4Jcfpiush+FPj+1ZmtfDepo7dxf2Y/Tzqvf8ACCfE7aVbwpO4xjc19abv/R1AHH3SReekF7mZvSIUPp1jCf3MUau3PzhiR+NdjB8O/iBCuU8I3Ky/3heWZ/8Aa1VJfhd8QpSfO8OajKG5ZGvLMDP/AH+oA4a7azSTyd63E4P3VJAWr9qssUQWCK2jzySVziulh+E3jcA+b4NuQ3TMd7Zgke586rEHwx8dxMCPB91j3vbQ/wDtagDmrppVjSMXBEp7YyKljttShty1zqMcUZ6AgA10mo/D74lTRqlp4RlhA7/brTP/AKNrIb4SfEaXJm8MXTuf4jfWhP8A6OoA5yJoxfE3t8XQA42jqalieC2Ej2y4Vxy0nUV01r8KfiDDhj4SnLL90fbbQ/qZqnPw1+I0nE3hGRl7j7Zac/8AkagDzuWBZ87LtwudxGd2T6Gub1JJHuyC6YHCgCvaH+GHxB27IvB8sSkclbyzz/6OrHvfg18RJWIg8JyIrckte2hOf+/1AHl6TSQOsKbC7dwMmmyQxLMN376XPO7oK9Hi+CXxIQEL4XkXPVhe2mfw/e1A/wADfiWZiw8MSEf3jf2u4/8AkWgDz2eYoTubao/hjH9akivmTAjiGWHc5Nd9J8D/AImuMf8ACMNt/wCv61/+O0RfAz4lIw/4pmVQD2vrQ/8AtWgDgxLJK+J5JQv93pmnO8EMij7MTKfu7zn8xXfS/A34jNMHHhq5OOOb605/8i1MvwW+JMD7rbwo4c9We+tCf/RtAHOeA0ZviN4RkcncNasflAwF/wBIjr9BK+NPBXwi+JFn428OX2qaA8dna6na3E8n2y2ISNJkZjhZCTgA8AE19l0AeYftC/EDVfhx4LstX0O3sZ7mbUEtGW8R3QI0cjEgKynOUHf1rx+0+NvxovLSG6tPh/HPbToskUsWi3rJIjDIZWEmCCCCCK7D9tb/AJJZpX/Yai/9ET1T1i51b+wPgTpuk3N0qX+nok1tFqc9glwFtIiA8sOWAHJGAf1oA5bVfjt8YdIsJb7VfAttY2UWPMuLnSLyKNMkAZZpABkkD6kVz/8Aw1X44/6BXhv/AMB5/wD49XY+INWvdS/ZV8aW+q311f3+maoLCaaeQy8pdwkBJSSZFAYAMeT6Divk6gD6A/4ar8cf9Arw3/4Dz/8Ax6j/AIar8cf9Arw3/wCA8/8A8er5/ooA+gP+Gq/HH/QK8N/+A8//AMeo/wCGq/HH/QK8N/8AgPP/APHq+f6KAPoD/hqvxx/0CvDf/gPP/wDHqP8Ahqvxv/0CvDf/AIDz/wDx6vn+loA+gP8Ahqnxx/0C/Df/AIDT/wDx6t23/aH8fSxRs2m+HQzLuZFs5yVHv+/FfO+iae97MzIM+XyFzya62DUDHCQSzSqMNcA8j6g96APf9N+M/i/UtO+0Wdx4a81VLSQyabOhGP7pNz836VXk+Nfjg2guLUeF51YlET7DOrl/7pBuOPrXiMReOIzSpLHAxCmUDOPcDtVqbWFmNst0uydcxmY8LIvbI7H3oA9VHx78dBxHLbeGo5SCdhspzyOoyJ6ZafH/AMcNcIl9a+HLdS2GKWU0hC+oH2gZ/SvMJ1vfs+Y5x9nRv3e7CsFP3iPUU9bea4skkkhSUd0jx5u31z3NAHsT/Gjxq7xmzk8L3ELA5P2CdXTH95ftHT8axb349/Ee3VWh0vwzcIwz+7t58/gDNzXmmnLeabM4spmmspckKy4kYjquamtbqCRJlumKweYML0cZ54FAHdW37SXjPaxv7DRLXBxn+zZ3XP1+0CtOy/aC8UXUjobjwtCVUtmWwnUH2/4+OtcA8k0Oz+xZ8WxGXguYRIPrmsDXrPUWeO9m0q1YyDassMgaNx9OxoA9oHxx8btAkyw6AY2IBI02c498C4qvc/HnxpCpBPhPzhkmNrScYHrnz68KtrsaYQLqG5sgGJWSGVlKn6961o7+KRt0OoKxkTP+lQKxOOTmgD1xfjx48klhSBPB0glHyN5UwH4/v+Kkh+Onj5zKrweE0MZ2k+RMV3dxnz68WLrcPPGbCznlfG8omwL6Y5rKke6s5hEdMRpFBYh/nDj1NAHuU/7Q3jGHaG/4RLzCcbfs0/B+vn1Ef2i/Gq58yHwqhXG4G2nOM9P+W/SvFINQhSSN7jSIJZXzhgxyF9MUl/qM0rBI7KytVA28D5gvuaAPb7f9oPx5cXYhjtfCu0jIkNvOFz6Z86rJ/aD8UKXEtz4ViK8ZexnCk9wD9o/pXgrR3t7a+Q1xbfZUHyxxsCx9+O9TWuhW0TxfbrtTGV3OSh+Y/wB2gD1+/wD2nPFEAAtU8O3cmfmCafOAB6gmfmqsX7TvjyeVUtdH0CXccKfsc4z/AORq80a1srWUsi2zCJ1O/qMdRgegpLvVrtppt1xGQQPnSIRjFAHq93+0h47sgBe2HhiJ8EmP7NOWGD6edUP/AA0z43EPnPYeGli6ZNrPnPpjzq8ggttOlTzHkubq6zzt+4fXJqZNJvLtoYbOzledzgMRhWGeMetAHrMH7THjiQKW0/w4oPb7JOT+Xn1bh/aK8f3EzJBpfh5hnCk2c4Lf+R682i0loLMOYSXXKuSvJ7cenNOsrCeO6Xz2cLnd5cTYLH39PegD0ST9o7x5FkS6f4aVxkFPss+R/wCR6NT/AGiviHp9lDcz6T4bCyZO0204YD+9jzulcl9jeygkeSKG3YtuVXAZl9NtY9xbNeTobmEKpJy0xzuGDk//AFqAOub9qnxwP+YX4b/8B5//AI9Sf8NV+OP+gV4b/wDAef8A+PV4prumNpt35YcSQON0cq9CD2+orLIoA+mfBH7SvjHXvGmgaReab4fS21DULe0laKCYOEkkVSVJlIzgnGQa+uq/Nb4T/wDJU/Bv/Yasv/R6V+lNAHgH7a3/ACSzSv8AsNRf+iJ68r0/9oDRR4T0DRNe+HGna2ukWcVpFLe3SSDKRqhZVaBtu7aDgH8TXqn7a3/JLNK/7DUX/oieviqgD3bx/wDHqy8TfDe/8H6X4Lt9EtLnywjW94pSHZKknEaxKOduOo65rwmiigAooooAKKKKACrNnbtdXEcSDljUCjJAweemK3NPt5LYpJEQJRwwPc+lAFmJYoJ0WMPEy4x7+tdA0UT4aOMqoGWPZj61iXnni5VnQh3IZhj5SK1LZzGRJHt2lc7d2Qfw9aAGQ6oYA0EUzKrkFg3IOKtHUFeZhcEOsg2YCjA96ybh8yuJbYLGTkhDx9aCJXZmR/3e0ZbFAHQ2N1LZkCBVkiYbTG/zDA64HardrJDeqIC0lnPu+WaPjcD6+w9q58iW3hjlMqyRjg9Rz6Vr6FCms6pa2kYKJIcEu2W8rGZPoQoJBHPFJuybE3ZXNW78L60ulQ3UQuXtHPnLJEAxiHGGwMkZHPzAda52+kZEeK7d1LyeZ5bxcye+etbg1d7jWHvrIta3kpyrxTMh8oDaqZH+yBknrVufxRd6ptTXLGz1Bw2FmmiEcgXqAXTDAZ496xUqkVdq5mnNLa5zhnuIjEscskELLtQIMgn3FbOoatM1kqyaaiFxgPGhRdo/iA9a2Zv7A1VFSYahpV0ZTlyonCoPujsQoP1JFPXw/Lf29rDDq1pckKUjHmNGd3PybWGORyOapVl10GqiMiC/S8aCGSZZ3EZRRcx52nOefapBaaM7rLNaRRpD+6ymDvJ74JxTpvDHiyEtK+kTLGyiLeNjux7bgpPFVP7IvrCW2juNP1EvKjFC0JIQ92245WqVSL2Y+dE8fg2wunkkWJrVoziPOXR8+hHf60w+EILlJ/M1AWs0I/eI+RkfUdK2bYXd2kMUlh5YVtxuVR0JwOm3pioXivbicfaoJIbbaW/cQtyB0JbGTT5l3KvHuYM/hLToLdWW/mLKPmEaYwD3x6e9RaZoOjySiOS2vJowcO6ON5/OtkG+mvPkt5pljG85jbDjt26itEaZ4g2LJ9gDiRC2Le3ON3+0em6hyiuoOSRy8OkZ1SRNPt1so/uJ5iAMQB1+tRWXhia8ki+06uYod+0ylMtn3roDpmtebCkggglnAMj3FxFG0YP3coWyq46nFbI09EsIFmv9KMKSZ224a5JUfxADGMnoD3xziplVgvMj2iONk8ARRvHHNfwOsjlmVpMsU7Ngc1PF4es4djNBLdOgDOJDnP8AiK6GO40uxs5pYLWRrhY2ZVv59hLHooVMscDk89TTdL8Ratf39lHLLa2mlH5bgBVjVgwwA7csQvBAPp71PtJNNpbA5vdIoQWiRB45kghZThCEJC45I49c96lCSNsd7qZmKlYhAAmznuD7VLpNj/ZV9cL/AKTLIlwyyvKwxIVPzFh0BPp71YluITPJMkMl1dSN5qqeGiXPbHFappq5otSlPpsSFdtxIs0nMhk449TVaaXzbkx2nlyi4KhSn3WA67u9NuTPvkZlkspnOMSNudlbov1Iqj8+nosdtc/6QwKKEHK+xpga39nqXmS0SW8iUjzpV4Ct9T/D6VRutKmmM32dWKxRnBVgQv1NV0vzETHK3miMqXiJKpK46Zx6VHdaqTNI1wsCpL93yWKhW/xoAr3tiupWk2lNH5UCHfFK38EuOXPseh/CvMrqJoZniddrodpHoa7e61O7ln2eYCpbGT8hye5xWBrNkiKTDI0rx/61mPLf/qoAu/Cf/kqfg3/sNWX/AKPSv0pr81/hT/yVXwd/2GbL/wBHpX6UUAeAftrf8ks0r/sNRf8AoieviqvtX9tb/klmlf8AYai/9ET18VUAFFFFABRRRQAUoFAGTirdlatcO2EZo0wXK9hnFAGloFjvja5lBZAdiqOoz3PtW99lAgEhj4P8QPK898dqW1i8iNY4lUK2FYt0I961fONorK4AYgIcYzt+negCnqc1p9jNuN3yLwd3B/2ge+DWHbJIMRxOQeCC5xuzWs/lNP5KFVAyCnUqD3Ge1VtQhbT4REGM1nJyGkjHHupoArSPdLOY5k8t1H3l+YNU0IVEUzxsCWJYKflI/pVeC3VI/NWVZI8jZtJxWg2LVikUoaOUfPnkn2zQBVYMu1FljzkAEtwB6mtjSk+w6Rqd++6OeV1sIplOGUsN8jj/AIAAuRyNw9ayHVB5zyIGiUZ8wHlQPatfxCJLM6dpcLZezgxITg4lkxJID6/eUZ64AHaokr2j3/Il6uxSivMSsyDKcjeOGP09Kt2simDzJ2l3P0wNyk9sms6WbzbePEfzg87RyRT4NQWOQltxRfuIDxn1Iq+7XUo2y9zeTxx5cybcEMeSvbPsKhkvriKf/VjcW2Mm8hQR/ECOhqCz1NpGE0kIndfvBDtKjtTZbmFrqSWcPFCxH7vPP1+tKwPU37bXLi1gIe4ukdWDqI5PMGfXB71qyeNtYhCwW2oPHASWwU2OpI557VxipD5cgZy6N8yoeML2z708SyeSxTH3MEtztUHpS5I9ieVHZN4kuykRfVL6OQYBUyHG3sc56+9LFrlzLJshv72Ji+8+bdElD65zjHtXKmUSrNHCkaeXjGSQCPoetR3EvmTrEwVGRMPjgDil7OPb8g5V2OruPE+qO+6bWbjz3lCyQRuVUr/eznpVW51uS6u98l3PdSwofKjkkO3PfAJ5+tcsJAyf6pPlXYHdc456moghMyQ+eNyjKyKoCpx1BoUIroHKuiOvTVTLa3EX2PTPIkwHHkLubnjDnp3zVS4kmmJFgEjSCTeiqd7E4xnPceg7VzMEUkkTJNLIu1tsZVOnqfxq7YG4MLyCV3MahcfdCjPXjnFUklsitjWklSa4jlvp4UfPIjTMme5PvSyxWjzE5mbrtf27kj+8ap29nKUJiimlkbLh0IYsPYVOVaICJI1II5DkAk+9Ve+jDc1Nc1C6lXSZT5iwXdusm0D5fMT924984Uk+prEv2CTyTRBY42GActxWpJNNceHbmK6DI9my3CKrc+W5Ebg+wOwhR/eJNc9d3yRPtVtyZxtds8HrWVPblFBtaEtxqlxJtkN1JJOgwHKck+1UpZvlXBMcjE4YNu5/xqrqd6JAI4YikS9ACcE1m7neRG3u4TkLjbg1oM0PNkijdZXLKzZ29z9ajnmj25UFhgcYxzVeSN51Zhn2G4bjT/KYHDHCnG5T2PpQARsWKFFVXJJ3f3fw71WceZLsiwR03Pxv9TVg2c75KqYmYkFfQfWiaOOKMRMwdFB2lRkk+1AFn4bWwt/iz4QVXDAa3ZjjsfPTg1+j1fnR8NIdvxM8Hs4feNasuccZ89OtfovQB4B+2t/ySzSv+w1F/wCiJ6+Kq+1f21v+SWaV/wBhqL/0RPXxVQAUUUUAFLSU5Rz7UAOhQvIqLyzcCuu0bSriNVbIe3TO/aeMnqQe4xVjwdpLRj7W0YeSRCBE3Xyj1I966y1W3spIdreXZkblCjIx7+hoAyo7dYi6RBjGV2oWGcDrTY44rnEJV4F67tu7HuO/4VrXQldoriGQKwJVY35BHrn6VHdQxCVTbpFGs4zHhsMp/wAc0AZC2itlBPE0iHCsmMt6Zz0qvcWz3MDJIHxEc+RIDkfT/ZrcS2tmYJIsXnbSsjn5VI9vfNZ96ZPIjWQySvG+1ZEOGKfX2oAzbBJhGAI18t8jCDOw+oqw0SocXT5bqAi8fWpLJmtnaOGV5oywZVdfmPv7mlneaSdZyV/efIHPBxQA7wxbW51u3uJkX7LbBr2Y4ygEfIV89mJVf+BVn3Bu76+aSZh9omdpJld8Ozk8k/55rdS1a28PSLcbVbUZtxDSAhoIs4YemXOBjspz2qhPZxIqDcXYjPm4+Y+mT7dKzh703Ile9JsguYmhuQoVC4T7pJKgf41WSNSxaRSA64BAwaQs0e9bd5D5vPzNgLinvIkUcQSN2dj8zOcA1oURQwxEOIR8qfeYsckjp0p0akyo80kPzYfa3XPbHvUbTxkhfnSTdlE65z3Jq3E67lJCx7eXDJuLn/CgBZFyZW8tsN/CHBJ9T64p9uskDKyTKBjCvnbuHv71UuVkKDeUPOVKHHX0Ht6U+Ir5TCZ1dFHDM2cD6UAWppo9gJR1YfMxPIP+NEs8ZVVdVZ+xHOz/AHz3/pVMSQ+WVEbMpO5STyD2zntRLIPLjDQ/vA2QIwQMe/rQBaa4i8sp5QE68oASQx9fyqvHcs0WZLdDFuBX0ao70mSQLC0kZx8rlcAH/CqkbKgbmYNkYV+n0FAG4upm2mlBjDNKu4M3TPYCq48S6ijyRwwW7Rhdjq6kn8xWabs/M+1EVQQ7NzuPYY7fWokjna4eVXMasozjnH4104V0VN+3+EznzW902YPFksDLHKgtmX7oQZ2nsQ3aqs2uLLEYkYyBckkLtyTnP+NYl3kSvHK6yHHUD+tXrTTb62sGvohC1q2FYg5b8B1rtxGApumqtB6DpVowkvam/wCFbl4NWs49SchLhTa3Ds4yI5Btz9RkHPoDVSSJ4LiaCWMfbIiUkQqdvB657H27jmsWS+QZEjP5nvH1Pb8q6TWZHu5bfVgSsWoW6ySsPmxcL8jr7sSAxPbfivInCVKouZFvWTmtjMkwXjaEIx3ZP+xntUcrGNi0oBBOSY+SMdjVhCsYCkAXBOS6ngfhTEiUQs+4BeS0hXj6U7AU12lZDsKEkHCd8+nvUsSIboqSxiAzgnpUYdy2GVlyOMLzj1rQgijmlAz+7GFIOCTjvQAtykczIkcgyBnAB2k/XvVHULeZHUoSxOASOg+lakU6OCrhB5ZKqY1+6Kp3UEckTeRvbLDOThPwoA1fh+CfiR4RVcgR6zYk7up/0iOv0Ir8+Ph0Jz8QfCjOg8r+2rEAj2uI6/QegDwD9tb/AJJZpX/Yai/9ET18VV9q/trf8ks0r/sNRf8AoieviqgAoopaAADit7wto76peBmaMQQkFt/Rj6Y71lWNrJeXUVvFje5wCTgD1Jr0GDTZNPtYwkDRwwEHzQchj/eP1oA2AdxjnlRY51O18N+Ax7e3ardh59pdvIYoJvNGXgfDAZ7j0FUrFYbyBRDPL5qDIidCcj2arO69cwlo1jKfKw4YqPQ4oAfa2ss17cBCpttwaSHHAB43KagudKsnmSOKNmjJ4m3fK59COxq9Yyy29hcR3IxEp4kXknHIzUh1KObSpRdxobjcoWSIbSB2OKAMea3jR0MLo6HMed3zqfTHtVKeBbaIuJn3M2fM2HjB5FWbuMQ3CyH98CTlg238eajERnlUIJBbIud3mfmSKAM/Nw00jwhAoX5WiTgDvU6nfHAqIyPwsSMcbmJwMD0yR9Kt39lHJ5ZtpPLXd8q7shjWjoOyGO+1eaOQXNguUBYACVvki2Z7gkkj/Z96io+WNxS0V0Z2vyWp1VYLKRHhtkW1jZlyo2D52UerOSSRwetZl6VEI8ppETdlgzZGf9mrKosVopIxHGdj4GPNPqcdx+WOKkFurQbbp4ApOVOeR6ZqorljYSWhRVVMgMrkbCMBRtUsalkSOW3mQXEqyM/zK4DD6inT272l0y3Mnm4CnDHcVB9Pao5XMLMzEyB8jehA+mBTKM6TFuwBjUuvDbRgj3qfz5I7bzZXRpX+6zofnH9PrTZRkY2MWJyFcfMR6gip5AJYWZmXzE6Ltxx6ZoArSnzVbbEpIIxhv9X6kVUijVWJQgrkk9ORV37MmwmUskknTJzmiQIsSK/l7h8pHTigCvK7yRYUZyACmOQKWKdFhUB3V8HkD7//AOqiRUkf5S7Kp2hlPT8afPDJGUjhEjyP9wAUB6lW4b/RgXupFYHBBXqaSWOaXb0ix39fpV26ieFAszhiBzIRkA+n1qm0sgXhiPVXX7w9jQFypKrtJ5cm4g8koTj8av2q3DsizJtjYfe6EDtx6UiXL7jwEROHJXqD0p8IkW53TqxEQGXLAYU9MUARSWvnfu9i7Qf4hggfWmW0V7aPIluyvE55TzMHHvmr90RdXUDW4kCBRlgeD9RTniMrEopfa3C45aumjiqlHWDInTjNWkjHuYJ7yYL5aR8cEnIPtkd66Czt5W8JT29xJ+9024WZVQk4hl4YHsoDhTnqc4qufMDqqB0x/cxtX3roNCUXOpwWr7WtLuFrF0RNzOZOAzA9cNtIz0PNTisVPEJOe6JVPkjZGDZrHLIBKrB0G4DIBJ9DULs89xtW3Mbrnqdyn8KsW9usNwyyuY2UtCSDuOVJBwe/IPtVgqgLFCSAMkZy/wCIrnUrrU1MwxzCF2lYluAdp5B/wqG4kWR/L+6doA8odABzmrpttjxt5pJzvkUqQEHbPr9BTMDzJGXzA0i/LsXAx70wHWsvl222GBlQDc2eS+ar3DJLB80Zh28kK3X61baMwxRPKyl2G0ocnaO2PemXMkI3BWcyKudr45oA0/h8Y28e+D28yUz/ANt2W4Hpj7RH+lfoJX59/D5VPxB8JMciUazY7l7KPtEeK/QSgDwD9tb/AJJZpX/Yai/9ET18VV9q/trf8ks0r/sNRf8AoieviqgAp646ntSJ1rpvB+lG5nF7JErwwv8AJEf+Wjf4CgDa8N6BcWlgJmi3GdQXOVOF6gD+tdbDJHLKsLmeKNIuCg6fUd6ryQmC73L5ojKb/LZcc0RZWaGSUOWkPLoeFoA02uks5SYFW7aKMBZYzg4zwcfXg1Xe5u7y4W8t0Q/aGzKqDaVYduehprSpMzC2keCODJLBBuz6kelOluFluUS5kxE6g/aIkyjN/tD1oAatzZ3U9wpnIGf9U6gFj70y3ttiymRZYpn4KEDaR7VZP2Jkci1Pm9FZeGYjuBVSJxcJIv2iUSIhPlsM59vY0ALFpEaOJkuhPBjdMpHCfhUkkVnEWNqFZBzjB+cew9asWERtfKE6tGki7twPQe9PmsUe2DrI0dzGcsix5VvRgaAMK7jje2kgiASaFsykHC47bf61emT7NpWn2FyscxuCLyUKckE/LGg9yvzZPB3D0qaOxnu9Rtbd0W3dmw5OMOByx/2cLk+9QXd+LrVri4tYk8sgeXGDs2wrwqj+7xzj1JrOfvTS7akvWSRRmiaIMsVqFIbyyzH5R6E/hQ9ukszecUZR9846/T1FSPs+zs9wpK5yUHJjzTsCN44pZI7hdm6OCNeSPXNaFEDadMywOYi754kX+Mdhis6+tLhcssZaMPkoqYbNbFnLPk5RCo6rlgVHoKa1xdx3DmNgY5CM+ackH/ZPagDK8lGnCtK6MVyS3IHt9agUfZ1lhcHYWByeavzusUU4lVlLHAH973FczrCXEzylZNkcTEAKfvDFCaTXM7I1o0KlZtQV7HR21h5to8jK7xZ2k5+ZfQgelVr2BYUx5WXyNpbrtPfFczoksxvkgFy8EcnDknhfeuouZY0dCZYpSq/fbkt+HpWlWmqcrJ3MrNbkMdvF5TJJtVwxIZW61Bd3Sx2sced+DhADhgR1yfSr1qXkR5C0PltwWVBx9KrCC1kePDb4yMF5QRk+1ZO/Quny8y51dGSFleYspbOf72QK0fKjWV3kRpHQ4Pz5H5UsqqrCGJEWJF2h1Uncff3qQWZUBAxLdfmPK/hUwjy7m2KqqpJcqSSICnJI3GAjDKwwV9j/AEqRB5kTEs3mdCWAGVqe5tpcQkqPKkbDhWyW9xmnR6cQqRyFzDJxvLbcDPU+pqzmGPaeXdpHFIm5iPmRyTjHp0p8FnIjSNOSVIPUYDHPUY71pyr5GGhuAEjGMFPnwahtmGxWGwnBBBcZHvigBgVbaFlG+RpR0T+E+4qs0BeFkgmeOTbyADkH2FX4zbwwSEhZJjyrFuT/AIUllemOIvPGol342uufzNJ6oCxrG641aC+X92uoWy3JLHcEY/LIv+zhlJA9GBrMmZ2uFg+RvLHy+WmM++e/41q3SjUPDk/lzYksrjO1eN0U+Pmx7OvJ7CqNkz2MJVGcschuNyH2z1qaezTJiymyzmSOGUfO53CE9/8Aa9qc+4NIkaMCp5ycgUeZHNPzEFUnl1zgj0FThYnDSSR/KxyQW+QAdvWrKKLRtNIuSQo5+Uc8Ulzaw/Z1uJHHmg42Dg59SKe8jXcTpbxONp5IOMj0pb0xRRqI0Kuw2x5OeR1oA0fh/HKfH3hd9w2rrNhvAUjn7THjNff1fn/4GvUf4geD7dQCw1qxBZWPP+kJ1r9AKAPAP21v+SWaV/2Gov8A0RPXxWBmvtT9tX/klmlf9hqL/wBET18XRqS42DccgAepoAu6Hp0mo6jHbJwG5kP91e5r1FUhkkhtrfy4RAgWIgY2gdMnv9azPD2kpp+mZWRluW+eWVMHaw/gIq1aGSeNptgfdywU4agDWkE4tvNupy8qcZHO33x3+lRF9lhDPbqsbgkOm0qCPbPektSbJ2WLzt7DcGb51PtVnzYPtDwCSRIbgbgRghD34PvQBNNbWt3p9tIk80M4JOHwN2OxI6iuU1O5fT0ebT4ykLn50P3c9yD2rofssdt5jNIXnj+ZSp4x7jvVPWTLc2CpHb5gkA3KiZVj647GgCHw7rmm38a2sty1rKqkiWU42t7HoQa3tPsZpEuZoGknQsCpiYMJMdc4+79TXkl1/o1ydsTqRxtkHH0ArR8Ma/faJqQu9Onnt7lTlWjOAh+h4P0PFAHol3BLNI6WKShP+eczEkE/w4qxc6aF0iL7D53n7jHKkcm4o3cY64qlq/xam1iKOTWtEs4brcC97YDypJWHdxnBp0fjHRdVnLzZ0qZE3m8CbWZh7jjJo8wTXU29Cv7qz064MkUE7qggtxdYXLsCXAb1CjPOOtYeoW6usTS2kce5twRWP3c85WtfXruxeKDTZ9X0+yaGFXk+0t8zTMNzZXs2CBzXCeIPEptrpoIFjuDFlBLFPujZCBtZT1z1yD0qsPhqlW8oIhO2p0GoXkMd1t2w73XbvjJCsvYEVRt5DMzxwws10p2oA+So65+lZ+ma4dWmtopWis4ghJu5B1cD7pI7VpXF7crBGkulW5s2OV1CzyC3r8wqdLuPVG0qUoKLa0aJIYbq6g/0teSSCkfyk471SaN13RRrK6Dv1Kn0NMu5pJ7eMLI7ODkAvyw7c1g3WvXkkzR2bFZlG1pWUblHoP8AGtaVKVaShHczckldm+kcbXAe4WMxqMKpY5A9CK5zVJGS7leRQ0E7ExeUcjHYfWs14p/O80zSmTrvLHNSafcXRu4YQfnJwnYA+v1rrxOUTpQ556o1wmOdKXNTZbsNPkmCXRITbJ8qOvLYrYt4Z3xugRSeNu0Emudnu7yy1DEsheRDkqzbs1Zm8XX0zKAIUKdBsx+teda2gVqrqu7OjuI4UtSJgsbDgxbTx+PY1T3WkkmDN5RVchZVJJqlY+IZGP8AphWSJ+SQop3nrNMyxzqsQ5RDgkmmZlyIskLKJpowfuBBkGkjcxqY5UJI5y3Vj9f6UWsE1yWQTDtnLjCirv2YxyBILZmUA53tkE+uaAIIo45Mrc3UsKPzsIBIx2AHrSK0XmKU/h5jRwcn602CAoftE6tvU7QFBDH6n0qxA0MM7yS7TLjOd24LQAqxGeVCUZZWGTubhF71dGixSkbJrZd4/wBerY+UevvUk97DNGJL+4xG52jy0BTHptHSnW9zpu7y41IGRtBQhfrz2oApRRpDbTzGCNmZtrSucj8BSw2siuhV1KYwQB8vPrWnBbzajLJLa2W506yKhYkf7KipLjTLy3tvMnhf7MT/AKxht/DNCdtQH+G2Mt7JHN5SQ3cL2bsrY+Y8qeOThgOB1rEUzJIDtKBD5ckRTBJHG0gdMU6W+itLzfLbRzShQYdhxyD8uP8Ab96n8V6nN9sF1bwRxWV/Ct0hB2nLZDjPXG8N9eaz+GfqTs7Ir3iJ5saq54GRuYfL+FE39nQw+Zc3azSkYMSnGPyrmkkhjuHZy77hnamefx7VZ0+D7XMBZ6eZXxuMjPhY/wD69aFF+yjk1aYQ2UFzI8fRU6Y9M1WvNONujDUrlIQCcIpywNOl15tJgmgW/aOXBB+zYOc9ia425uWuZPMdmIByN3J/E96AO2+Hc8TfEXwgkZWT/idWWGzyv+kJwa/Qyvzc+Fbf8XS8HDP/ADGrL8f36V+kdAHgH7av/JLNK/7DMX/oievlTwlaRq7XdyGDKv7kbcg+rexFfXn7WdjFqXgbQLS4lEUUuuRAsf8Ar3uDj8cY/GvmzURJZzxxTRJF5QwHj9PpQBOrTzFUQ5Q/N6Ej196ebSYIPse5lA+dU649/SolnkiVSS727cFgvT/CtSyge3d3yJJGXgDgkfXoaAC0hmu441HzSY3AMuDn61HYvIZpFfyjH/tpgoasRQNesI44pHkA6I+wqfT3qxa22JG8uCUywjMiSABwPUf3h9KAGiCMTec0hMgGWAwR+Kmi0e5igkWFMozEsY3GCvfjtVu+u4NVKM9vbmWLC7wSrMP61l3bwiM3CboV3bcjJAx3oA4DxJKkmqSPG5dC33WGCtZBcOJcnKMOp61qeIp1utSPlqu7qzrwH/CsckrIQ2U9CRkUAAVIkDZO04+bBP6Vv+E4hLrdt9pfNjAGvJiFGWSIbzgHgk4Ax3zishF84qZJMKAceX2/A1sW+3T/AAfcNJjz9SuBbR5JGIYiGfH+yXKgg/3RjvSltYmT6FNtShu76Wa/s4boSuZpCjFGBYkkA+nOADWzPB4a1q4tYtHlfw+ShMy6hK0sRPqrAZH41y02HePCy7HznaM9KhWTe58zdg8Z7Gt6VepR/huw+VLRo6SJW0qd7G58pmQ/fRtyuD0YHoQRWtC9+tmsFhfTRQcsIVf5OevFcXHJMiCLzVyv3VP9PStHTdUlt3CyHGK8vEUZpupTep9Vl+ZUa0FhsSlZbFm9W4sYmEsGyRhgSoeTn9Ko6cnkyfey7deea9S8PwWXiLSWjuApI4GeD9a5rxZ4Ok0K7aazWSexkOUcjJQeh/WvR4dzag68qGIVp9zzOI8shhoKrRd4sxpYf3W/IxisRn2XkUnGAwHPQe9bM7vJbiNRjHNY88RGQ/Q19i6cp0nA+Twz5Xdmjd2SXIby7ZmkBwZd3X3rLbSZl5WSInONjttYH6HrRbSi3WRZGkVGHysh5BrXsreO4tt0pLM3JJ5NfG42LwcuWS0PpctwLx83FO1kYJsrpnCGPJ7c/LTJIHgO1sCQc8GtzULQQw7oWI9BmsKcyCTD/exWNKoqiuicdgpYKfJNk9rfNHIj7AzJ/ePFaUXiO5HmCPYC3IyPu/0rAYl/lbp7UhOOCMfUVocR0yeMdVSMfv4pOcKGjHT0qSHxhchh59rbS4PIEePwNcuZCVCgDjoacgLj5WOe5x3oA7iTx9NIsf8AxLdMiXfyixdce9XP+FlTtYtHHpNiu/gtsyfwz0HtXneQGw4AIqWFJHyDIsajpk8flQB6ppHxg8S6PC8WmLY2/nKVaTyFL49BnpXFal4o1LUZXW/ubi4i3bvJLlYwfoKxCHi3s/zE9WzgY9qXf5kWAg4H8RwaANoeJJYbcLDaWqA/KGYbialkmm1Lwd5x3tPpt6UZlHCRTDIyf99MKB05rm5VBKbQffjgVu+EMXWoz6Y4BTUoHtgOAfMxujIJ4B3ADPoSB1qZd+wn3MM3cyq6mQhT/d60xrq6WPyxPMqEZYButRkEHLYB75WiRy5yTkgdhVDWwgzjgflTeQOu4k420qhiMqDj6U+NAzDedoJwT6UAdJ8KwB8UfB23HOs2WR6fv0r9JK/N/wCFpx8U/CKjlRrNkAcdf9ISv0goA8R/a1Ct4D0MOAV/tlMg/wDXtcV8yRXBQyRN5TIBjL8sPcV9N/taKG8CaGCcf8TlP/Sa4r5cMKeYn73CgcA9R9aAN61aS2jWdBHLGRtdVPBH41rl7aKy4jwh5DAnK+oP+Nc1bxgwyKgZlA5ZeQK1NK8h4StzcyiTA2I5yD/n0oA0LW6MECzyFPKbiKXbjB96n2yXFtHcu7ecjbWyQCB/ntUBltcGOV28k8CNhgA+oq/DJ50CWluI7l14+YYJHofegChNcWyTYgWD5xy8mUbPpXM+JtQOmwvDAAFc5256evNdP4it1WxUsTBOhz5b4ZU9q8z1zzbiZnCpGv8AEEbKsfUZoAoyLJcgyLGDt53E849KY8kJQHYXbpy2MD6U9w0kKA7XZe5OePSmTZ27pbQbOm5TzQAQxzSTQxWtu3nSMI4+eWzwox9TW54rKx6pFbwmP7Np0CWULuOGZMmTtn75fGeQOO1M8GK1ld3GsOUeDTYWlAkG5XmI2xR4PXLHPHIwT2rIzNIFMgXzc7jISd2eeeeuTzmp3d10J3dyCFonYGVzHkllZTgA1FHtk4YqpzkluhpX3xbmni3GTucYPvVi02IwaSKLBHAJziqKI2VmthuAc9AccqPqKiVJNhYMhx/DnmpmC/M2GCZx8hyDUyI7x5UIu3opGSfegDQ0PWLrTnHkOXRcErXd6n408/QpDaOsdwU2EN8wIP3uPX3rgrTTPtUqKSYy3PzHAzV2Lw5MJJI5pPL5xmXgVxVsDTqVFWS95O57GHziUKEqFePPFqxn2138gUdT94dxU1xEsgDLk8ZqS90a6icPBFHMIxtYxMNzf7WKbZzBoyO44PtX32GxCrQU09T5TE0vZSvEypYsttap7G4eJ/Ik6VYuIS0hIA+tVJ0KOsmT8hFYZnhIYrDuXVbHoZZjpUK0ZRej3Oom0iaW0DqDyAw+lZeq6ZcpbpJOokyOOMEV6FoF1aXumxtHIrFVCtz901JqdtayxZlkQr6V+XwzCpRqODR+mYjL6GOhecb32Z4pIrx53AqfpUJb5sk5rutf06288Lb4ZSM59K5bUbBoTkY2n0HSvco4qNVLoz5DMMlq4S8o6xRmk5OCMD1qVmBA8tdh9B296a204IySB0xU9ratKSMPj2FddjxRkCGZ+cA4/OnJCwyzE4HTPFbCQRRxbBJtlxjD8YquYJPmAQs2ME5zmkU4ySu1oZjOfNUYwD05yPrUzN8p3Md4FST25tiCFbJHpnFPjhVm8xlyMYwaCSuu/aNnKk96nt2lt7iKS3ceejh0GOjLyD+YrYtbFJVTEYWMHI+U81vLosAhDli2fRR8o96LX0BmF4vt431172BWW01BRfR5OQvmDLDsNyvuBA47dq59QhBYSEc8ZHB969WbRtLfw1Zz3Qd1sZ2t8yZJdZPmVcD+EHcAO5Y1z+p2VvcJMIFi83O1RswAKiErq3YmL0OKlLmMdNvsMZqNiV2kjqOlatzplzHLskRfQLnnHrTW0uQKGyw+nAFWUaHwqVx8TvBxwdv9tWQz/wBt0r9Iq/Of4ZRsvxM8ImQHI1qyA5/6eEr9GKAPE/2sInn8D6FHGMu2spgf9u1xXzZBCzQSQXEWWB5OOV+pr6S/axnNt4H0GZVLFdaj4Hf/AEa4rw201TT7ywEjR7bhRhiBgr9R3oAyoLebTULQZaM/eGMipbCwiv0ZZBGrbs+Yh5/KoL+OT5pNPeWaHGQQeV9jUGkpfXBIt2Dr3j24YGgDXn0fVdIsW8/9/aOeGdcn2waa1xPZxRzPMWjIxJtPP4/Srttc6j5BitprgoB+8jb5sfQVQu3kvi0LQkSoeHK4z+HegCtqkk13Yyz2yO8IxuJyRiuBljMsrq0THI+YhsD8q9AshqGnO1nIFVJefLLfeB6c+lcbqtlcW97OHiEbbiSBzigDKiVFDpFDweCCeR70+CNlV40bbIR8u7kN9fSmwh0lJYRs3YOP5Vd0mylv9WtrEJ/x9SeXvUZKr1ZsewyefSgOly/cg2vhe1t8H7TqD/2hcMOMxrlIh/30Hb2z7isDd5oRFR93/PMH5T9K2fEtxBf6tPPbMrWy4ht/LbpEg2pnPsOfXNZMEbKwCbgO+RkZqYbXFHYiD7HEaE5H3o26ClKmZGZULFRkgrjNBmdJGAVXUE5U9voalWONFXdNlieFGeBVDGWUaFSAxAPYd/wrp7OytfJiDKd5HIc/dHvWNYWqC4DIcbj1U8/hXVizjbTiZ2YynhDu5/GgARPs1sW+z28qsdu3JIx61DIrPGQryEj17fnVNbSTzTHmSMAZ5bK5rW0uzhEDebAocdXZjzR6AUp4gtuqH7RHImCXUdPx9PauVumliu5ZGB2M3U9TXea1bxNYAxuiNn5ljlPI+lcVdeXHcYlYuj5+Zh09q6MNip4apzxJlBSVmS29ysiDFOmQNzgYPasg5tyHibdFnHNasEgkAAPPpX1mHrQxEOen8zzKtF0ndEVtd3enu/2O5aNH+8AOtObXLsNidixPTBqaeEMoOOaz7i24JFcWJynC4pOSglI9LB5ziaCSjN2LyX7hiJwc4z1zVa5ulmJd2XYBj61UVmt2JXO1lwacjI8YAjZv0r5qtlrwtTVHq1M6xGIpOnJlHiScnGB2ArQtojGWYsgbbnlsGmSWJOHZfJj9SaYwjI+UlgOpOBmpezPPg/eUr7HQW9qhgWQrksM5POahuLdYUZyMox+7npVzS5PNtoySCMYqTUSht5EwOma8eNWUah+iVcLQr4XVact0cxO4aWQrkwLxxwTV3SPLlnWNIlfH8OeTWdI5lwRuLDgA9K39BlhWT5ljQhepOefoK9i9z85ejsd9okNrDZSPJbu2/wCVdyfKg9c/WrEBsHR4lOShO9ycLIfQYrG0+8+0KAsjMwGBHtO2qmt3k0scaefEu3I8tPlK/lQ9tAOq0m8jmvJ7DdHJ9ohMcaBekoy0an/a4OP972rn1vFuUEsabN4PzHhR9PX61jpdJbT27QyyrLERIoBKoxBycnr25+ta2vwrBrtxLATJDchbi2jDY+SRQ2cDgLyQB2xzULSdu5MVZ27lc229xycDpsH9azL6zjG5rmfywDwTkn6YFaUj3BUKtykTn+BRuNZdxMybopzIuT95u5+gqyi38PrZR8RfCcsYfy/7asTlh1P2iOv0Gr4D8BQunj3wqAkoRNZsfvDA/wCPmOvvygDxT9q0I3gnQFkwFOtIMnoP9GuK+cNUhRYlKgLKOA3Yj39a+hf2wZZYfh1o0kAUyDWY8Bun/HvcV816eJ7m0BL7JB/C3IoANNuYllzKzwSg9DnBHrXYRwumy5tp4VkYfI6tgN7VzFzaNcfvldDcKoVlk4B96NKu9S0C68+1ceU42vDIu+Nx3Ht+FAHST3Nz5rvqMRhkx8lzCcAf7w701dRjuI4Uv5FDg4S4BID/AFPasyXxBFqF1IIIFhH8cBOQB6CpdJ1BtNd5LKO3uI5DzBOm4f8A1qAOultmubYwzmA+SNyuU3MOOqt/dxXHeK9EikU3FpKokX76lvvV2vhjVbG4tXjeFIpEOY4y22VD/sk8MAazbzzby980RgsSVYtH9/1OPX6U1qB4xLDvkeSGN0RgV2kZz/hWzoYSx0/VNVi3eZEn2OBGHzCWUEFs+iqGOQcglR0NbviXQ41ikuIoJok3EHcCpJxngfSsPX1NnY6Zo67ldIRfXAJwzTyrkfgI9gGPU55rObT90l66HOtKUAAHlx9GCjofxp21olDI7YH8PRqaRKfk3FhjB3DtUqWyhcRyEjqUB6fSrKI9sjtmYEg9yMfL9RQSuQsSqzHoc9KkkupfLCI/7vsQOfoaiTHkt5a4kPLbj/KgC/YMdyblVRnBwORXc2lzGbbaAoKrnL9684hDpcKmGIxkkmt2G+RYtv2aSZQPmYHJFAGxcNFPteOQxN7YYfTNOBRYyrtKzyHBymAa5xL4xg4V2UdFIxV+31tY1YDe5K/LtGcUAak7S2lsxisJHGPvDnFcZqUgeZjIWTB4DLjNad3qFzLkx3Dgj+8SCKwbiVpCWkm3sDnJFGwFmKVJE8vEbA8ZxSeYsFwoiLAjhgegNUg249Spx1qSTcQArALnqwOa6MNiXhpp9CJQ51Y6BJC6A8U9og681hWs7JNtY8DvW7FMrRgjk19VSqxrQVSm9Dya1GVJlKe3DZCjrVVFktHDKcrnJU1q4B5PFRTRK4461pUhCsuWpsVTrOOhqeHbXT9fvxb6lfPZxEYRkUZz754rYu/Ag+xyNpzqXiyfMncBXA9MetcOVSG4STy87Tkjsa9a8Naj/wAJXoYt3RIp7b5VCnGUx6V8dm2DxOXU5V6XvRb18vM9qnUoY3EUKdV+zgt338n/AJnmjLPpsnlSbM4zgHpWbd6g0pwcBT15612HiLQHt77yzmRM43Y7+lcnqlk0NyYvukenUV5GFqUqzUurPq82pYqhSfsp/u76LrYzhuyR0U/pWlp26HLLJtHrjms4RyKxwrD3arcXyhVZ+W9K9I+Saa3OmsppZIsRqMdC+Tt+prSwrgfaQhjUZygwM+uetYFjJDFCVcptU5OG4z6VorepOoVNgx0QKcP9aBFpIrV3FwxZkXIRU+Yj6VuwxR32hafLGViazle0cTHaWVv3i9PT5sn3AFYcF1AjL5rxxKvWGFCc/jV7QJxqMuo2EEPlJdwZRmb/AJaxkum49iRuHHXIFZ1NlLsTLa4/Aedls4ERVHLLksfzpkUKO7GWRHUcnC5NJpUo8p5HjVz225BHsfSg3So2CwEbcukeMEema0vfUo2vCSWyeKfDjWysN2taeDuOT/x9RdB2r7ar4b8KXKy+NPC4QoqHWrD5F5bP2mPrX3JQB4Z+19z8PNFHXOtRj/yXuK+YrZ1g2mVpYkPyjbyD/hX1F+1qiSeA9DWUEodaTOP+va4r5gVUUEb9+PuuB1/CgDUtbmGOaEErK5b5WY4/Cuqlsbi+hlhiWB9w6BcP9Mf1FchC/wDo+2eAbm+5kcH8fWrtpfXNo0UkyuzxsCpzhj7D/GgCkdGhF0qWsvkXiNyknf1rVks5NyK+6Kc90AKn8a1pIINbuGuoriXzCgLKUG7PoaqWMYstQ23vmJbtwSnOw0AZ0NkJ7zyW3pdryoPBY+orUi1S7gxb3k+1AcATDawb61rXV3p946xXW1lT5ftKcbh7jsaq+INPSKwDWupR31tIQuydQXX6NQBJp9zc39/b2+oKHsw3mzBzlWRfmJJ7L059TXOeKfDt5eXFxqnlYlmLSOv3mYHrn0PQcY6Vq6Nd3lhoN0VMNx9pmNtFuGQqKu6T65yq5/Cksb9EuAt+U4GMOx6f3ayjrLmJWrueTzwyxzughbf6YqKQxSYeFjG6/fWvUdY06y1Lc+nlNxz/AKtvnBrgNc0jULCRo7u1/dMcrKOuMdTWpRhzF8hWHlhz25FKirvAmIhIHDAEg/Wp3+Vo4zsTbwHY53VBNCwdtmTH6mgByyNvYN5me5XpWha3iMVCNtZe7YFYz7l++35GmCV1bC4Kjk8UAdfKzXSYk8hWUZ3A4JrMSe3gZ1aN2Zh97IrHW4kX7jMo9BzQZWIOfmLd6ALctwJMLGCPocVVbG4q4JUjFSRyZHKkH19KY+RlsN9Cc/jQBG+SxK5B/pViy2tcRrcb3iJA2q+CSfc8D8arZyMnK49+aaSQMEE/TpQOLs0z1HUfh0/9mR/Z08nVjh2gaffhCM59P1rh5TJp0zQuVdlOCAeR+FdP8PtUaa5XTjuzj5WLcsB/npXqP/CO6LLEwbT7f7UyAyM8YDofasJ5jUyn33JzT6JCwtT+0MU8FVpqK3UvLordWzxeGRJYVkGAp6ZNPQZ5OPqK6fxVo9jdFoNOgsoZUOQxdkPvwAQfxrjLq7EOIiSWT5S3rX0+WZxSx9Pm+F9jPM8krYGpypNrvZoszRgDPBzVKeW4gdJLeRoyp3Ag96fDdq/y88etEzBwSO/avZcFOPLLU8ympU5amva+Lry8lxqsol2gBflAqzqWmm8EUybH80bgFIyK5GaDuOKsaNeSaZeLISWUDjPpXxmZZBPDydTDo+4yzP1OMcNiVdd2asqR2cyxSIrREdXONtRSWFmzg2N1H5r/AMDMDj8egqaTVLe/k5UBv50ySCEg4QV5McRUppRqLU7cRlFHFTdWhNWKBt2tnZViCjruRw24/SovtMqZAZlJ67uMe1XpLeMDKDafUcVQuYRsyJTu9Oua6IYhS0PIxWUVMOrp3HrfyyHBKbh0OSB+FatprE9leWt2kpDW7iVI1HLEHPX36fjXPQySxO4jdgcemdtSpPIFJV2LEZLn09q3aurdzx2rqx22rulprc0McgGnyN59usR+UxuN4wT1AzjJ9DVXUJonUok6J6EHpVaVlu/DGk3+Q0lnI2nSu/cY8yI+/BcAfwhcd6oRXMZKxo3mvjOQvWphtbsEXc6TwC8n/CwfCahhsOs2OSerD7THiv0Ar8/fAKzv8QfCTSIdo1qxbJ97iMV+gVWM8W/arAbwXoAMhi/4nSHeBnH+jXFfMDxq0rSCSMSDqyHAb8K+nv2rWCeCdBYruH9spx6/6NcV8s3TZkY7MKeMYHB96ANNLuJ7Vo5F8pyOin5WPr7GpBqgnMMWoW7yJGPlkQYf8+9ZkbyCAxXMEUhAyrr976GrFn5jxKEKMucfO23b60AbFrqcECSfMVAO1G+6T6Z9q7zRdWki8PP9q0vTNQtG/wBaVXEqHsc964WK3t44XW5jcsV4J5q3p2myTwlLASJ6jpn0+tAGh4m05Wt477TIl8t+R5bcr6gisC1uPN/cl42Y8bH+Vtx4AHbJPHStKynSyuTbara+XKD8jhiAfqDwa6W2trWWVLuayjBtFM0U4+Ul8YQKexLY5PpUylyxbFJ2Vyje6DY3UEcVjqcKX2nQiPyPuqzAlnx2JLE5I9KwrQ2USFb8I8sZJZOoH1PrVLUIJ7C73+Q7Slt29Vyu48nB9Cc095vt8eJYTFcHGcptFEY8qSCOkbIsu+m+b5mnXEltL2RlDK34+lOn3NaK96iiJzyd26M++OoqhqFl9jCyCSKTIHH92uV1XWL6yvUSHZJYv88Y2k7h0OR2rWFNzGXNe0GGGRmtZ47hXHIK4GfauUvhPAvlyKwUcbSOB75r0izNtLFvFpxIONwztrM1XSSw2xKHB5OeP51LA87P3Bx+NRvnoCQauXtq0V0yFWG3rxxVaVdmN67SR9aQDUzxng+ppxKcFjg55A6GmYB75+lLggjPT0oAnTKqDHgg06Jd5JZtvtjApkYh43khj60sm0ELhuejDpQBGgUFhux/Wo85YYIp7gICTgntxTGOTnCg+1AEkLbJAyMysvRgcEV3fhnxndRTQQNLK93naJZn3BvQZPQfWvP8EdDk+1SLM2Nr7SvTkVcXGN+aKkn3Ma9FVo8svVep9EO1p/ZP9o6lHDHMeN8ZADg9wO9cx4g0i01bT1ks2hMm7jbgE15TFcShVT7TIIl+6m84H0rW0XVbnTrpbiMpKq87XbivAllU6c3Voy1vdL9D63Lc4pxoQw2LvJreTJdW0GSzXcC2/rkDH51kBpYhmRD712c/jCK/JF3YIisfvIelZusX2myw+VBw/ucjFetgc1xuGtCauVjsty7EQdWjNKxjpNG+0dz2NSXEIdMgCs64VIyPKbcw6kcClS9k4UcgV9phsxp142asfEToOLvEV98RXHY9QKtpcq6ZScof7jr831pu5ZRxjPpVeWLPOOfUVjjcopYn347nXhswrUFyxdjRiAcqHkd884VeD9TVTUQWuDwsaj+FOBUMFw8JCu7CPodvWpb9WWBXMm5WPyqvJ/GvnKuElhnyyR01MVUrr3pXK8M7QrhVRUz1PVh70STtPwp5HT0qEkkkPHjAwDjpSBNm0q5PqQc1kYnS+F99za6zpSMfNurbzo2YY+eE78A9BlQwJ9veqEEcI/fIyYPKxtwM+v8AhUWjag2n6tZ30WALSRZQHG7IB5BHfI6jpWhrdmmm6/eWvy/ZxKWiLgM3lMNyE44ztYdOAeKn4ZXJWj1Og+Hty0nxB8JpI/zf2zY/IoyB/pEfU1+glfnt8PLmI/ETwhFEAqnWbHAAxn/SE61+hNVsUeHftcsy+ANEZCQw1lMEdv8ARrivmqxu5QFaeBZEYfMy4Jx64719OftWSrD4K0CRwxUa0mduM/8AHtcetfM09qpXz7J1Ifny92OP/ZT7d6AIbiUyZ2RjcjHDD5WA91qzaSQyMnHkTkYMhGVYe4qrDJNIzNOoYr91x8rf/XqdZYJcmREd14JU8H/69AG5Y6O7Tol9ceVBIcJIfmjX6nsK1b7SNS8L3UMhvIpoZhmGW2fcpH9KwWur2XTmjSbfaZ4RxnHtnqKjSPdZjZLJbrnLR78hT6igDS1m9utRH/EwZZMD5HWPJX61pRXt1H4ftbcyhbi4czGGTHzxJwhHpk7j71k6XaQXE9vbPcPI87CPePkPPGfQitrX9MslulvLG7iljCiGOIgqY1TjAHpnJ/Gs5atRIkrysBv7UxRi9guo4v4ieg9gaZf6XYahum024ZMAFfMXH61StNUubZriHevzr8y3Ch1Ye2eR9avaXayXVjI8YEhjGWCN93/gPcVoWZ08DxKsV1EGJXBcj7w9jWVc6baupktrhknBxtxnNdRFNFcpNsjKzDHysMxkfTt+FU5NGnuAWs0Ky43FlYEZ9qL22A5NIPIZRcSzJjkgZXNJcXdvIApSXb0+aTmr1899a5W7Uvj5QSAefeuevZ7ZVYzxwO55ZFJB+tADdTtkCb1lQnspOMVnQtGQIprYMP7w5pTcR52QqyxEcK4zj8amhk2HJjK9mbFAGZf2CxK0sK7U9DWeYS2DxW7qMbyA4uG8rsAvFZv2S5JxGm5fVaAKYUkEFgT9M08S4OGZjx0U4pzQzoxM0TjHfFNaUuNrIueo45oARSp3bm69sVCOvCAj1qQAZ+bg9vSmMu053jHsKAEYDtx9KQrS5Ujpk0vJPC/lQAKSQFPA9R3pysxYuCARTRnPOM09Vy3TbjtQBbt55QmWBK/3dtXFMjIohC5PXdwazoZ3EnT5h78Yq59pEK7gVJbk4bJFPTsC9C4mnLs33NwEA6BUyarXcAVGOWIxxkdRTf7XuVjwXUJ24GajkuzKp8ss2eq0JtbCtfcqqxTGHyT2FTp5rkqqZoit2yJgh2jtW7ps8T8SAKR14raebYmhG0Xc9LLcto4yfLUlZmELWRmYTHyxj86jkCQpghmbH5V6BFp9le42k7jWL4r0EafZidB1OM15zzeWJqKFXc9TGcOPDwdSnLRanJx4YlmJJ+tI8ilQFJx6miNZP4EyMc8Uh4ALgKOw711Pc+aJ7WQq48sc9QxOOa6PU5kvfD2kXqsGmt1bTZceiHdCx7KCrFR3JUmuUV12/wARxzxXReGSL7SNb0wcvLCLuBCf+WkRy21R1YoWH0zUyWzFI1fhzFs+JXg9pGQudashtH3h+/TrX6JV+cfwwYH4n+D9zBnGtWXQf9N0796/RyqGeGftfKW+HuiqACTrUfXp/wAe9xXykuYT+9YpCxwQTlQfrX2t8evA2r+PvCen6doFxYwXdtqCXZa8d0QoIpUIBVWOcyDt6814lD+zt46jbJvPDDIfvIbqfB/8gcUAeYJ5jQMUA24yHj+bP/16jDWckZkldgQPm2Daw+or1s/s9+NUdGtp/DkBHUJfz4P4eRSf8M++OGLGWfwu5bv9rnB/9EUAeZ2byWkTSafcCWFx8yyJmrMbzo6l1ihL9Bjch/OvSE+AHjZBhZ/DYHtfzj/2hViH4FeNkRkeTw3IjdVa/n4+n+j0AefaSvk/bb9CsJhXyoBuyBLJlc++E3Hb0OaSJ5bVEis5WicAfI/zIPxPWvSR8D/Gi6bBaR/8I2hjleZpBqE+XY4A4+z9gCPxNRv8EviCy4+2eGsjoTeTHH4eRURTTbZKWrbPOdXbUboxG8ig+UfKyrg/mO1ZL3ktmyyNBLbbzjKgkP8AjXsY+DHj4weXJP4bcds30/H/AJL1Cfgh47NvJA03hp4n/ha+nOPp/o/FWUeUW2rNFOsoO4A8jkAj/GvRLTWNNvrDZCYEmKj5HG3H0al/4Z38ZEljN4dD9iL+fj/yBVtPgR47BBa58NnHHF7OMj/vxQBy91aNcEiHacZ4Yhs/jXC69YFLl0kh8uQ9igz+Br2ofA/xsFX5/DoYd11K4Gf/ACXqG4+BHja4bM0nhtx/tX85/wDaFAHz7IHkHlF9kijjcMZqiGnjkJnRpR03LxX0Bcfs6eMZJvMWbw2rEYIN9OQf/IFV7j9mvxhKPluPDaN3IvZ+f/IFAHi0NtPIMxiV4+pBHSr+nQRLJgyrDIvY/wCFesQfs3+PYWymp+Hdvp9rn/8AjNTt+zp42Zg7Xnh0uO/22f8A+MUAeYS20+wguk6t6KOazZtKtZ2AlQxFB0BAzXsq/s7eM1GBceHgD1A1Ccf+0Kev7PXjNQQZvDZB7G+nP/tCgDwK90ZI0Zrcyv3x2ArIazf0PPpX0hL+zv44cYF54bUegvJ8f+iKil/Zu8YyYzceGwe+29nH/tCgD5wMbKcKcetMOVP8QPtX0NJ+zH4zd932zw0v0u5//jFRSfsveNXPF/4aH/b1P/8AGaAPn4KzD+ED3oGSApYD6Gvff+GW/G+eNS8Nfjcz/wDxmkP7LXjfORqXhkH/AK+J/wD4zQB4UjMy9dqjj60u2JV3Kr+5PP5V7sP2XPHOOdU8N59rmf8A+M1KP2X/ABoB/wAf/hwnuTdz/wDxmgDwMROfuqSD6ipEt5YySUdQOuF/rXvsX7NHjmJwV1Hw2AO32qf/AOMVbl/Zz8byxbGvPDh9zez/APxigD5/RZBBuaRiufu55/KlWXaufLBJ7nNe3/8ADMPjfczf2h4a3MME/ap//jNH/DMPjjy9v9peHf8AwLn/AJeRQ1fcpScfhdmeN2+rPZNvhkZZB27VDqGq3Oof8fc7SJ12KeDXsr/sueOGHOp+Gs+v2mf/AOM0o/Zd8bYH/Ex8NZ9ftU/P/kGslRpqXNbU6HjsQ4ezc3Y8Ja4YKVLYxwNvaoWOTlgWNe8j9lnxtuJOp+Gzn/p6n/8AjNKv7LXjVSSdR8NH0/0qfj/yDWpynge1Q2QSF9q1fD1+mmavZ3pUusMgaRCdodDwykjnBUkH2Nezf8MteN+2peGh/wBvM/8A8ZpV/Zc8cqTjU/DRyMYNxOR+Xk0PVWE9Tg/B2mDSvjL4eswxxFr1mY8rgtGZ42RsdgVZT+NfoVXy3oPwC8ZWvjHwrrF/eeH9mlXFo9wYbmZnmSGUNkAwjLbRjk8kDkV9SUle2oK9tQooopjCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigD//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Umbilical cord insertion sites in the second trimester.",
"    <br>",
"     (A) Transverse view of the fetal abdomen shows the normal fetal umbilical cord insertion into the anterior abdominal wall.",
"     <br>",
"      (B) Normal cord insertion into the placental mass.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_63_2038=[""].join("\n");
var outline_f1_63_2038=null;
var title_f1_63_2039="Sexual dysfunction associated with selective serotonin reuptake inhibitor (SSRI) antidepressants";
var content_f1_63_2039=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Sexual dysfunction associated with selective serotonin reuptake inhibitor (SSRI) antidepressants",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/63/2039/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/63/2039/contributors\">",
"     Michael Hirsch, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/63/2039/contributors\">",
"     Robert J Birnbaum, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/63/2039/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/63/2039/contributors\">",
"     Peter P Roy-Byrne, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/63/2039/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/63/2039/contributors\">",
"     David Solomon, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/63/2039/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 26, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Selective serotonin reuptake inhibitors (SSRIs) have been reported to reduce libido in women and men, to cause anorgasmia in women, and to increase ejaculation latency in men [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2039/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. Estimates of the incidence of sexual dysfunction with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    have been higher than initially thought and may be 50 percent or more [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2039/abstract/5\">",
"     5",
"    </a>",
"    ]. The incidence of adverse effects on sexual function with other SSRIs is not clear, although clinical experience suggests that all SSRIs have the propensity to cause sexual side effects. One randomized, double-blind study that compared",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    (20",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     sertraline",
"    </a>",
"    (50",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    found that the former was associated with a more significant delay in orgasm and ejaculation in men [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2039/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Of note, many other antidepressants including monoamine oxidase inhibitors (MAOIs), heterocyclic antidepressants,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/45/22233?source=see_link\">",
"     venlafaxine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/62/37864?source=see_link\">",
"     duloxetine",
"    </a>",
"    have been associated with sexual side effects, although this phenomenon has been less well studied than with SSRIs. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/28/5578?source=see_link\">",
"     \"Serotonin-norepinephrine reuptake inhibitors (SNRIs): Pharmacology, administration, and side effects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/25/7574?source=see_link\">",
"     \"Monoamine oxidase inhibitors (MAOIs) for treating depressed adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/20/36169?source=see_link\">",
"     \"Unipolar depression in adults and tricyclic and tetracyclic drugs: Pharmacology, administration, and side effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF SEXUAL DYSFUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Options for patients who complain of sexual dysfunction while on an SSRI include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Decrease the dose",
"     </li>",
"     <li>",
"      Switch to another SSRI",
"     </li>",
"     <li>",
"      Switch to a non-SSRI",
"     </li>",
"     <li>",
"      Use a second drug to offset the adverse effects",
"     </li>",
"     <li>",
"      Drug holidays",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is difficult to assess the relative benefits of all of these approaches as clinical trial data are limited. Nonrandomized studies should be interpreted with caution since many patients experience sexual dysfunction that is related to the depression itself, rather than the treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Decrease the dose",
"    </span>",
"    &nbsp;&mdash;&nbsp;Decreasing the dose of the SSRI will sometimes decrease sexual side effects while maintaining antidepressant efficacy. This has not been well-studied but is frequently tried in clinical practice; in our experience, it is sometimes successful. There is a risk that the antidepressant effect will diminish when the SSRI dose is decreased, so this should only be attempted cautiously and with careful monitoring of the patient's level of depressive symptoms. This strategy may be most appropriate for patients who are on relatively high doses of an SSRI.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Switch to a different SSRI",
"    </span>",
"    &nbsp;&mdash;&nbsp;Switching to a different SSRI may be helpful, but it is often unacceptable to the patient who has already had difficulty with this class of drugs. Furthermore, while there are reports of some SSRIs causing less sexual dysfunction than others, there are no definitive comparison studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Switch to a non-SSRI",
"    </span>",
"    &nbsp;&mdash;&nbsp;Switching to a non-SSRI is another option.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/29/26073?source=see_link\">",
"     Bupropion",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/0/2057?source=see_link\">",
"     nefazodone",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/41/32408?source=see_link\">",
"     mirtazapine",
"    </a>",
"    appear to have no or only a limited effect on sexual function [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2039/abstract/6,7\">",
"     6,7",
"    </a>",
"    ], and one randomized, double-blind study found that switching from",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     sertraline",
"    </a>",
"    to nefazodone in patients who had experienced sexual dysfunction on the former resulted in improved sexual function compared with continuing sertraline therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2039/abstract/8\">",
"     8",
"    </a>",
"    ]. Switching to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/62/37864?source=see_link\">",
"     duloxetine",
"    </a>",
"    , released in the United States in 2004, may also be an option. According to the manufacturer's prescribing information, rates of sexual side effects in placebo-controlled trials of duloxetine appear to be relatively low, particularly in women [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2039/abstract/9\">",
"     9",
"    </a>",
"    ]. However, many early trials of antidepressants have reported low rates of sexual side effects that were not confirmed by later trials or clinical experience.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Use of a second drug",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of drugs have also been investigated in combination with SSRIs to alleviate sexual dysfunction. Most published studies have been nonrandomized, case series, and case reports.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Phosphodiesterase-5 (PDE-5) inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies indicate that the phosphodiesterase-5 inhibitor",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/19/33080?source=see_link\">",
"     sildenafil",
"    </a>",
"    helps relieve sexual dysfunction caused by antidepressants [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2039/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. As an example, a six week randomized trial compared sildenafil (50 mg to start, adjustable to 100 mg before sexual activity) with placebo in 90 men with major depression in remission and sexual dysfunction due to SSRI treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2039/abstract/12\">",
"     12",
"    </a>",
"    ]. Improvement of sexual functioning (including erectile function, arousal, ejaculation, orgasm, and overall satisfaction) occurred in more patients with sildenafil than placebo (55 versus 4 percent). Other phosphodiesterase-5 inhibitors are probably useful as well. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/36/30282?source=see_link&amp;anchor=H72305547#H72305547\">",
"     \"Treatment of male sexual dysfunction\", section on 'Phosphodiesterase 5 inhibitors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/19/33080?source=see_link\">",
"     Sildenafil",
"    </a>",
"    has not been approved by the United States FDA for treatment of sexual dysfunction in women. Although several trials showed only nonsignificant improvement in sexual arousal disorder in large groups of women, positive effects of sildenafil on sexual arousal and orgasm have been demonstrated in appropriately selected women (with normal sexual desire but sexual arousal disorder or orgasmic dysfunction). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/10/34985?source=see_link\">",
"     \"Sexual dysfunction in women: Management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Women are treated with SSRI medications more frequently than men (in a ratio of 2:1) and are therefore more likely to be affected by SSRI-related sexual dysfunction. A randomized trial of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/19/33080?source=see_link\">",
"     sildenafil",
"    </a>",
"    50 or 100 mg in 98 women with major depression in remission (analogous to the study in men described above [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2039/abstract/12\">",
"     12",
"    </a>",
"    ]) found that sildenafil for eight weeks, compared to placebo, significantly improved scores on the Clinical Global Impression sexual function scale, associated with improvement in orgasm function [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2039/abstract/13\">",
"     13",
"    </a>",
"    ]. Sildenafil use did not impact sexual desire, and had no effect on hormone levels or measures of depression.",
"   </p>",
"   <p>",
"    The improvement in arousal seen with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/19/33080?source=see_link\">",
"     sildenafil",
"    </a>",
"    may reflect the improvement in erectile function; in our experience, sildenafil is not helpful in treating decreased libido associated with SSRIs. Although there have been no studies on the use of other PDE-5 inhibitors, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/4/19528?source=see_link\">",
"     tadalafil",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/40/21127?source=see_link\">",
"     vardenafil",
"    </a>",
"    , on SSRI-induced sexual dysfunction, it is likely that they have similar effectiveness due to their shared mechanism of action.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Bupropion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uncontrolled trials have suggested that adding",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/29/26073?source=see_link\">",
"     bupropion",
"    </a>",
"    in patients with SSRI-associated sexual dysfunction is of benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2039/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. A three-week randomized, controlled trial in 31 patients with SSRI-associated sexual dysfunction found that adding bupropion (150",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    was no more effective than placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2039/abstract/16\">",
"     16",
"    </a>",
"    ]. A subsequent study using a higher dose of bupropion (150 mg twice daily) demonstrated improvement in sexual desire at four weeks, compared to placebo, in those who could tolerate the higher dose; there was a 25 percent drop out, however, in part due to bupropion side effects (dry mouth, headache) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2039/abstract/17\">",
"     17",
"    </a>",
"    ]. A systematic review discussed a third randomized study which also demonstrated improvement in desire, though not orgasm, in women treated with an SSRI and bupropion 150 mg compared to SSRI plus placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2039/abstract/18\">",
"     18",
"    </a>",
"    ]; this review cited five additional open label studies supporting the use of bupropion to mitigate sexual side effects of SSRIs [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2039/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Buspirone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Placebo-controlled trials of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/19/30006?source=see_link\">",
"     buspirone",
"    </a>",
"    have been performed, but have yielded conflicting results:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study, 119 patients with major depression who had failed an initial four week trial of an SSRI (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"       citalopram",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"       paroxetine",
"      </a>",
"      ) were randomly assigned to receive four weeks of treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/19/30006?source=see_link\">",
"       buspirone",
"      </a>",
"      (up to 60 mg per day) or placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2039/abstract/20\">",
"       20",
"      </a>",
"      ]. At baseline, 16 men (43 percent) and 26 women (32 percent) reported decreased libido, and 12 men (32 percent) and 19 women (23 percent) reported orgasmic dysfunction. During four weeks of follow-up, women taking buspirone reported a significantly higher remittance of sexual dysfunction compared with placebo (56 versus 18 percent at three weeks); there was a trend toward improvement in men taking buspirone, but the difference was not statistically significant.",
"     </li>",
"     <li>",
"      In contrast, a randomized, placebo-controlled study of 57 women with major depression who had been successfully treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"       fluoxetine",
"      </a>",
"      for eight weeks, and who had reported a deterioration in sexual function since beginning therapy, found that treatment with neither",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/19/30006?source=see_link\">",
"       buspirone",
"      </a>",
"      nor",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/46/13031?source=see_link\">",
"       amantadine",
"      </a>",
"      for eight weeks resulted in improvements in sexual dysfunction compared with placebo; although, all three groups reported improved sexual function compared with baseline [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2039/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The explanation for the discrepancy between these studies is not clear. It is possible that the effect of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/19/30006?source=see_link\">",
"     buspirone",
"    </a>",
"    is reduced with time; the latter study measured effects after eight weeks of treatment, and the former found statistically significant improvements after three weeks of buspirone therapy, but not after four weeks. We have not found buspirone to be particularly helpful in treating SSRI-associated sexual dysfunction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other medications that have been used to try to ameliorate SSRI-associated sexual side effects include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/25/19862?source=see_link\">",
"     cyproheptadine",
"    </a>",
"    , stimulants,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/46/13031?source=see_link\">",
"     amantadine",
"    </a>",
"    , and yohimbine. Although there is some anecdotal evidence suggesting mild benefits from these interventions, they have not been studied in controlled trials. Side effects may also limit the tolerability of these medications. They are not recommended first-line treatments of SSRI-induced sexual dysfunction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Drug holidays",
"    </span>",
"    &nbsp;&mdash;&nbsp;Drug holidays have not been well studied in patients with SSRI-induced sexual dysfunction. An open-label nonrandomized study of weekend drug holidays found no benefit for patients taking",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    and inconsistent results for patients taking",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     sertraline",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2039/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?28/33/29205?source=see_link\">",
"       \"Patient information: Sexual problems in men (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?12/4/12357?source=see_link\">",
"       \"Patient information: Sexual problems in women (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H173013535\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Summary",
"    </span>",
"    &nbsp;&mdash;&nbsp;For managing patients with SSRI-associated sexual dysfunction:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Clinical experience suggests that decreasing the dose of the SSRI decreases sexual side effects in some cases but runs the risk of diminishing antidepressant efficacy.",
"     </li>",
"     <li>",
"      Randomized, placebo-controlled studies have found a benefit from switching to an antidepressant with less propensity for causing sexual side effects, such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/29/26073?source=see_link\">",
"       bupropion",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/0/2057?source=see_link\">",
"       nefazodone",
"      </a>",
"      , or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/41/32408?source=see_link\">",
"       mirtazapine",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Randomized trials have found a benefit to adjunctive therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/19/33080?source=see_link\">",
"       sildenafil",
"      </a>",
"      for both men and women. Sildenafil is particularly helpful for improving physiologic aspects of the sexual cycle (erection, orgasm, ejaculation in men; arousal and orgasm in women).",
"     </li>",
"     <li>",
"      Randomized trials of adjunctive therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/19/30006?source=see_link\">",
"       buspirone",
"      </a>",
"      have yielded conflicting results.",
"     </li>",
"     <li>",
"      Nonrandomized trials suggest a benefit of adjunctive therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/29/26073?source=see_link\">",
"       bupropion",
"      </a>",
"      ; randomized trials demonstrate conflicting results with bupropion 150 mg daily and benefit (although increased side effects) at doses of 150 mg twice daily.",
"     </li>",
"     <li>",
"      There are no good data to support drug holidays.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Recommendations",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients on SSRI doses higher than typical maintenance dosing, a decrease in dose may be a reasonable initial step. This strategy should be evaluated on an individual basis, as there is a risk of diminishing antidepressant efficacy with a decreased SSRI dose.",
"     </li>",
"     <li>",
"      For men with SSRI-associated sexual dysfunction, a trial of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/19/33080?source=see_link\">",
"       sildenafil",
"      </a>",
"      50 to 100 mg may be tried initially. While unlikely to improve libido, sildenafil can be quite effective at improving SSRI-associated erectile dysfunction.",
"     </li>",
"     <li>",
"      For women, and for men who do not benefit from",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/19/33080?source=see_link\">",
"       sildenafil",
"      </a>",
"      , switching from an SSRI to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/29/26073?source=see_link\">",
"       bupropion",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/0/2057?source=see_link\">",
"       nefazodone",
"      </a>",
"      , or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/41/32408?source=see_link\">",
"       mirtazapine",
"      </a>",
"      is appropriate, if there is no clinical concern about a trial of a different antidepressant class.",
"     </li>",
"     <li>",
"      For patients who do not benefit from or tolerate an antidepressant other than an SSRI, a trial of adjunctive therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/29/26073?source=see_link\">",
"       bupropion",
"      </a>",
"      is appropriate, starting at 100 to 150 mg daily and increasing to 300 mg daily if needed. There are no data as to whether any specific bupropion formulation (immediate release, sustained release, extended release) is more effective, although most trials and case reports have been with the immediate and sustained release preparations.",
"     </li>",
"     <li>",
"      For patients who do not respond to the above strategies, consider a trial of adjunctive",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/19/30006?source=see_link\">",
"       buspirone",
"      </a>",
"      5 to 20 mg three times a day.",
"     </li>",
"     <li>",
"      Adjunctive therapy with stimulants,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/46/13031?source=see_link\">",
"       amantadine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/25/19862?source=see_link\">",
"       cyproheptadine",
"      </a>",
"      , or yohimbine should not be frequently used, given the lack of research support and the tendency of these treatments to cause side effects. In rare cases, when other options have failed, a trial of one of these agents may be considered. Anecdotal reports suggest adjunctive dosing as follows:",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/60/39881?source=see_link\">",
"       methylphenidate",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/44/32454?source=see_link\">",
"       dextroamphetamine",
"      </a>",
"      5 to 10 mg three times a day; amantadine 100 mg twice or three times a day; cyproheptadine 2 to 12 mg one hour before sexual activity; yohimbine 5.4 mg three times a day.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2039/abstract/1\">",
"      Ekselius L, von Knorring L. Effect on sexual function of long-term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care. J Clin Psychopharmacol 2001; 21:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2039/abstract/2\">",
"      Shen WW, Hsu JH. Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients. Int J Psychiatry Med 1995; 25:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2039/abstract/3\">",
"      Zajecka J, Fawcett J, Schaff M, et al. The role of serotonin in sexual dysfunction: fluoxetine-associated orgasm dysfunction. J Clin Psychiatry 1991; 52:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2039/abstract/4\">",
"      Waldinger MD, Hengeveld MW, Zwinderman AH. Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry 1994; 151:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2039/abstract/5\">",
"      Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol 1999; 19:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2039/abstract/6\">",
"      Waldinger MD, Zwinderman AH, Olivier B. Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone. J Clin Psychopharmacol 2001; 21:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2039/abstract/7\">",
"      Zajecka J. Strategies for the treatment of antidepressant-related sexual dysfunction. J Clin Psychiatry 2001; 62 Suppl 3:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2039/abstract/8\">",
"      Ferguson JM, Shrivastava RK, Stahl SM, et al. Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline. J Clin Psychiatry 2001; 62:24.",
"     </a>",
"    </li>",
"    <li>",
"     pi.lilly.com/us/cymbalta-pi.pdf (Accessed 8/5/04).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2039/abstract/10\">",
"      Nurnberg HG, Gelenberg A, Hargreave TB, et al. Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. Am J Psychiatry 2001; 158:1926.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2039/abstract/11\">",
"      Dording CM, LaRocca RA, Hails KA, et al. The effect of sildenafil on quality of life. Ann Clin Psychiatry 2013; 25:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2039/abstract/12\">",
"      Nurnberg HG, Hensley PL, Gelenberg AJ, et al. Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. JAMA 2003; 289:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2039/abstract/13\">",
"      Nurnberg HG, Hensley PL, Heiman JR, et al. Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial. JAMA 2008; 300:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2039/abstract/14\">",
"      Kennedy SH, McCann SM, Masellis M, et al. Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects. J Clin Psychiatry 2002; 63:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2039/abstract/15\">",
"      Gitlin MJ, Suri R, Altshuler L, et al. Bupropion-sustained release as a treatment for SSRI-induced sexual side effects. J Sex Marital Ther 2002; 28:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2039/abstract/16\">",
"      Masand PS, Ashton AK, Gupta S, Frank B. Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study. Am J Psychiatry 2001; 158:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2039/abstract/17\">",
"      Clayton AH, Warnock JK, Kornstein SG, et al. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 2004; 65:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2039/abstract/18\">",
"      DeBattista C, Solvason HB, Poirier J, et al. A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants. J Clin Psychopharmacol 2003; 23:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2039/abstract/19\">",
"      Zisook S, Rush AJ, Haight BR, et al. Use of bupropion in combination with serotonin reuptake inhibitors. Biol Psychiatry 2006; 59:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2039/abstract/20\">",
"      Land&eacute;n M, Eriksson E, Agren H, Fahl&eacute;n T. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 1999; 19:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2039/abstract/21\">",
"      Michelson D, Bancroft J, Targum S, et al. Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention. Am J Psychiatry 2000; 157:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2039/abstract/22\">",
"      Rothschild AJ. Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday. Am J Psychiatry 1995; 152:1514.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1706 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-58.240.98.179-4C9EBFD82E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_63_2039=[""].join("\n");
var outline_f1_63_2039=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H173013535\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MANAGEMENT OF SEXUAL DYSFUNCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Decrease the dose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Switch to a different SSRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Switch to a non-SSRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Use of a second drug",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Phosphodiesterase-5 (PDE-5) inhibitors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Bupropion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Buspirone",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Drug holidays",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H173013535\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Summary",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/25/7574?source=related_link\">",
"      Monoamine oxidase inhibitors (MAOIs) for treating depressed adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/33/29205?source=related_link\">",
"      Patient information: Sexual problems in men (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?12/4/12357?source=related_link\">",
"      Patient information: Sexual problems in women (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/28/5578?source=related_link\">",
"      Serotonin-norepinephrine reuptake inhibitors (SNRIs): Pharmacology, administration, and side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/10/34985?source=related_link\">",
"      Sexual dysfunction in women: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/36/30282?source=related_link\">",
"      Treatment of male sexual dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/20/36169?source=related_link\">",
"      Unipolar depression in adults and tricyclic and tetracyclic drugs: Pharmacology, administration, and side effects",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_63_2040="Carditis CPC Light";
var content_f1_63_2040=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F58307%7EGAST%2F59215&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F58307%7EGAST%2F59215&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Esophagitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 238px; height: 360px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFoAO4DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6Zwck5yPSl70pFFYmwU4UgFLQAmKBwMUtFADQOTx+PrS4pRQaAEIoIpaaCPrQAEjGTxSAggEHINRTEb8MDjqPSkifcfk5AODz0oCxMRzQOKy9T1C7tbxIrfTpbiHymleYOAAR0QDuxP5Cs/xD4qtNIgRlaOacMBJAjZcA+lXGEpWsVGEpu0Vc6M1XubuG2eITyxx+a/lpubG5uwHqfaudufGEY09p7a1YzBN2yZtgHH61UN3oviePSm1VC9xbTLcxYVlVZB369PrVqlJatFvD1ErtHaA5GaT60owVBByCMg0jDisjEaWFNY0uM9Ka7AHHWmOwUyRQRyDinKGwSRj0zVWCC5S6mkmujJE33I9uNv496ENLzMPxD4z0Tw7dvaalPMtwkP2gpHEz/JnGcinaF4w0nXNQu7TT3nL2wUs8kRVHB6FT3rVubW2NyJ7i2SSTbs37ckjP3T7UjpE0ZVIDGvptA/lWnu2219SkkXA2RkHj2pk24YxnFMt1G3C5XbwAaWVJmhcRzBZCMKxXIB+lZk21HISVyetKajtUljt0S4kEkoHzOBjNP6igTQjcDvU2lNm5YH+6f5iom/yKl01MXbFTxsPB+ooQnsX8UmKcaMcVIxtLjIpcUtADcUuKWgA45pAJgUgHrTjTGzuHYUCBj2AzTRlTwOTTh6dqoXFrenWrW4gudtmqlZYT/F6Ee9NFxSejdjQGCK5zxFf6xprgaRowvzNNGisH2qgOd7P6YAGPrXSYqC6uYrcoJZEVpG2orHBY+gpxdntclCSxebCVf7xH5V5N4wsjZXDF1zIjZz6qa7rX9bdJ1trPDKGxK4P3fauM+I9/BHpsMs0mGjViWP8AEAOldWHjJSXmejhIyptN7Mz9Uux9gTaOZIyST9K0PAmn3N8EkUlY41Vc47//AKq43+0XvrJZDbSRWYiAWZx8jgjkg17L8PGtn8I2Elk8bxyAsWRsjOf51vXvTgdGJq+zp6bs1rmVbeBY1fBUYz9KoaLeXEs86XL71A3KwGBiuO8UatPFfXoGBGjbd5PA9q0PD2oNJYSZlQNJjJznArn9i1C5xewtC76mxpllqP8Awkmp38mqyS6bcIiwWZXiFhjJB9+fzrdjhSM7goBPfFR2IjhgRd3J/vd6sE4POMVhJts5Zb6AcHimlaXevrR1GcjFSSNYDFRNH8px+tLFKshJTJAYrke1Sn0p7BsZ8kpVwhPJ9O9OUleec/WrJiQ9eT61FJBuGOv407l3RWkuHB9CegrJutXvLaQiaJFX13f1ra+y88jIByM1zni1FUxZXaGGCcdT2rSFm7G1FRlLlY2y8TpNqLWkjKrEfI2RyfSur0gSm4LOykFD2x3FeE+NrGa40e48lI5nVfujhjznqO4r0r4K6lc6h4chS9keWWCMJvk++Rx973HTPfFbVKKUeeJeKoqC5o7HoHaivP7jxw+maJa3l7ayebKqs6HjYSMkH0xiug0PxZpesadHe2lyr27jhiCPY9a53RmlexzulJdDoMc0hz2psUqSrujYMPapOMVkZ7CUuaSlxzxQIKYR81PzjqRk0mQWIyMigEIBignAzTXYA43Dd7ms7UL+308C41K+ggtxx852jd9aaTexSVy/56FtoJJ9hXMeOIm/4lt2WKm3mJXB6MV4P4Yq7b6ydQdW0poJ4DnDBsg475Feea/44F/eNYTNE9tHLnzIuu4ZGPp710UaM3LTodNCk+dM0NNmLzsSeJRnJ55FVfEmiy+JNOaztiPOVuh4z7VzVl4luRq91bJCEtIIjIp28465zXQ6Pr0VrrNmzSqYbuMOjDtnjmux05Rd0d1R7tG54N8EJZaZFa6shmt44ggjduAe/wCGK7OwsrHSbIW+n28UFuuWEcS4Hua818Q+LNZOnzW8URglt7gK7oM7l6d/wrKsfG+onVbOOAkxrKI5VIzkZ/TvWToVavvNnFKlOpq2YHju+upNW16yR8xXlxHLanH3x3H9K3PBdpM+jOruI7gS/MjcYVR6+veug8X3unavDPCLH7PeRws9pdhcFGPcY6/SuAtG8QWNhHZfa1uJrhGBm6kH/wDVXTBudPl2N4Jyja1j169vFtdL+3S3SwwQgEuXDAjp09agXWEm0tbu3uXn81N8Yx0GcZNeZR2OqapoFvpVxNvkW5KSqp5IHII9RWNqehavps9xexyytCnywxISuVHRf6fnWSw8Nm9Rxovqev6ZrjTFxdXSov8AAp5JIq/b6zm3aQsRtBwoXhj6Zr59tdUi0yxS+FnLcapPK/nB7g7IueAPf+Vdv4f16a+sfNnNvGnTbFlv+A5/rTnhbaobpRk9j0238TwxxDzY8DqWHerH/CT2TOFQOSR1xXEW00bZeRgcDpjgfSrMTQtGJFwD64zWDox7EvD07notrNHcwiSIgg/pUtefW1zexyh7W7IxztI4P1FaNx4sltZVSaAMMDcyj86xdF30MJYSV/c1OuJqreWkV0o8xRkdDXK3PjZN6rDbuS3rxWNqevarOh2TmOI9lA+X6nrTjQn6Dhg6t9dDZ8ReGwbS4mt4wxVC21R8x47e9ch+zzHPdatrF+lzP9lKmPyJAQUbcD/Q08+NrzQFM1+4ntVI3nJbjP6GvUfB0lld24v9O3GC7XzFZl25Bx2rZudODT1THiHUpw5Ju55nrtrol9JqkTaxcLDbq3mwNGxjhkxw2ByBXJaPqdvZ+G7qGG5lvJILtY5QcoUjYZRkHTacEH3rp/G/h7SNIk1C70WVLPWniZ549jT+dETyNvUduat6TpWnat4Xsr+208SfaI1junMBjcFTkYH90EYHtXQppQT1sVTqcjUludF4X1uKG9to21OKRrpAi2hHzKVyCcj+tdrPfpGARXjmg266j4/h1DS00yfTrWJopJYHw8T88MpPXPtj3rYsfF1lqHiWXS4ZTMzMUUgfKhXknPfJz+Vc1ShzSuu2pNSMZyckd1fax9nh3SSLGPUkDP0rMtvGFt9phia5UGTKqH9ccZPrXO+OnsLXTzLrTSy28Zz5MS5eT02981jWun6D4h0bNjeyWbeaqo042yq4GduD1OD2ohRhy3ZcKdKzUjrNI+JFrql/e2aQSRNZk+ZNIhCcHHBok+I1n580EMVzJJGm8HyiA/0Nc94lW1l00W1ykiqGASRQA7YXG5vx5rj/AAZuuYtUs9Pj1C/eFj5ckzr5ec/15rWOHptczQexgknY7C68V3osrXUzGlutxMyyRzSYY8/KfYVN4r11dJsPM1i3W9sfLVlOA3nE9cDtjjk1kxaRqt5f2ja1aacNPgXLCckkfl3+ldR4usBJa2D2cMDiNlBYn5EHb5e4zQ1BSSLlNaRSM4+LrSx0GG40XSZpINhdoYCFaInsQO9cHYHw5JKb+9/tmxkvmYLFJb7grZ6ggdM+1djq8eoXlg1npep6Z/bshB+zFlQkHqQV9u1c/wCFry38O+K/sC6nd3t0AEuIVYvGspGCBnqAfbNawSSfLuRe22502leDVt7bdb3cl0kiHLOmCQfWqX/CBvBbrFFc5CNvicsDs/2foa1PiFfSW9vHdxW95NPaHdFFHPsjkf8A2gOSPx9qk8Jyw+JbGK5vrVrO7C5kjjJVc1mp1FHnbNI1Ha72HlDIYrSa9gFyFxKm4cr2NJZ+CYoJPOEoMkhyXC8MR3rmn8MPbeJNe1zU4ZYYZSfKXzgPO9NvBx069KNI8U+IpQpTSDHZbhEIzIXIHbB7k+vSq5ZNe5IXtJfZOn1vSL0i2jsbqzUKGEj3SscfTbWZpl9YX1w1vOZlukyPNVdquRxx6Vf8ReJofDAgbW7ORrRxlW/j9wBWm95YX2lK3h28sItSvbYy2a3HViR8p2n3rO8lHVadxxrxinzJtljSdKt9Dbz3uQJH4DSAKf8A69S6rrFukiWt0lnJDMdrK7hSR6g9M15lFqniS1W9tdVeC/1iG3INuCoYsSOQQMAAHOas+FPDWpasfL16zmg0+5TejGT5onHoe/T8abope9ORhJX96TPO/iFoVy2tzTmOO0tUG2K3jyRDGOrEdyxzjua6bwXqdzBoaiDTY7exjYJHLdybS57nHcn0Fdr4hu/D9nb2mi61qxa+ZvKhnER4weA38s155448Pajb6ioLGedMLBGJMRRJ2YZ6k9a6ac1NKMjVWeqPRra6W73xTJAx4JLYCgVNE1u4KxSeb2Miqdq+wry7QL6LTpjb3ryXd67fNMZNyofTb6e9d/Z3RuogqlY40AGxSef8KzqUuUvdaGpHdxwAhELSdGZ+mPXFULi482TzAxbI9OMe1WfsypEHkliMfaNE+Zvb3ovUEcZmkIiG3CoSMAVkrXCMrGFqckjOyqGLAZUgdqltLjdbqJ16jII71cePyRH9pKg9Dz/Ce49ax9ZuRbWd5NGYh5Q4y2Fz61olfQ1U7nO+Ip7/AFDVYdJsbcTW84G8kdQff2r6H8JaYum2VrAu4CG3WILngAYryjwJox1ODS9dg1OBE2gT27AjaQegPQg17NpdxDNKwhlR9owdpzjpWGKltBdDhxdTmVlsed3Ou65qF3BaaXZQRvbzL5pvVwJISCCFP5HOe1Wdae8WwZ7K6/s23DnzmXj5h1Ofy5qjd+OzaCWzOj3E3kKBNLGOUDDKnjsea43xfe+In1fydEb7Xa3FvvFsuGypHzDb1yOc1rCk29kh8tnsXtH1q10ie/unito7S5f5JY8AStnknHfHWoW0K902WaXSmujDIRcBYU4Pou/t1rOfw5ex+HdHjjtTLYIWuJlkG2U46gDPccDFeleBtWafT5b6/hlsYNwjijmcYIAwAowPpWlSXIuaOpcpW2OI1gX0ev8AnapPbyiEecttIjMUAAJxjqQMjk1r+HNJuvEV6/iHXYo7e3lGLSHAD4zw598dO9dd4h1K10XSJ9ZvbaL7QiHajgEgE9OneuI1fXL2LwsL3Vy8U0+ZUgCANEp4A46f/XrOMpVFZK3QqCc1e9i9Dc21pd3661qFnPp24LZwQLtZRjkMepP41xOmaXc6lrMtjbTPYaEs/wBoVrR8MenEmTnH8q4LUNQabUIha2csjBN+xmOGPPNdP4W8VzaaRbavp0iecMFUBHB4Jrq9i4p2eo+VWseo3+oT32n250TULJLSFvKkklwSzZ9SKojUb7VvFMdvaX4uLPT4d1zZqgzI3txjnj6VUnk8N/8ACOjS3XbFGPOEQcecGPfHc/WrHh7TrvyrGbw5cwQWLE/bHniAnlw3cjOeOnNc/KorVENWIbFvtvi+aOfw2mnXDxkwamf4Djg88Z7cc1oaRpOuaFHNdS2mm6pqE8oUywKFcp/eY4H+NSeK9IikBvmikvp4Tugjlm8pEGeSeRmotS16+ns9Pt7XT5GiuEP2u5spVMduAehY+1K7klbYl9zT8R3MzpaJDdrZuJNskIiEm8nHy80zxjqmrWMMSeGF0+f7MR9pt+AwHvjpXnF19rsvFFmumnULuK5YtMwk8xXJPGMcDFaelXei6Le6pqniC9W61aJ/LkSzYk4fgA9s9cnFV7FK3XyG4pbmz4hs4vGmmWj6RfNA9tcZlRnOwnHI9T9aivL3VdBj1Wwtrmw06zggHkXEjfM8rYyV7jvgYp+i65oFnZ+RM0mnwTuTHwST39OtSeF5vDfjOVWeFrkWQdw12+0bc4+YdD070axWq91DkuXRnNaZpuu6vqGmtql8uo6bJGVLKu8IecnOOo961LgeF7z+z5heymC3ZYITENskTA+npnn8a9G0lLSzjSGxBgjDbwY4soR6AjjnrmuEjsBFrOs22n6DgM3nwyODsZ8+p7+lKNXnb6WBNXt0M+58WXR+ISxWWkQGaQrCbxVLSyr03E9Kt/8ACT6l4T1549d1GfV7WaU/Ov3bRegLD19unHetDwnbQPp0Y8kaPqyTbnWdwWf3UnBqHTvCWkalLq11JbXkpZ9lzbPOR93kY78n+dU3BaNaImyG6Nd2niTxVcW+paat40Uf2mCZ48JIAPvAiofFl3BqmkmO4gijvbXI8lCeI/XPqK1PCPjG01S5Sxg0S4shbYjTd91VHQVqfE62tovDl7ewCGG62qXm/ixms+blqJNWHB2lqeIaTtt7xDbG38suAwYfNj6mvUNMeyjR0jdyx5wFyce9eH6NNJqOoyAM8gB5aUcHP9a9X0iO7itkVHdIcAFo13n8a7K0U1ubRV0dWkhVoSkQiOcBnIqvczRkyF5I5JA+4KpyU/D0rOuAkrLEvnXMueC+UwffNWPs9yhW4NukGBskVSCx98d65OVIOUoa7IbmAtBO0cgTcmcBSD1x6DNeVeNdZuNQkt9NhDCYjD7ekmf4fwIr0bXEfSbaW6Dkxxxkxb0LqD6GvK9A0241rVmlD+TJI5ZWT+Fs/wAq6qSVrg+yOo06wutP07TzcCU26RbWCngNkn/Jr1f4Kay2p6xqMAJaGGLK7jkjLLxnvXA3qXN74WWwu76FJrabZLIrnDD0bFdf8DtT0a08Tano1ppiwXsVt5j3cZO2dQyjjJPc9qxrpuLZriMTFYd0uX5m94d1O91XTtMnU20GoNj7TC6eWZF5wP8A63vWWdNsBrGr/wBpW89nDcttgDzKN57iPHIJ9OlUbyJ7TS5pbfWW0m4+VvtEse9CqnjB5IPNXJ7iPUr7S4rm0bVLy2jWW21aIjYrsME8HHHoajls21scclyyshNG1HSfD/hS5uPDWk6hNOHcraXcpdhyM4PXA9KrXDaleJZeINdn/s/TrRNxtnG0rJ2wO/aus0DRtR0jTguo3kF5qPLeZghQMkjgd+eaNRsLjUcJq/lNHMN5XYSgx7nv71CnFN2+8UbJ6HKQ6mFt7bSNCtpb9r7bMk15l0QZyTlufftWX8Y5Z3eNYLhfIjQq7Kc7mA6V2Oo2hSDT83pitlkC7Yl+eT0UCuf8VeCLSw8H7LF5pUimeaSWRsks3v6VpTlFTTNItX0PHdFsZruxeVr0wOHILODudfQGuzPh+00uxk1R7uae6kjBWBjlSTxuA/XFctYznTpkhlObdGLt8vXNdvpdwbyJJ7gyHamI09uua7al9zSGuhz9nY3cdzJe6nPECRuBdgHJx79KgTxfqttK/wBkl3og3EwEsij3J4/Kt7V9DnuZJGNs2HIJDDk8dapah4cay0XaImSJyQcDAyOxpc0XuaKl2Y2w1zTPE+oQvrzyxSYCmW3nKZ9mHQ10sGn6tZeELvT7W3iurd2zG9uNxlUnkOD2x3FeOanosqhp1mEUa9QeMfTFdr8PteBtJtE1ya4k0W4G13VmVk+hHOPUUqkNLx+4ya1s1qekaZf6d4P0eyu5bGe1tWAEzbziNjxyvPJ9M1zHjrWLKfRo/wDhHbOa1lvJBNLvs+ZgehJ6nHoa6y+02bQ9Bls9Nm3+cv7jfhlC8Y2g5HArlfBuq3/l3M+ppJdXat5FqbuIhMnsWPQVzwSfvkzik/dZXtdJk8N6hazT6RJrUd0FlEl6xURsAGJRBgj8a7T7Pp3jnRHjsbaLTLV5GF6qweSzdCDkYHXmuT0/SNRg1P7d4vuZmuYpGuIsTb0TI+6o7/Ste4vJvH/huePT4Li3igulWVWbaZBg9x1+lE1ezv8AMjlb95l2y8IeIrdtQsrfVgmj+QIrRg/zDpj6e9bsmqWvhTw6U1a/M0trEBOQCWZjwuPzqwft2jeHbG3t0bybYfvmB4CAcg56iuI8b+IFbU7ER6PDe6XqO1jcNl1k9RgdwcViuaq7PYcUne5h+I76z1rXdL1KXS9V2tGPKnQ5VwO+T0xzW4mp63/YVvc+ELYXJFwFnuMh/k9MjqPX0xSadq8f/CR3JeR5dHvoPs13YR52x8bQUHbj0967bQ/DWjeErKSW1vZ4bAne6SHhfY+vFaVJqCSa9Ac2vdZyrHWbm9vtYsLstEpV3tmXDbwMMMd1Izil8VeIIptHtbSS2kW91RXkWLblECcnJ79K19X1DSUitV0e/sIGnbdA5b93KCTkM3Y59a2NTFjJp40u6EX9oGHckMOM5IwShqHLVNoFK1rHlvgXTIbq4uDMsRZ8bI/Vs8n8q9I0yBYnI+zeXGh6qOuK8x0jV5NF8RjQY7SUtG2yWVR8wPrnpiu+1zVJlS30yymk8/bumkU4D5/hz6DvWldOT02ZTu9EdLM6TMRLEkKYGZJeOnSqU2paEHIN7aRzFtgz0Dj36VwGoahczRyxvNvdTlWJJ3EdhXJa6gkjM6SkBjmRcHjHeojhr7spUO7Ou8XyXFq80UFzaTh1/wBUs4AkJ/h2nqfpXGfCaB7/AMWAJbtHCrkkEf6s91Irz29kn1C9G+4dnVv3UpbJGK+iPAgsPD2jQ6jqc0X2+dNzHIDNgeneuiSdKnbdslt/cSav4G8/W9Q+z7TFeAmSJW284xkZ6Gul+GXg9PDN55EM0s1utsyqZsFgSykj2HFaGn6vY6ppZ1aFmEBV/nK4K461U8BXFrqWr3Mthq7XTpEwdQOACy4z7jB/OuBzqOLT6HNOTcXcxNWvtHbRNO07XdNuLu2vZvLEkOP3bZ+XPOR6VPqmh6Xolg8mm6fcSrt85bWOUqSR/Dn/AAqlomj6hZ6pf3ka+ZaC3QpGRkSNk5Ue/vXO2F7pt9qtldSazqenvLMUTTJw0qk5/h4+UZ7mt1HX3XobS0k2dXoGuabOF1GOYWihcTWsjsWQjOQB1PSs74ia6+ptoemJDfRWc8od5bcEMATgDH610el+H7TTJbnULWFXu3Vv3jcgN24+tYCeFb+8sFgOurHdxzm6vJip3AH+FW7fyqYunzc3YmyvdjpvDUdlYalfanrEkmnO6osjj5kTPOBnvwDW5c6lY6x4Nu7TwxdxytZbY1UKcPgdOeuRXOa94d1XXr7T59HvbRvDUfzTEybgR/FkfxE4PSuja507w7ZW0cVrGsc7+ayogRzgYziiWttbsejejPF/EFqtrqFtJqtpIVkwfLibAQA8j3Ndp4dm0+GeNyHFvKgYBiMjjioviVYPAILhEYw3JLIWXJBP8IqLwtpdtMnky3JNyF3eWRwvtn1rrclOndnRFpHpdtfaabEkoCrd/WqOqvpd9Ym2YKN5yCayxaRrEQs6MhIjO1s7D6e1Y91BBpkqQvcvIHOQW6iuWNJX0ZKUb3TLreDrCBDOwjnjJzjOQR2GK57XNKitb0fZI/KQcCMcZ/Cuy068sUJ23KMirh+flHufSs3xBrWiW8kU4vLK4YYyFDMcflWkJTUtdRSlK+pftDL4i8KHTorxLPULfapkI3YTt05Gelc/pN0+tmXw9eaLqUlvANjXk24BiuTu9s9uazfBV4ZNb1GWW7VtSngaNAi7YcHOwkH+IcV1aSeI/wDhErcrcRHUSoF6WIURpk5cdhgYpSXI2u5LT3LmpT30VhANMSBo4htZbgK3HTgmmi91SPQpLiztLGS9ZNsNrE6KJDn73Hf2rjnK6xqVnpmmal9o0JlLTNJ0JU8gnqSTyPSqEvia20mSQafFcRx2UpUW8a+Y0xPRtx6L/Kn7K6t1DodZN4zWx1B9N8RW00+oxwrI1qiDClx90nPPWq2jeILSGwmstF8PzWMZZpnUuX8tscMmecVb1K8sdd8MyXslkL66kiDxorL5mSOE3jnrTPCeqXaaXHPNpcNjqZbyoxk/uR6fN0yKXKrbaiURvhrw5Y+KtDuL3V7BtMuTd7YpVZozMByDjtnnOK5z4l2C6VqUMM1zqM4lcb4bdTsEZ9T3NdjdWkXijUdIvbXxErTaaxaa3hOdzbs5/LitXQvFlvd6lqVnOkkMti+1mdeCpOAVPpU884y5lr5Cu1c5zSfDfhO/0kaX9mkCBi6rNLibJ6kf4AVhtFHB4z1XVLu5Cw6ZB9ngaFt5hUjaoZDycZzW547u9C0nUo7tsHUlfP8AozglGZcq0i+nesy68L3OoaZf3d4JbTWbqAK1zBys6g5HA/iwADjrVxf2m9GPR6nN61f6/caVNqtuptr5WWOWdGUtMhHyyD0+tXtH8TR3NqkMl0st+kYEhbgs3fBp/gS10vWp53kmkF0Lf7JcM2U34HBKeowORXI61o114V1ueS3TMI4yPmXFdEeVvkZon1PSLSK3lktt64wuQEOefeodZsbN7Bh9o2ggknbuKj6elcRF403SxeZEqnG13iGNoPfmsu68S3ptrgQN96TaroOq+hpexle4+bsZeg6Wt7r8UEMwV5pikUu0lHx2Poa9Y13w091rWkotwTZ2sZdx02N3GfQ4GK574b6Zb2ls+tagBbC33StNJk7QeAQvrzXTebc6F4On1C5u59YhuJxKWUZxEe4z2/lSqzfMkjPbQml1XxJb+CoYdP0oPeSvIvlBcbYweuM8963/AIN2txBrd3cnTYdLkntf9ItlQgmUMvzDPY5PArgvGmp39muk67b300VgxWAxLkNggkHFdV8Kde1HV/GTi61iK5t1052jt9pDr+8jG48dO3WsJxfs20ZVY2iyDxdJqVv4g0rTraW6t5BKZ4rhcmOQ/wDPJh6cCuu8Gaq+q6Vci9iSLU4gfPQLwGyenp9KxLKa/vHs7l3kSxmtvOi80ZbcfvA9+M/lUmtafqNzbXFvoAWzm1GHzDLK235umB6Zx+tTNKSUX95o1dXK1l47h0abWLDUb9L3ULbJUGPy0BA4Td0JyQKzo9S1XxZoEqTeZoqzj7Q86RllKg4KY6nOeKl07wQs2lSabrwEU4YP9rVePYEn71dfKw8OeFxFeSx/2daqAXtlMhK9M+5J/KiUoRfuLUbUUrp6nmviFryw1DS5dIE8+kabtUW8D4eRs8k7c4Oe/vXfXgj1Z7Gd7KVr3bvjS4fGO5DY6iq+g6NpraHcv4aup7P+0nLPOysHC+hB+736fnUegaSnh9bg3muzXJmwA0wxsGe3Jxn16U5SUtt0Ja6ia++vXN/ZzactnJYI22ZbhwPLPcr+H41kQRWM2r3K6dcWzS7WMvlyHI9SBUtiniHVdf8AtWsRS2+i2qtsjt2Ajc54Pqc+tJrqaVC82o6JpSx6hGpcrGDulY9QOcVUdPd/L9TSOuhnazrFpoelNYWjySXcsoLSEYO7HGPzrmrTXRiKG/Y3VwGbLs2NmOwPetkx2t9b6a+tILDVLqR/KgYHc2Mc/wAqli8KQWd2k5h810JPlv0yT1Pt7VvFxSs9ykktUY5wY510NfKvpflmR25yf7tcu8sUVq63epj7aH27FTIx35rvtQs44ZZtV023lW6GcRgDYp6Z9a4fUtBaS0lvpIminMnylV+U+uR2rSDQm3cls5GttRsJ7WQXM0hUNKpPIz0x7V7PqmnHW/Ddzp8U32ae5VV830UHkH2NeWeDo5YJo4rmMO+0EHZt5yf6YrsbDTdZ1i8Wd52tbVraSHcrbfKcngkdT2rGurtO9rFSs46HK69BfaNbW+j6bDLa2kEzQi7xh5pTg5AHQdqnlurzTrqDTvEqXGoQX8Jhd4nKNDlu5HU4rZ0PVol0vUdJTXYr3UrNWCSPAwUSDPO49RmvK72/vNUntobi7ikSWTZcSByrnJ7Z4wO1XG8tGZ3Vjd+GtvqieIojY21xDYidlZZVJQReoJ69K9Q1AXOsazd6NdaVcWthG3li7kJ/eg9HRunTtz9a4/SdVudB1qy0OxhElqVLLcXEoZiO55+6OOlekxT3Vq9zetfiXTWjD+WXwFfbk7M9uDisazd7itbZmB4U8CaZoWvNcaXqU8k8XLRMOV9eR25qv4s1XUtJ8Tagt2jQ6IYlkE6qGABAGcDk8mtnwfqMWoQXurQxn7QzFOXDcAdgOgq14Z1lfEdlcjWdM+zIkhgdJF4YHnvWbclJuWtiWrbHILo2pS2keqaJZQ3GqT7I1mmcOrxj+Nc8c8e4rofDmqXNrpt1B4n1G0GoWxIkkhPAQ9C2B1rG8Y3GsWdvbjR4YZNLs5GM0ls/zL2XjPGOeK09HshP4ckk8QK19c3QKhgAXEJxhSw5J7+1OXvRu/8AggS6VplrJNNNFeW81/EDKs8Rwjqw43j6d6q6Zo2s6tPdw+IorSPTJkBVcZkVsYBUjqtQ6J4WtNK1myv4b4WySRm38mdwvnp6EHvWnry6Dqd2fDqaxcWuo2cn2hEiyWHAyoHAP0zSctbJ/hsDlY898WeEbbSNYj06C0uLhpyixsgBznrz2xTtQ0G50C8jskSykUyhckbiD/WvV9H8RaNfSRxTGazvydn+koIjIQMA59T25qnfeDNPuIZYbppWYv5qsWzsIByCODz/AEqliGrKZSn3ON8RWmm61qejRadM0lxEjxSQggQzDvxXRy3d34es3EWltNFawqIoohnfngqAewzWO9l4eXxPBZabdEX0VnsjjRcJ0J3Bu55yRVOSS7up3WeS8iltQNnmvuL7c8gDsaNJJLp5m1Gj7VOz1NqbVV1HT7c6lo7xQXWY5YnUEKe3brWt8L10T/hJbm20yGzS5tbQxtuz5wXepKn2z/SuVsvD1xbeHtRay1OR4LljOCAWMfGcd/zFdD8HZnmv1uorG3lme0kjub9IsOzq8exCf90k/h7VNRR5HynLXTjBplMXi2ng+e2j1aGWaKaWJL5y2ImyMKxPTJ4z05pj2N/BaaVqRButXtUUmGOTMRzk7iR/Stq00HSr3TbyGLm0vD9raNudxP3gMcjpXH2F3pem6Lqr/b7r7FMWbzHVg8SMu0R4PcelVF3vYtWWh2d7rC+IPD8jLLFa3csbJDiVSqydOM8HkdKxYPD+qzeHYLfUtYniSPIlzy0w7A4/Gs7wXYeGfEmnRy3aSx2No/l26TyhQ0h/2uMk9cV6TqelywaY1vbhoSYisbYzswOCfSok1TfLEFJLQ5LU73xTbY0vR/D17PEsYiiuJcNFIuOvbn3Jqt4m0A61pNjZarbS215s3tFG+xwR/MVr6HBdHSPJ1a7Z50Bz5UxBKnpux1NYY+0DX0XX1hxYnfbXAnkRlU8YYEZcHjI6U4vXToCutzH0DXfENhpd5p8UMdtDbALDc3p9W6FjwfpXTxX09vpE/kT22oeIIog0kEf3It2dre+eOPesfx3e6Ralk1TSbiWwcrIt2rttRgeuF7c03Qp9Y0XwDd3drY/bFnnItpCy73i/hfOMsPQVckpLmtuF7bFbSf7bNzpuoyQBluyZbhLvLSwPkgiIY+VTwa1YtMv9PtL64uZ/td3O5aFJXwQvUAj/AD0rk5NY8TuBb6Pql1Fc6gAZEmHzxtkDAP8Ah2rsX04yLHf6rfLc3uiweXcPEcLIT1LD1z+dOV4vUtXi7NGPpd3/AGpDdQtKv2u3/wBaE4VfTn/CsnxXq93Y6bC8FoJ2VjGW5Kj04FT22pWluJH0e3ie3lk3zOh3Fmz0P0ras4rid7qSSBo7U/cZoyhJ7gZ69OorS/K7s25bxszmvCeo3d9NBcXZt4o5DsWCVAN59j1re8b3urLeWGn6WjywXcRkkjhX5uDgjP0rESwvNS1WMXmlz/ZreTdHLGcADPUnoeld9ooni1q8a6AbbbiSIlSFVDxgN07c1NRpPmM7W0OZ1/SLjQm02Syjgt9GSNnvGcB5CT092YdMCua4l0ZdXsIYI9NjfdJaiFHZm3YD56jI556V6D4u/szVNKmufEMcthFFIGjVXPbpyB3+lZeg2ei20j614TKqrjy7qzeUeWcdWBbnnOcdKUJvlu9yZJxdjnNU0xbfVdP1HRdHu77VHQSCS5GyNcrkE4Pv3rXHhxrrQDHrV9b2t5dyfJbC83KMd1ByBkkD8KueLPEKaj4ZMkOl3F1pTzCK4Ds0WMf3Sp5GeM9Kq2GjabqUUK6pYXWkNZ7Esij7vMjc8Ak8s3fNPmla70JvrcZc6PF4dtrAabeSaTJPcKl1E6+YZyP7uPu96t3WiXek3w1rTtZeOyeXzLi2uEJ3L3UfnXKPd6w2rz20X2G4vbaTdHc3A2RwqDjccnk+xzW/o+s69BoutS39m2pTQuHhXZw6nAJA9Mc8USjJa3E+xseFdQBuNSlurS3ttMvR5qTpkb2HBRh0z7017KDSIdRje9kXTLqJiZlPNvnoSfTHeqM8S3+qWq6ip0uQKrwoGysi57rxgc4zW/4uhl03Sorn+zZtUs+IXWBd2wHqGX0rOVk/UvRaXMKbStH03TrC81meS8htyFt7yaTCHfypO3Py5qLWvFentr4kj0v/AInkOIzMhGy5VepXvuA6djVuaFJvCUum6PbYiQbvsV1AZDtHOzB75qlb6p4Z1+703T9Ws4F1IRosc0LGNkkHBQ44FNa6tXM2ibxhLofiu9vRqdtqttdaVAJyIEGZ0AHK54PUfSug0rxHpvi3w1NaaTJJHdxQhAL1SSF6csOvesrWotV0LVJ9Q1iTdotggltJUjyy8hTH+IOCDx0NXri58M3enJq9rKtlBeqN0qfuypzgEgcZB4JrNpNKxNhLi20XwL4chN7JdbWmASWMBnjY9Rkj7vHSsOVojqEhjvY1uJN5twjYkkU+3XArpfGNnqV74dtYtOhtNVeIBmhmACyjj5gc/eH1qm+n3drfaFfrp+mCK2Qm+Mib5YhjkRn9PrRCStdvU2o1nRlzRMEpqtp4fnjtLmWykQ7vMKHB5yQfT1r0b4YWP2K4knlu1ke7g8xlVhjcCuSAPc/rXIaxqctzt1PS76S80aWJwgBG6NwMFJB7Z/Ktj4TXIfWJ7W9iVZI7ZnjwMKoLJkADgfwmlUu4M6MXF1qTxEba7kU4+wwaZqENyLeI2rKLZztd2K7lUe/Wsqz1XStRh+zy6XM9tfxvLIZCCXdWCgAdOd1XPiFYy6r4V0y6tMtHby+c8UfDMFBwF9Ooqp9qGq6U+nW+LXUHsmdQThlOQGx64zn8KuNnG5yoz7zUfDi32n6LptkJDBl7fyjuiSRv4sdyPWreif8ACSafNLc3dxM0EyHajMS6yDgfgazPCejW39tPFMGt7q1GxdvHy4wM/hXpdyVhso0ncAqMB8U6klD3VqJ3TsZS391daeftNs1lqhUjypY8K/HysOx9a8s8E3uqnXruB9Ou7i4aQidXLMkfJO7BHAP1rrrXxddahfHTdSUttlLwOOqOpyPwOCPxqxZ+K/7LvLiFpbUJdbzayRnBkXJHI9R0qoxlBNW3HZ2LujTalIuqxawLWW2t3JK4GVjP8JU9QPxqnq3hiTVpy8Wr3cNtOwe3eJtrR7cfIq9NvTpjtWDpV8dRszFd31ubmTMV9C7EeYi8K6ADr2NU59d121vnstPs5Y7aFxDaRqMxSoxwGJ67h6g/Wn7OSemgM7+0TU9G/ta51W4W7t1XdblIlEyqByGOKpaQYte8PatcmKWIXi/Z5EZcEgHgg/jXP3V7dp42htdUN6WRRahbdQYZVZATls8YOT+FdXBZzRwXdjNciNZCBAN2Mntj1z6Vm1ZXe44O+pzXgjwlb6NPPYk3EoZvN8x4yF2juD0rW0W9tU1e80i3v5buJbdXhU4CLkk4HJJI7mqEHjKzgV7A3GyS3PlMso2/NnBA/Gq1tp9no3iuG9uLi4mu9QctEoQBVDL91vUA9MVTTd+Y3+JehS8TXN5Y+Jra5ur2WKw3iKOOIHYgI/i/xrQ8aarPL4S1S1tRObmwlhW5MYzujIyCPYZGav3F99p1IaffacRavytw3KAg9+3Wrt7cTWPiewRWs4Le5kjEokkEZnjwFz83BIOeOtNvbTYzk+Xc5rw/qGsa9bajp0Wgpq9rFHE6LfBokLDsG4OcHpmqfibyvt+jWFtpqaXJNG0V3ZQTF0QHj7x6E9q6a8v/ABJqHiYw2wSDTbdmBJHlhuSBg9zgVT1bUF8L20jz2CXMskgeeVmD/MejHuB6U03e6JSV+ZnJ32v3mk68l4iE2On2n2drOWTd8ueh2jBPc1Bf+KPEF5pun3a2ItWkmMwnHPmRqcB1B6Aciu10HVNP1Z5r1rW2uJZ18qW3JG2X5c5APtwaydR0jTrzUdQtbtbl7m5sDhzIsMUCIcpGq9ABj8s1d0nqiWn0OY8N2l3f313Lc3FvbXcsqiJr1sQzgf8ALMkcrnjBrttWk8T6fpdzbLHGqovl4tlJdT/eVuv0rhItNltbrTZ4vs1x9rwJrNpc7EQgFsg/yruL7QNUm8b38l9NJpWlaf8AML4ynytoxtPPUnjiqqNX12FdJ6nPwaSniXRYrnULy7/ti3LRxgygPJEOcFTzxzXeeE9ReP7Voun3Vz/alpaCaHzT9/K/dDd+orkX1y5Otx3Phvwp/aEkL4a8aIJJNu7jHH489a7y48RadptlHJqhitNRRQsyIwfyCfuoxH+RWNVtq1ibrYq6Brc2oaGftdxCmpxlorxUGGgcnALf1rldH8HNBPdarq9vFd6hA3m2Ygm+S4HVWOO/863PDXiKK68UGC50RtM1W8cb5UG5LgH7rD1z61em8Wacnie502/8pZLZdwKDBX0Hpk5qPei2ktykc5f/ABWktxNZXmmIZYCouYpwdjKThhg59Rwa6/T73RrvQbiPTNEhaMo5FsoGyTj5lHpmvLZ5dMuLSa5+zS6haXV6Io5GT97A2clWPcdDXpPg62tUu9RutP8APgKyCKaF8bC2OQn0p1acIxulYlpEGt6L4gu/DWix+GZ5NHaLiaBnLME7AnqQB2NUfCJ1+HVtQ0fxFbFzbKPIu3P+sVuqn1B/StjxleHR7uLWrKO6vZSnkC2hbC9cknHP5UlxeXWq6vbPb3gtJDEEvrGcBkJZcja4/jU/wnFZJtx8mTscHpUt1d67qmleHbJrC0im8x4X3LGRjawJPc9q9I+HFgbPxA29CrG0kVWB+8A8f3h2YH9K4bWL/wASG9i0K7CeZMCReW84+X6r616T4DAtdRSO4ujeXf2Vg8gOMlWTJI7E5FXWb5Db2rjSlB7M860TxlJYaK9lqtnIZ4FWWKQP8silwpIPtkUukai9zfX2q3UMsd9ZrLFboy4Mwba/6YPNdFp50caSljqQheAkW/mPgcuQMA+vFZ2r3FlpGpaZptyk7SCR4ombAwMbdzevatLptpIfWxi6JreoavrU17d2McG4YEsZxwOxHevWdcsluvBsE4BZwqkEc/XNeVrDLousyNJNEbcgAR9WBPcjtXomm6yq+HJraaRgS4ICjjHpn9azxC1jKAOMla3RnndzZXcGtW8kaDycg4HVKu61qFlqOoT7LPQne3YG2m1FiirIP9YAFPOOGwRg81D4hiun1uzuLN38o4UjPHXnNR+KvC8V/o9/HJCj3RuDc2oi4d/l+Zc/g3ArZ2dmxTTaY7XpntbvStWjtNPvo7qM2s93Yp8qscZOzsM961rjXRbQfZVhnW3OIpLmPBMDkcNt67eRzWX4bVLfQ7LTtNsbi40xoftn295QBHIAf3ZQc+xpLS8vfEUcTrBc6VNpEjzswwbe5h43B27MAOAeo96Vl16Ep2Q+PS7E6HrNz4jkEKTYie4gk4JUjDKv145rTvtRit9F0y5WwuL3SYgB5qph4ZVICSFTzjGea5F7C5j0bUH8OTJq0d0/2kI53eXF14Gckk8e2K0fD/jDWINP0+z1G1mEt3MxSTcHEyoeY8e4zjvkCiUW9VqU2kZ8eiWGo391f3ltKktnM+YUfHmEHIY5HfOeK9h0VbaW1huryGMCKHcu8AleMda818Y2F/c3ljfWTQ4EqlX8wR4Q4wWz1PtXbO+NL8t2IwvzMOh9BWdb3ktTSWuhma8Dc2E1raJb4myGD4yq5zuT3FYavolvdXd1qM897CipJcJIvmLGxYD5B27dKZY6hZz3sT3VysJifYUMZZwOoB/xq/8A8IvbXOvy3xv1hjjJmeBU3bkI4z2A9jVWUNGJtJMwPH/i0QaxY3GmSMY4IllMb5EciMcD3zkenFW9a03w6NbmuLvU1S41W3RhZEO5QsoyAQMYz0Oa1IQG1aeCSOwGkpBmO5kiDKU6lGb8/pUFnpE+s3us61bWZtneLy7W5eVWhYHH7xB2wAKaajboZO6dyrbeGBaahpdykJitrUsUjiTDMSOM5/nVvUNMt77VI0nsi11dybnwxZGiA24Yds89DWjoJfQ/DyX+uvLcvbOCHjblwxxk+oFdEmt2F6GW3uU8wxh9x2hkU9vXjvUSqST7jcjy/Sza6VqE+o2VhpsVvpLtFL+9bMe4jru656cVc8RXV/baLZzpN/a9peXf2qaGVfMTaemB6Dn2pwv4I9ZOmadaWH/CMyK0t1M6hxLg8lyehB6CsFreTT9Vm1i2v5tRjiVCliQQsaOCBhugUAenpWyV3donzaOgvbu51WxtbvwJctbQMwjvIYrfmJvQdgD1qtc/DrTJ7i4uhK7XMqANbmZQGOeXznjn8Kypdehl1RLDRNNligkOJDBNjcx6k+vsaSUWVh4et9VsIbuW4ZGtXhVsljuPOafK1toNI17zTdZ8MyaNLNqsVnY20qmQFt74yCAnGcew4rW8YX3hy517U9L1Exx6hdGJlmKMhZeGQKw5+nGKfCLHxPp1taPYajBcwwP5b3Ee5RgdGPbmuR1C33eL7f7U5e9FosYK/Nkqvbv7VCXM/e3QKKbOlsSmoRmTwfaLbiGT99A64y394DoelP8ACmpMPEVxYeJvs+j3F0+603tskcg5JI6BTjqevameCJbuPQLzXLaGRrq53eXbsNpBUkDP/wBasTUEg8eaJeXU9mBrduQHEXDME6Lk/j37VLV7rp36lVFd+5ojqLvxBqVpq9/pt/4fuVnhkZre5RiEYgEg+mD7Vyz/AGB7m4vNKu7q31C7i33VjD826QHh0/XI6+ldDbeLdOk8L2eneM7qbTdRZRHEYn33Cp90FgOmQO9Ztx4L06XS1+zTIEsbkNBPBIN7gnoxB69PcUQtHdWMk76dS0LGCa3sNXvr98WuZDuj2u/+yfxFdB8EL7Tb/WdXms4ZbZ3UuyB96HLDJ5GQenHSmXWraddoomWK8t4n8qVkz+6kQdD3Jql8KtXa+8e3DWmwaTJpryQoIwmGEsYbp1Oe9RJuUJXCq7wdxNPt9C1Hw9b2mpiSKO5nR0VH+dZA3AJHT/69HjbUrJ5La/uUgkdbgeQDkDKnlcj6d/Sud0y40+XTLyVop5okuxcyI7CORAByVxnI71Lp9zpix61duC+m/a2XyLhN2wlgwl+gJOcdq15bSuata6l/xrc2mja5bztaSzNeRNKWLfIuAMDFVdN8V2d81xb+VLDNEocludw9RV/7VqWtaVDDqFhb292C0E0ajcDF0Eiexz+lc1PZvBGNOvVs7a/l/dWkkZJaRM85bpVQScbS3BN7kjSahq+ppHbs5h2kgwrkpg5zjvVqxvJNXv7XSRJd3pTM095HF5TW8gJKMO2MZBrf8HQ6Rp2mXcNy8scqRiO4klGOG4Kr356VzOkTa7Z3b2eh2NjHYxMUjV8/OmTyWPsehob5m0ugO7N24he+8XQRwxray6bH5rSLGQsqsPmVscEk81i6vfXVnBelojpt3EPPimSMvDdRk84PIHXkVbl0/UrbWm1ufVY7WZkBlV7curRAcoQTjOAasz6jZeHLO1tUmmn0e/uSYZSQ6QxvghCD1Xk9elStLWDZ22IrHS4be20/UdGgnsr2W1eKH7MuYydu75j2GTwaj8Cyw3dvc6dbQ3dpfhvtDi6bzlRwQCFUjIzzyK6KS4g03V2gS8sIrMxgxReaqPF7bSefUfWuS0XVryz1nWTaI95Ct2Egm8rBUsOuf+eecA/nS1kmN20NrULF9W1/UbC4vUSziMTQJ1K8fMcdR+NdrL9nTw7qNkn72S3WMNng4FebiKTTPGj6rqU7yzA7MMc5RgCMnuQDjPtXeWcM/n6xePCohuUVI8NnIGPmrOqtEOz0bOIgn0q0vbq/uUb5NokjK7sEng+5qrf63aTa9eXFvezRafNaNE0bIQd7jbv9wOKvapql1bNrUdnaI95BB5qswzvQcEH6A8VDe3eg20VnZ3011GLeDbu+zZjlZhuK56963WurHK2xFYaLq+n6Fttkh1Syki8ma1lOA4ZuGDZHGDXU3+tWGj6FNbadb27wWqCJoS4SMDGMbj2zwa53WP7IufDqQQx3ksEcilYxMUMZU549etSeJbPSbd7KW4s55LTWFMTp18r2YDq2eeKlrmfvE2HWotLiXTrnUFfT1kjMb6bvLpJsPylT3Bz0qOS98MX17PqNhd21s1rB5E8bfKsfPBJ7nqKbe6Sthb6VJohZR9qRXW8+Uqo4JUMOB9azPFdmdN8T3+lLo2nR2c8O+ZsZaburqRx1OfzppJvRitYi1DUdM0fTTA9lLNY3qtBK7DDdciRexBPP0rdgk0+x8OT6fNbS/wBnNZLu1CJSWMbNkIM8kgnGPrXNaGdPvoG0XW2u7+SAqIJChRY19j1IHpV3VbvUND0u90aOKNTJMiWZum3CdMncF7elXJX0G7WudKtto0nhaOC1SKzSRsQMzAys69x6n2rMungtvALXfhyN0ljuPLxgsY3Y4Ykc+ufbNdBN4csbq305BLHby6bIsiCDB2HglWHXr3q462DaZqUX2JFgX97IUYrvbOc4HfIrDn7dxtdjN8CaH4hsvFFtqtzfK2nJaBZYi5DTvsxt2nr9ap6TZazqPil9Y8QW8MTQPtt1jUIAvOBx25+prF8G3dl4o8Rz6hPrF+7aZ5l3HZyAqvyAkKrA8Dj0z1rof7Vs/iHbaYkd7HZ3NvdebLAhP75F7gdetErqV3/wxkn71zovEl/Jpuk3N1AgEkg2BuMxjBwcHvXG2F7f6RoTTad5GppI24vHCAEPcYHOfXNWhfa5YzyHUYRPFdtI4jwW8vacBc9OR2rR8P2EOkabJFbeYFkbzSCMlc9vwpRXJHXU2SjKPmc38RfB9lJYw+KEmFpeXaxmRZGwsZ28gevTpWPoM8ek2+uwQRBpVaKcSSXG2GQNyD9efWut1NI/E15a6HcI8enCJwkhGcTHgfSubur3wjY3F74fvBcoojW2nuw20EpxzwSOR6VrBvl5X/SMfh0ZDrGqXfh/S7S5m0VYxezedekNxv3dV54yv6mvRfhV9ou9QilhtPsllDZyxrAijad0kbq4buCM/rXlF1pmraZrVxboPM0S6G/zrhgYmRl+XDE4zjvXu/wztY7NYIYBmFLQKmHyMZXp+dRXsqehFT4GeWq0c91G/wBnSGSAkq6glJR3DeoNO1PVrXWLJ5NEi+x39lOgnhli3xvGcq2COCCD0Iq/eada+GtXtTf3KC1J8kDksfr7U3UrePStRhutYvobXT1k3LHEh/0kH7v3fT39a0couzR0SVy/okobwvdaxBAxvtOxA8VswKyRY4XHOADnise+12XUdX0KLS9JtEuCreVHeRhmLk9RnGDxWnaajp3hGaW4t4Ps2lXSF5eSQxJ5Hf14NNg8P6hb63pWr6VcR6zpBkadWfDyQsxyB6j69KhWTbfyM2raMinVr60u4b65imkhuCRKCBibjjPoOlcTZ6pqOsak1vdPP5hkkjQJx04r0DVPDNrp+v6vPK8sdlOP7TJflRIpywHtWr4FitbyxeeSyihuldmD7cbw3zA/XmmqqjHm3K5kkefjXtRtpr3S9REEVvt8q3mVd2CePmB6+9XY4Db6s9pfmCW3uUE8axRswdlXDFD25ByD6Cut8R2NqtldNLY+ZICHbyx8zEHg1z2nz3V1o+pJZwXdhJM/m25/ijkAyy5xwrYz9c01JNXSHdmQwsvEuoC+tYbW6trnFtLb3WIzGyY2uj9SRnJHeukktJH8MRi002W0eO8RZbZnw21Jeee+cZ9xXnzNd6jp8VnpumvcW0eZHzF/qrhiCx/4DtOPrXoseoT6hZOtwkcCwOm9ZJ1RidqszDJx/EKJpq1ghruUNUtZEnv9RW5TUraa5VINw/eQsM7o2B9Ox75r0jSr1b3w/wCayCOVYgjx4xyKwEsYo7C51DI8q4VZWtSV3F1XbvHuRgHtwDVXwJqJkuZ7Z42ZcnJkOTz0rCa54+hT1VuxneIdZghtryWxuLa11K2GZPtEeQ8QPzADvxWN/wAJvpd1qrJc2iatppCu6GIh0XIwQe5GRUnj/R4rDVrbU445JJI5gHXOQ8Z6jB47n61B4Wllt/EzTtpywWkzNbgJCFjljB+Ug/XGa3jGPLcmR1/jGzkksYH8NJE0FwBK0LoB5iHqOehouLeCx8L23kWR1A27CRU8zcyP9fUZrK8N32tt4jvbTX7dZbaGN54FTlo1GTjjtVzR/ElhLoWs6lpdttjtXJW3fKruI4yD1GeaytJK24r6WZg6p4Yc6Pp9oLqdlu53dp5jloNwGF/2uRzj1p/iD+2IIZ9OjtRnSisNncumXuYQMltx4wf/AK1ReGLKfU9ObxN4lmmnmtJXmgiiYqenQL0wT/Kp9W1Se60s67HLPHYTxizurVjuCkk4ZfQjNaa81n0DoiGLwzFaPeeJLLUL6/msx5smloMjewwvzZ+6Oe3bFTeG9OOp2djJ4lW6cyur29uwI8pk53ZPbsa1PC/9raXdXslz5TB4tgm43SDA25XvxWB4vvNXi1CHWUvbe5EEq5jgccRHgqEzwRyCKE2243ElZu/UuabY6VaT+JNa0TVZ7uWWKWNof7so5OB39qxfCcuvHUdBiaeSfTGikuZ5XXAdicbCe+MD86uaxHYXt3eW+ns2mtpsqX8s0UYXzEYfNx34OK2L/wAVQWmnQXNxZ5tPM/0eeA/LKmM/mD1o1t3BKz1KXhzTm06TUdf1C1gs5ZPMSSMIQm05U5HuPTrmtnw/Y6LZappepaRbOpEGxEUABucH3yMmqmh3U/iS8mmeBxod/YtseTgJKrYKk9K221XR9CtNEXUQIvJZo436hCByT+lRNvbqEveWhbv9dttIkjtL2TzfMkd0QAZVe+a8u1LxHLbeOrxUvJfs0fM0QHy7cdAPWvTtO0TTNbvVvbiZLpowzxFD8rKx715x4kez0/xVf3MWlSOzkxNznJ7nHpiijy81upVN2ukbfhnWbW+mQWdwGllDBUfgow7n0+tQ3XgC6urOS6upbKGSWRmuy/7wyx9cIR0PBrC8OWJ0zxdHPaoi2AO8qeqoV5zXeyeKYrez02fQIvt1hfXRtriOVf8AVkdSPT61c+aL9zqTVu2jl5NFn8Q6Fq1lpF9Dc6aJEVLdmJltnQfdBPBUjNdN8Eri4t72XTJIWlS1geMyHPylWjGPxyfyqaG50jQPCuuX2jRxWsxLO3lnJ8zHAHpVz4VjU3urO7dHkgudPaWVtoAWUumBx1JGfyrKc7wknsY1HeErlaK40vWINPk122gS9uWaPCvvRfXp36cU7U9JiurDT7OWCK6vIAFV5hlFYLwcd/YVyFl4L1/zrbUY9Wh/s15nZmTIRVBwvAH3sVt62ktylte2M8ssEMZjWRTt3S9N35VXKk7RZvB3ejMbV7wX2kwQaxdN54naGNjbjBcDmN04BUjGD1BxV7w1qtxNZSXejKlrFZny/I24X0IwaX/hHrjUdNtZru/Fx5MpmCXSbgGxwSQQeDVO309dK163kNjdvPqh8uUxN+4g24Jk4/h43c9BmrvG1hyVtWdDpl3c6hqe+8mjn0++s2DQP/CVO1uPyzWlp3iWxbVbuwgh2tbouOmDx0AH4VzUuqPYyQW8CJepLHcXMM9vIPnwMbB6HofyrmtQv57O+0rWbRTcpdoEnbZsPHBDDsw6VPslLQSimeq6xeJPFDPCdrlArgjoRXnUk2paf4ueOymlnfULc+Wm/G1lOcc/55rpI763WUQyXUImVdzRl+R35rktE1DVdU8SDF0jaf8AbRhyuAYumB3xn/GnThyplOyVja1HXba6sNUins3t3G+JAo2+bLs3Mg6fPyeD1I71h2dkLiTQGjiiWxu7X7NIbmHLMQPusTyCR0Nb8Oh7pNfs5xHctdSC8SOcEiMgY559R1FR+H/7QbS9TuL6Ix3LTkxxXOCGIGQEPfocd+KaaS0CN1uXdEstLt73+ztEWJ4LSSQTI+WkhYggBTnIHA68EGs/UdTna9Fra26x7HwzR/eYjs3pSWFrqMDpF4ctLO3t7vbJNcyuzz5IB+Yk8DtgVq3ltpA8TXRspWuLmeNWnCjMSvj5gp9fakrKWpS3sS6tFcXultHZRI05IcebgqVA6DNYup/b1ttLS2umaxX/AEbUIbfLrbK3PmAeoPeuutGY2XkWqp5i/c3cDH1rmvtFjpOoTXNk00jmURXEaD5BuOCR7A0oO+hM462JtC0WJdZub6LUbxroQC2fzV2eawGA30OKpeEV+0Xeo6LqY8iRlbMUgChwO4b175rVktdc0/w1ctZ/Z49TWUSqZJfMAQZ3A57EdKp+HDZ6xcx6zJGDcKzW1wCpRHbbjIHpg07tpsi/REsml3dvqukPo94ZdMgtvmVJQ27k8nHX61b0PSkg1nVGdZ0hvgbmSzuUGwf7SHuMmsXQ/Dv/AAjl5cvaxOjQzmS2SScSCWEjDx4HQHgg+oFaeq3eq6tJaJplpMumXMMkVxHI2ZYy3G4dOB6/Wpd3ovvGttSaN9dfxAT5dsNE24+RRvbI7nrmud0vw3oGm775ridYQSrPOcFXJ53Ad6ueENM1LR/EqW1xdrMotPK2ENt2g5GDjkip/F3iHRrrwp9qW2mvdOnufs05jXY6MP4s47dqd3F2j+APQtag0Z1iXSGezXTrmyAinkPMzHjAbuOelcxFNJ4e8CarY6mtvJd2NyWhilTeCTjBA9Otad14eGreJdK0yXUVaGO2L21uw2yMoGRz36Vf+IV0g0B4tNia41C1ZQ7xqGw6/dDgg5HX8qE0rRBvoO0y01vWNNn8xraHSrjTDtt0IXy7g/NnHv61lq6vazaRfqpv7a0M0JdQy5C5wxPA9a2/h/e2lxp8Nk88by3QJmRcvslPVPb6VsNp1rdpc28kSI1xA8S3C/fKkYx+FS58raY46bHl0era7LFNY3N2qlreNFKKFU5OSwI+mKpeIPEeoavby2sFi8csWPnQH94MYJPqTXaf8I1Y/wBpxWDiQtbW6oGHGSo61Yg0km1tTE7wNC7FyBksueBmtueCd7G0Yx9nfrc57RdOsra0sl1KSY3t2Aka5+6fQj8cVPr1udE1DRNN00XdtprOZ5p4wWTzC3II+nGKj8UR6ToN/a3/AJGJ7ZxJ5KceZn1q+PFEcMd9f2YmkheaKN7Z1yEV88+4BobbtJGNRbGh4s0280nRZovD0cd5c3LE5crlE552nrWp8IrnXGu7aDU0dP8AQZHIZcHPmIBn9eKoeIdXXSPDr3ZK3F5p8iu5DZdVckBT6D/Guj+FeqXOpeINSjuAE2Rb4wQAxQlcH1I9/eueV/Zu5jV+BnJ+MdRktrIPZaZdXTXkbQyLBIy85BUED23EHHWun8M2C6HodvYX3nSaddfvbd5U2sgYD5X/ANodM1wJ1rWpNW+w2cQdYto2Y5ljH3sH17109nF4ih8Ktb30kplsdUjkglX5hLbyHawb2XOT6YqqkWkkOatqUPEGoyXVj4h0/R1lR7IoiKn+sOerD8M1cv7NdR0C2tLt7mMEJ50ay+W8mB91gOoPcVn6vLe2ev6hDY6SgWa1M0l2ZCBuQdCegGex68VhieM6LaahcvFqWr6Y/ntHFL0PTazDgnHOBVqOisarVNG94jXT/Dfh/TtTsrCUQu21ox2YYGQ2OARXP25n1y1cvfW32+0bzoRAP3mzurr69Oa3rK71/wD03xBZ6g50qS3EsenSMrJgD5l2H0ORkCq3hzT9N1y/bxDYQvbXlzlhCWwIZgCGx6q3GBTi+Vakxk7lG98Mx3d2l5BfmKXA468nr+NTaBZ2dhqTyXF6sVpZHz7hp+soXoF9s46c1u6hqd7/AMIfLfT6dDBfyRyJ5aEZBX+Pb245rnYYFudF09ZZre2vri2zFNcSglQWyxCnjnHJqlJyVmar39tCxrGqf2tp988BTySo/wBLO4eYjNyOOR979KwdT03UvN0m0lluJILKZfMErGJUzgbg468YYE+uK7qa1tI9LOnTqgSWDyi0afKzdc4zxzzxWLa63eWOt3Npe2q3UVzGTEZDhSF5YZPA4zSi9PdRnJdzQ8PzLpWr6sb6KJbhZP3HlvhrtNvy/ITgN0GRWZPcQ61qhsNF0i6tp5WWWSXYUWJgFb5x1Byah8X6jpN7JAbe0We4tJmV4mZt67QCDhTkqRnHbIrqfh/qlvd2U0NtdXMptyzq8yEF4mPy/Mc5AHHqMYqH7q57Dk3fQzFn1OPWGS6O+MsQSowOKxfGNqs1vB5Exs5Wn3EDO1sY5I/EV22p2Eh1UPBHgrh+p+cd81leLo41tzdSoJFiBnXIzzjvThNXRqkpR0K+twamt1Y3UmoyR2E8Iikt1Tcd4GM+2awfE17caC0OoWl4v2a3bbJawAMGLcfMM9TjGTW5Fe6pqOqWN99ndEdbd5MH90FKuGyen901jeHrG3sNR1r+3IobJbmRUieVvMRixJRlz6Ec1UXZamT0VmdPba3DcaVpWoCyuJ7hzmSIsA8EYU5kC9WU8dKzPHxu9Y0uzm8PTZljmTzfLPzqOq8DtnrWjY+HxBcpe6n5sk8UoAe2YgJxgE8cr7VyFloNjFqt7DBrsq+JVuS8M5hZI/MB3bffIzkd6hKN7roTdrQ27fS45/H0V5aF1vY40upJBMSkih/LlXb0yMg/hXT6pFbW2lXUNtaIVYvN5KIPmJG7gepNZGpNFpeiW1neCG0u7tGg85CQImkJJIbrgnnFVZ/CWv3Wmm31PVJprUwhkuIBlldeee/UUtHq3Yb0JvD+q2G/SvENxZT/AGu6dbZQ2f3O0n5sfkK63RtIsYbnVtUsZZXXUWBaBuiMM5wffNeeeIr+/Fjo+rQz3EiWMoW4jJDlQOCDjuff1q9ba5c6Lo19fyXpuxe3AWzgUbVtwVON2env9KJ021dA1d3Ns+B4LTT5bbQ5zZXs06zeezFinPKqe3Hes3w/qd7pHi/VNN1I/wCgq5c3Mg4U9A2fetuLxBGNS0TTHBe6vLQ3EzgjEZA9uMVHHpN5qg1NNamjkspZUNuYcZ2qcjJqItpNT2Bu7uWLq9gsNe8zUdQgS2udkFtGR8zSHvx0z71z2naR4nfxKbi9kS2tA7AR787xnjj6Vn+PBpd3q1/YRXqwXsccUgZlOI2XBHPbj0rCvvFHiCZg+kaxHdSIUIjX70oA5GD0rSEHa6DUn8c6bqd7qN75ukz5KeXHMmSjDPysPcCrlqbvw94LQzRyXc13dLHclk+7GuDgd85xz7V01vruoX0Vnd20CtaTIsjjHzI3cc+9VPEXiK6ito5tIjsr23a4CSRSr5mV/iIA5zVKUrKNhyvYyvD2k2kt1e22rXavcarbqPIdwTKEbIb2OAK9F+H2kWmn+N9Uu13Cee2CYc5G1WXp+lc3aaZZahLPqYijgvY1aFD/AHEzwfY10+htE3j1dltJg6bIfN8w4z5kYIxj8c1jVle6Mq+kWjzrUNSOkWs9y+VkU/KFxuPuPWrWieKPEF+0lx4eZboyW4ZYJlwPMXh1I68jFZdio1Dwzc3d7Ys89uWxb5O5gD271uWOlaQjaZ4nvvP0x4XjiRATl2fICEenetp8qWqNqj5tWdmN13bhru3hRr62Uz2MxGFPUrn0zXmll4WnbX/OtLb7LbGfM9qDxjPJVOpHWtrVL+213VtY8NahcHS7+7AXT5XiOxuePmHZsYq5/ZS6noVxpUOpTjUIVjglvFz8rKR8ozgj86zg3TXqZR0Zy2vWl7p9zHqd1d26fY5hFbpboUXys8qR2I/Wuvi1nTo5bhbVU87TlV2zHgsrru+U9B6Z96wvCrWms2mr6dNbXNhcqQhFywYzOON65HDe1U7rWh4cjFvrmn2xuZD5S3CtgXFuv949mHPWra5vd6oq6E1iCS61rR9Q0WSebTb6bzJZkUEQ9AVdT7dazPGMenNJbalp9mbk24CHcu1EUE/w+nNa7Sf8Ijcp5l3E3h/VmDWSod0sG4ZWUr2GSM+tRagUhFhaeJ4JLWaWWRDPGo2SbhhWI6Ed/wAa0i9gi02MttV1DTrK91q3nizfRLHbQSDKwnOM46Y4I/Go5dV1XXPD1vBe3NtG0Fy8d5GG2GaP+JEB/UD2pPFAbRbYtBqL6owMVpLZTQACNQAQVA7E45qlpel22reNJLjX4rnTzJKwjhLbR5mB0yO/qKEotc1h6MLIPH4i0EaYhn2hZVmaPa7pnGDk84wefau4tde02w16SC3mjtTLNJHNHJGUVmzuyp6DPHsazYfDdxJ4hlWS7lt7X7O8EEcHZCMZ9jk5rj/E1jqa6XqFre2sk0scsVubnbkuVB2SJnq+3ggelS7TdhtanrFvqNrd3+pBLsC7tGCmNzgY9Qe/pWfqGt2kiy6c2FnSHzRleGU5zj3H9a8nupNbslt5NPjnV5olF3Kw43r79h3r0bw7brf+HP7Ru5lmu1iZHMZ+VhngfhUSpKGpdPTcz9E16y1XwzNa3llcXNpcXAtJUR1DxK3AYA4zzg4rQ0200zw/pcul65NFr0lrcCOGOOLd9nUdM56fTnmsbRn0q/0/V7P7PHBGY8B3GAX6KfrnFc/c2Mkvgye6kvmTVdXvRC00QZBFtHKHHUt61Thq0Z1Vd3R69eRRDWbe8t9TFtd4xPbH51mXHG4dBisu61e11LUJTeWljdWkX73dAuyaCaMYByD8wIyPxryf4Z67JYX66PcD97IHU3EiFipPQHJ6cdasaxczwXt5a6Za3H+mQbg0WdwOT836YOKXsbOxpSpQlTcpdD1LQ/EUHic3T3Wg+bpsSlopWPyEryMEgYOR+FLfeN7WXTZ20lAlzFlXiuSEKsR25+aua8L6XcvaaILa4MmktaFbmInGXzk5HrnNXviH/ZMa2TT6Wlxcy+Z9nhQ7HIAGFBXk81DhDmsZqFtbmf4RtxrGrXOoXF3GgeIrfWvAD4H389j6murmsPDd9oN+ZngfTGAaVlk+QFeOo6e9eZ2DmZ5tPuNAa1/teCTyUDsksioM4DfUenPSug8LLqI8KWMFrFZWWktDPb3FvcIXkklOQBkjvkdaupF7piuaWgT31x4Cv309bC6uYFkhsJbXBDRAj5PUEDsam1dddsdHt5syQy3k1rugQ/6gBfmHtnH61c+HXh+/0a1ZZI4rewmhRxaoTmCX+Pg+vXOfaul1VltElurqdI7WJA8jSHAABx1/GsZVEp2WoRWmp5748sLC88VvaQWskV1eWge6uNvyAbONp9a4zSPANylxO63jW+2VTG3UlB646HNeh+PdWsdMnXbPve4gLQMBkKDwCD6VgeGZdTl0zfqU9uJt2I97jcU+neuim5KCaKja2p2ljpymKEvIxVR24BFJd6Zpmg2s7jKRuQ/HzMOeq+lR3up3GlafK1nam7l2jykJJzWVHcS+KNNvLWaWKO5Eypkn7vy7mT36VjaTd29BtnQt9nt0fyy3luglkmB6xjkk+9T+CNZk1Dxm3kQE2TaezRykEHIkQYP515xo/iGebxRDHZ3TLpyn7K9oRy5PGcehP8q9U8E+HbnTfHOo3skm6C4tSIolOFiXeuBj8DSqRUE+bsc9dtp3K+l6tJGFms7i0ksjHvZ5IF3r3wQOQRWP4o1RZvEOj6bNJa3FvcYuHiuF2mQg5V0YcAjHA71i6nZRvr8Gp6TqH9lXd/Is11a3eAjImA2O34dKWyu7R7Z5ItXS2jhkltLAXESSMjqeWJP8PIwBnimqavc0a6W1N668OSR2dzfrM+pyLKbqzWXh4QfvpnrjOCMdMVWt4Rea7d39hexefLBvvNIfAYMcdT0685610HhXXftOlRtqtsHvI0/eSQOPLd89FHbjmo7HXPB+r+I7p30uaz1ezwss8iFCQRgcg4YfWs+eaumhNvTQ5jVdPguNUtNTgvTHfWh8xdPdgDcjOfLZjxnisPXBB4pk0/ULm9t9J1G8V7cSIvmQeZ/zzfP3Gx0Ndd4m8FWEmkXU095cX+lKxuIyrgSwuAeN3v8A4VieG49Cg8JKl2zW0F3eeWrXaESBwPlyDwDjv0NbRmrcyYJXehznjCWfSfGmmPd2c99b2+mpA6qnyZUFS4Hr3xXaRXNpfx6HA0kc/wBqUFIbhMuUAJ3AdVIOK6TUXttPgzcTxxRYCKzHKliMdfU148usWcHh0zwsLbU1mdYpJJA0gTOMp3GPSnB+0S8hpKJsXsFpd+IZvDG1riZVeZZN5V0c/NwfQdMGpdKis/El1Y32txXCXmlKEL7jslwTyR659O1WYhNrNjpPiDQbyNZraKRNRmkhCvPtXIbPU8YH4UzS9Ju9d0O4le78m3uIC1u7ZUjPU471d9NWOPvbm/4kgN7bahqmkXAWZtPkhTa3CnIOQexwDUX9lRz+CtOgmu5mun2TwTsw3ifacH0x298VXspz4dXR7eR0nhuCLaeRUOx8rnPPQ5HGat6hrtjbz31l4hglh0+28oxPbryFYHDemQw7VlqrJFWViW309tS8JhNQ3JdvERMzLtZyCQTj8Ko+GtL0680S2i0+a4S3EhbKvyTnHzfiOlT6hbW/jzwql7o+oOs8JChHb5wgJ4IHY8kH1qHwzbw6DBHCZPOVGaQ5+XPOcUJ+69dexUJOexQ8Z6DewMkdlLBbW5JE6YwHB7mmaXbGTwhZ2MllBMsV2rFgxJLbsLJx1HTPSuh1SSfU2luoDFf6bMqgrGu5oW44H97rkntVT+zIvDKxaqshCQOC0Q535NUp3ik9w3jqZka2M/iHV9ISCKK+3LNiTgspx8yHHPbiqE6RapcWF1BmGC2ka1S5DhGEoJOCc8g88e9bPjO4t0bRdZWO3khLg2qldsm4nOPM7Dk/LjqKf4s0q1ufC92ul2RiumxeeWF5MnqR9M0KWzY6dSSsvMwfDmrXcvj1bR9TV7Rw37tMAAgd6z/HqXGqeOzb2sV+tzZxskE0QHlRgKWy5PTJJyc9KveHdA0LT9MvdSuWuIZbWMrdHrgyAYI9uQRWt/Z41HTdLtHh23d/ta4k3H5oEP3j65ABqrpSv2Jqe8+xzuleG/Gjz2epzwxNc2Ue23R5FOVPXbzz17+tdXqdraaTFq15qt1IbZ3ivVhR/njYYVgAeq5rNvIrS1uZLLWLmXTrHTpQ1qVzskHHUnvxVu88LW+ueIp9Tubn7RYNEGgiQ5BDL8wJ9MjIpSld3ewkmXNf1vTrXxJ4evJdTkt2eKVkH/LGVWHyhj7mr9rLa+LdFu9N1Kby0vAUiDnaxK4JIHcAiuD0u1ha1s5hBDc6fFeG2u4LwAiGFiRlWPTGevaunubTShrkx0SZrvXdCsiY9LjyQ4U9d2OvzZ4zms5QjGy6kTfK3cuXfgyGWC4g1CFZrWAILRpG5XAwcegPHFcxfWum2Opx3Us6Tx27iLyY1yQ2KuXV7r3inXL7T7mY2OlqsE6Bh8y7lHyEjvnP5VoHTTb3EYtLYBFbMjSDuBwRmtISkviY4u6K1pNd3WuC1PmC0l3MJCm3YccAe9TeD7NDfTW/mwvHYXAeNYyfNMgBBL/if0qBZLmXVYtWuJTLFZqxtLRTtE0mDjI74/pVfw7Lqgu7gPbw29xND5klxt2s8v8ACp9eKGm0yr9Cr4h0/WB4nsk0eOzjd3PnOqDLFjjJx3HtXofw5bVobq0tNSkM1xFZzedJI2WJ8xNvPfjNeaatrbaD8Q9O1W+kfyZBHGIU5Ckgbj+td38O/wC3J/ihr9xcyZ01rci3z90jcm0r+Gc1FVNw17GFZWizOk0eTxKLm1uwkmmMgl0+7UYdQeGQ/Q8c+1M/4QPSBo1jbSSE3UDO0EjMF3vj+Id+gqp4J8RtbXLae9tcmy3/APHyy/dPrgdq0Nd8OXt7rdlcNdt9khmMgQdFJIOffPT8ab5oy5b2RsQW92+nWD6bAkNtfRRh8O24H1OfWpbbfPo5imZWnflpFGB9M1zVzPqMPi3VbnVLUhTjyeCY2gHcEd+ldRo17YX+mpJYMNvmEFD1H1pyVlc0jrqObVoNEtFW5Zikw8qSLG5ZAR0I78Vr6W+i6/ZRaPNb7Da7Gh80ZVgOV75496tJ4cj1qzmmtjC00YG6BwGRiBxj0NYYRrFmniiMcgAyMYPHesvdmtNxaVHpuaniCKG+1b+xNVty9vdwlklRipLqc7T/AHT6EVkPoPhWDWorS4gistVYB7dbgkpOAMEox4D+o7mtrUvEkFto9tqdxYXE5DiKbyRloQf48dcfSlvtZ0dNd0qy1O3eUTgSW11JGGQMegB6q1TFySsrmTvt2MDQfBU2harcCC4muNPlj3FDnesgbjA6YIPNVtQ0WbQtCu7nS9UltlS786HevmRorf8ALIr/AHc9APWneINL8VXmsraJPPaWXm7xdW8mNgB4bryParmoXpvEOjarEbiKaFkudSgIRFkU8Sbf4TnB+taXk7Nu420ReG7ez1idtWguVlVx5dzaFDsSZe4B5Uj3qwbu0vtFv7DVLeWC4R/Jw8RcLnlXOOq+9ZHhrw7eaReyNPrBnGrK0Ms0JyCcfLIR2Y9zXO2N1rNjqNvpMGk3NxJayus1w+WbDHAYHpt6EDpVcvM9GPmfU6zRbGy0GB4rOKOXU7eHJEasoILZ2jnkZ9ab4qvD/okqRxi0lJEpLZ2NgZQn1rmtJiurGWLxRr11fXEyyG0lggXaWByqlwewx0+ld9c+GbG80O8M4LJLcpc+XnAVsYP50pNRleRcZJO6F8N2ECRWIsdPd4MnZ5T7UhbqztzyT0q2dKi8+bStRnlvZPLMu/yyEZM9CemRWV4N8RGWXUNPUpbmAtErKMqT0U0Q3uqaXb/ZbsQCKZXLSxuW2NjqD7ms3GXMxO8pOxHrOhMNL0+xWMpHZ3iSpkbmVc9Rn3rI1lr258RarJHcLbfYYleJXUjKEclh/EuT1o8LahdvNDJLqnn21rcs8pDFv3Wxty/yP4U6w1p28H3UuqRpPK7SrHERh5oM5+udprW0ovXX/gis1ox/gyFTDpz3K/aLW+tfJkSXDAhVYjPrzx9KfdeL1sPE8+jR2KxpHZl4rmMbtoAzjHpRaeJ9L07Q3kSOP/iXloYoVYEvtBGRnkgA8muQv9c020vIL/Tbm6WPUB1kj/dAZOYyeoGe/amoc8ndCaSZrQ2sniPSLLSNe1C0vJnujMVR/wB5twSq5HTPvUul+KCumzWSLaaTqenyeUbW43BAinoTyeRnkd6xvDmlNLqMV1oMipfhzNdRXS8quDsCZHIOc5HtVq5jvPEOlXWo6xoyPq+n3ixyvGhVniPGePvY4weaqUVe3Qet9DubXRrHUdHuLSW3WNb4HzFR9w3Hup9PSuNt9C13SfFltJbSEv8ALB5+ADNGADhvYY7+grqPFCXz/YrDT5GtVuVU29yoIEU6HOxyOzKfzFZ/jxtaim0y+0aF7i7hDiUKuQflHb68is4Sd/UqS5jtdPntLq8vIPMj+0rL8xVQCADwp9cVgajc+X4pNos26W4UskIOdg7sT2FJ4TlupZbfUn08f2lJhruBGAJBGN4U/gSKr+IPB8dxdT3FpOIby6csSz8564HoKzilGdmzHZnL/EW2v7U6HcqHdYrjcPL4HUcfkK6jxN4dn1240y9luki+ysZZEXjg8gY9feql1qGoaJp1vb6np4n0+1jNxeXMg3DrwsfqwqrqGpfaUt7jRhi11pMl5Dl92cY/DHQVqm3a33lJ3L+t6PZSWA1HXIBMtkTKdvBdVHGPf+ldZ8OtXs9V1CG4tg0BnsmlELj5lXeoGa871J9R1bXdT0S5tp7bRLhUtY7lTyGUAiQ+oPce9dv8K20qe9E1pLJdvaWh08zgEBtjJn+mPpWdRe57xnVk5RZxGr3OqtcWkdtLFaaaEy7qAX8z+fTtXR6fq5ks4rSG7juLptrRkkKzpnkY9RzXK+JrV77TBaRSMpWTeXA74P8AjXJWtld2N9Jf+aWWzgLxgnlnBAH6mun2anE3acT0rWPEd5pmprZ3GkveLLuJMbEFoQMNtXoXXrjuOlZs1lBoWm3v9m+YInBdSTjlsY+la9tcWPirTrS11ST7JqBUTxPG+HQ+oPatC+t5LXSbtJ7V711ULIhGTNj+MD+93xWSko6WGtLmJ4G1C907TreZrl0lmYqFP8S56Vv+J9S+0aPcIY5ftOxgpT72Txwa5ldMup7eO/0c7pG2slu4yNoHVfT6HkUeJ4Lm8t7G2vVurWdXDu0SYiI7lm6Cm4xlPmGrPZEXg7xE1hp8UV0bm41FZ9kMWMkj0JHQGul8EanPqup61YaxBELizn8yAr90rnoM9x61m382keG7Y3sSIZ5xtjIOQSf5Vp/2fBqWlAAi1u5wJDIvB3djmpqcstbWuS4m94kgEumRpBqAs5y26KRj8hYdVI7fWs7W/DsNz4U1W0uQtwlwC4EOVcuF45/3hj05rg9e1bVtP+yWrkXOAQ7+hz29eK6Tw34xma0a2uruxKBflmCbWiY9Mjo2OPQ1LpTjFNamck2jndFC+HvDMDajeXVlcXBMVoblCxgl6ANjt71p6lPqMlnaaLqc2+6vA6tewqQI5UIZeMDgjv7U1beZ9Q1UapZodJdFkEYQyLHNnl1PeNu46qSPrUOm2eoWl9cR2t/9p0kMZUjnk3y2zHHy57qR0rTfU0pe9JJmlqcccF5p2qC7mnljhNpKqn5Lj3YdiDnmrbwPbagl5JdyxW72hWaFhmNj0BHvXORNLcad4h0zSBcC9imS9RcYYKxBYL68g/ga7vXbdpLKZihlZIyVU8g8c8VnJ2shtWbieU2OqatYXlx9qUSWkiloGjCGNiD/AHk6HHY1uSXIvNNhvb2R7SMNggqWJHsK5zQ9N1C3SS91G0iTTJmaSRIQUK7QSDt7elaz3thqtslytxJbW4OzDHg4rqaXQUeYs6Zb29rp2rahoUc10GAmMDJyQD83H0zRpyR+H/D+n6jrJFy6zPGQX3COOQgdB32jp71raddwT2NwmlXECzRLvUkhMjHIzVTSLuxe8vb26kOxI/MJADokpG1uB+f1rJu9ymZ18sd0ZbmTRLbUdIQqbVX3QkQt/dIIJ/HOKd410Czn0bRNOsvMt/D65uRO0mXiY9FIwM9TyfSr9zqw/tL+0tMnW50azsd7qhGGwTkbc8EVyGrfEeTVIp0/s/z7NXAZWXAKE9R7+1NKTasRaF9TX8DeHU1HVre+mmnluLQMovEcqJcHCAjpjaMHFd94g04NcWmoT39zYfYMyMYX2o6Y5De3Fcr8MLuK01OfRkJjiAEkXmNjeG+bj8D+leg6pbLd272t6hlgkBRoyAVkB7Gsa0mp6ltR2iY3hvWYtZjuXtryGZUbgwnII7ZFTC7mXV57B/LKSKJoGAIJx95D7jgj2ql4L0fSNISd9ItJrQO5WSGfO5GHYZ6juDUGs/2lrFrfwabbPZatp8yyJNnIdezA+44IqWk5abCTdrk3iDSLa212y8TLcSwNpkbSyGLkzR4ztI79/wA6xNJ0fUNZ8WWWt6bfSNo11O10IpmKsqkcoV9iOPrXdWqTCJJZEEmdpkQD5VOPmx7Vy3h201PSfFWpwFpJrRoTcwXMowGlJ+4O2AKIysn3SM5q7ui9461iHTpLHTZbCS8+3yiGQRtghT6cc9asX/hOzlvNMtFSaG2tFzC8XG3Dcj6965K/8bS2Kta3gI12K4QSboQVAZvug+uO9SSSah4d8SSTapqF1MutSG3gigJby0P8foCMjj61ShKKVtH+ZLvYv6tYabrupXVrb5tng2yCZWORycq2e/FbXww0oWni68uNOvoxpj2hRbWEHar70Jb0J68+9c/ZaXpmmNDoV1eSXV9cM8ksijBkye57EV1XwktxZ+INfsorZobS2ZViZjnzMhSTSm7QaTFVt7OxgaQ9rqEk9o4U3EEfKghd3vz/ADrQk8HxXVh59iV+0AAvEDleewOK4bwxqNv/AG1BYiIpfJCImkbow6kGvZtFvraaKK1nSTk5DxHCoRyST2GfzzTrOVJ3iaTqNK6PEbrRrm0nCSBhcRMV54YLXQ6J4xt7p7bTrtpfPkRmEp5C7cda9J13SLLVbV5FnSS/TO6RWUYXtu9u2a8xv9Et5NQeK4iSxnj+XzFGDjOSPxNXGrGsve3CElJXidDceXbalaSQtEJLnKCMHDMR/GvrisbWfEGuQWghls7dgbgRmV13xXC88BTyG45HaqF20eqhbBJPLksyXgkcZDcfdYdgfUV1GuWY1jQre3uW+yvKqOzRtveNx/db1HrScVFrmHqc43iGy8Q6SsVvpcbajauRLb7eEAbAI/w7Vo2uqQ3WsNFbXatPGgDxjoMdQD7VxUs1xp3jmTT7CDyNSz8lzOTtvAV5JyOGJHXpmrqf2hp2paneyWVvEybSwjP8Ofm/Hn9K15FayCMmzsr+K2uIDHdLksCGZOo7A5rzbXtEudGmjhskkljnOQwXJYg9q9KjK3K2mwsI5FXJz69K29e8OXOmqjIyzR8YOOVPtURq+zdmDtomzO0ue+kvraJYv3T26ErjH8Izn3zms7Ur230zWhPc6bFcs4eOGS3kwXIGTEyj+Ic4rptKB/si4kmD/aUbKOi5OK5CXRba1+1T2jyxX1zOLyNnO4LMvIOD26j8azi05MLN7Gp4Z8TWWpxJfLbG3eN40QEAld+QMnrjIIrRvtYnstZ06CW3Jsr3fE1xuwIXAyNw6YPPJrltdthM0FzZ2kc6X4igvIYciPCndvXvnnINdbBYPJowtby4+0s6PE0qjG5TkD8cfrUzjFagtdzHuHmfU7iOGeC7s2JVwjBgvHfHeuGKaNfX0mjDduhckRoMAE9a6z4feGLvQL7UPttvF9mZdkfzZY/7XHqK2tNg0PWbe4u9JiiLsWjkn8vawYcc+uK0VRQdkaRn0Z55q97ot1o17osMsm+JCQYxwpXnBbv71BZaHe3ej6PYaKtza2l2hlmdwCokUnksOcEY4rptK8OtaXjx6tplommQlnN4jkmU+69q6+41zTNIks4ZBIY51BiEacBe3XpVSqW0irim0Yfhfwha6HY+UtlHLM0eJ5NvM3cjB4xWNDHBaatqVxBdWhgRP3WkLbhWRj/e4x1711vjPU7zSbKS6itp7u13qrCD74U/xY7VF4R0K0is7i/sJmuvtbBy8q4dOOAQe9Zqbs5yJU4nLaPp19ZatZ654h/s+3lbMQjx82D9wL7jkfSu20S/mluri0vCjIf3tpMpx5iHqD7g8UsyWh1W2S/hBvNjG3d13AHuPY8VJr+oWemaW15fLK0UbL/qEyyE8ZH9amcufoN2LMhW3xv2LGgJPYAdyTVaDV1a9jFi8FxZyho5HjbcQ6/wn8P5U4eTqMMMlu+62wGZHAO/IyNw7Vh6kdN8LPNN9neKDUZVDeSOFkAPPtkCoUU9HuJvuaXieTVotIuD4dkRLpGEhDAHzFHUc+1P0TWY9Z0bTr2NQEmQOwIwVPQ8fUVUvPECpZQNYwrcTynIiLYZkHUgd8d6xnsNZtrmG7tL5DZrBLtt3+UbmOVz9Cf0qlC610FbW502sadYX5he7s4ZGWRXDFedw6E+tM0zWrHUQWtCJ7dJGUzY+UMOuCap6xrU9jpWnSmya6aaWKKcRNnyt2AW9xms3wwbS/0uaG2hXT7aymmjWIdGKt3z3OaSi3HUT10Ni40qyiuxdIgWXJZJAOQSea2PB87xa68Ry6vDLJuPYhoxgfnWHPJZmaTSy8sMkEazfP3zyePTkVueBnjfxLewgZ2QbgT05K5/lSldx1Iqa02cPrPhQXN19tsI47fXBB5k9qpwGXJG9D36cjtms+08QSafqj6dMJPPlKorqOegzn8a9Pn0+0guLCe83zXFpCESUEhgQACePXFcB4k1TRpNahs9TikN4snmWt7Gm0r7N61tTqe0VmrjhLud1DqFje3IDRmG5jtj5Tu+5WAX5gV6cgdB71zuu6RcXtpHqRa2lstsSwyxEqSO25T36Vzb6rfaDeFb/a6M2+CcDI+vt1r1Pw5q9t4r0L7OrLBcDaXVQOMHggfhWU4yo2ktiGnSfMtjymazhHnyR4818ARAYPuc02JZZhHbw3fk3qxssalvve31HY16J4k8KRz20k9m4aeHIkCjn64rynUolsr1b+4lMUkC7QBzzmumnUVVaGykpK8TV8PPql9azaP40/fBVNxp16oxJG6nlN39KlU6lP8A2imo6aJrgwsIZoxxPtHIPueCPxHatHSNXhuYoYL0NKrqJUlK8VNrN3LFdw2yW8pt+Ge5twS9s+flYr12+9Q21K1gty6xOS0rxE801hFcqYRcII/K2nJYHGR3FerLrfk6XF9sfzZE+Uqx6jFcyLLTtZ1+4tTHFbeJbSPzIC/3bmM/xL75rN1HRPEskMYmjcBH2uRzx36Up8lRpbCspb9DsvC+tw2ks4YbopBuVRziqOqXUOqXP2hYljEZO1egHqTXMaN4d1G01prxjJ9mMZAXuSexFWvEem3+qWTafotzGs6uv2pUcBkjPX6VPJFTumVZJ85keKNNdNDs4NNuWfE6uhT/AFjcZ+UdyAc/StPQfFVraMtos0twZb1oVhZQrxu3ODnsWBH41yeu2turXlvpeuCTULW9Q2y8r5Tqm0qc9cjj8KqXek6jLqXhzKxWWuXTfviQGSU+Z98/kDWzgpRszN63aPTIdevL/UoGtrdYbIBkvIrlCssBAJ3g9xnjpXP+Gxeadp82o6TPdazDc3JQpJD5CqM8uR3+oxVrWfET6r4klQRT29na3MgkmX/lqEHUfU54q/4G15P7HjXUZpJLiW5aNEMeWCk/KD/jWXK4xukWujOvgWKTT4xdRIxKhijDIz16VDdrb3Sos0MJZT8jMgJT3H+FT3KF4yIyd9ZVwsoXOcso6VzxVwUVJ6meNAvLyGVYPFE8uq2zF4pnQJ152OB1U/pWfdeFdVe7ufP1m6EN+QsotxhVbaTz7DHap7aOd7ue80+4Q3qqMwHpKB1X6kdPetiaWK+0+KW3kKxsRIsrN/qnHZvT0Na8zj/wxDjYtRWkVjpqFnaeWKPJMjElyB6npUFjeJqNvHcWPzHapZcdQwzgiopLyezuJnv5YjbjLKsYz5a9ue/HepLS7t76yeSxdVSTIDoBwfp7VFna7LgmjmU1aHwrq14mtko+osZkkVSQ2CFVFHTgE1n+LbyEapJaXKXWoWtwNk9lFxJDtAYSJ3zjn3qPSdU1mXVF0nxtZxyadLK4trmSNVxt5DHsAeOau6xDeWk1zrc0FvNJDcr5At87vL+4Q3rkYNbpe9d7/wBWBanOW1zqEMumx+F3j1PRrGYybmQJKjZO5ZM9Dg9eAcV2Wl6oPEvhyZ5owJk3RzQx/eVgScD61j6Xol3qN3eXt60dibldkbQ4VnRs5DjvjjryDU+kXF/ba/KunJDPpKRrFKHQLLHIvHbls9cnPWqmk9t0JK2pqeGdRt9Z0aK508NHGq7Cjn5lIOCD7iqHj23WPRHmjJQbtx2cZbvn61PZwadaeL9Znsr9WZo0e5swuDG5A+b8aj1nXdFk8NyXt2ZZrEyiCU24y8bZxnH61kviTWxtSrcjU10GaTNb3Gn6BqTKz3KI1hOCeqdUJ9eDiu38JWjQeI5Z4Msj27Kf9n5kwP51yV2tto9i91EqG1CKU2/dYYGGrtfAlw011vETANb7sdxkqefzqavw3RniuVxlKPXU57w5rTajpe27ZFu7UlZF3ZwO3P0q9qlhFqEUUscMTzgfLIoBYe/1riNLheyR2ncrBdZi38c56HPtTPB3iS40bXFhLrdWRZtsmeozgj6jmtXSabcAkrLQvC1+3I2na4FeNuPMI2sGHQisjStTm8IeKrTD7oNwUlWyHRjjP0rT+LMkN5b+faXDRLlXDKD8revFU9O0eS88PwyS7Z5VzKhxnacfMAfQ9a0jZwvLZ9BJcyse4CKKORruE4inAZmB6e/0rgPGvhETTzTQRi4t3YNJGRnFN+E3jM6hcXGg6lH5TwjNvv8A4k9PqK9CtbdD5p3g5JTA9B0rz7yw89TljKVKTueQy6U01kxgIS4jTES9gQOBiiz1W8n06y1JrInU7cmOaIAhpIh12e/fFdR4h0mTTbzzITvgYbhxzn0Neca9b6/Z6zdarExltreMSRojdORkY9uc12waqI6rpq62Orhmsrg+RrVxFJJclhbSL+7leM+g4Kn1xjkVqWM9zomksbu/ub+CJwqTMhaRE7byOT6Zqhbtb+LdEgvo7byLmCRZYHlGcOOeCOx5BFa0+oWemfZjfTeStxKI0ODtLEdCe341jLt+Aabsfpmpwa5bTXFlPMYoZArhQU59s9qW206ztbi4ktohBNM2ZXUYZ/c1NqOm6nLqemXuhT20NmhAureRT8y5O7bjjJ4qjo0GqnxLqUt1Oh03JEceMkHORj0GOtRpZ2ehKknc5vXtAhufEdrGktun2hGuLuFgA7lfuyrgZJByDXQW0FlqkdnqELI21P8AR5gvIB7jPSrtxpVjf6tbz3ARr2xyVZTyocH5T7EZNcpF4q8P6F5mlxGQRWcsdqgQ7iN3XJPYHOa0UnNWW4Xs7m34guoNMsnu7qJZ0kkSJYlQZB4GT7epqazuLL+3EhEsO6SMmOPABDL1IH0IqMXkWoN5Nu9u1tEfMmd2Gx4iD8wPoCOawbC503Wr7S9f021hMNnK9rcl3KvG24BWXHDKQQaSWlmXJpK3U2G1ia1m1CaZWNtFOio2MAIyjkHvg5rQ0WaC+1GLZKJopTtJBqs2ko2kXtrfTMVvZzEoz/q8KQMfXrWH4f0qXRLqOCKV5pBIGLHgDHoKajGSdtxb3RUt4JvDXjZ2v5QkLOY1JP3sngj9K2YdFj1PUvFmkwzumn6jEHkUD5oLhSNwHsw2sPWtHx74LOvpb6jJcPGUGW2DJFWdKtVgvxq0OWaaBbW4UfxMpwj/AJEg/QUpVFKKknqZN8yujz+00vUXv7K4nvJHS0d45lb/AJbJt29O9bWnlNHgWGwtXKSS7iNx+XPpVHVtureJDb211LbXVlMdy4+R0/iA962L5o9OtxNMcRN90963bulfqbpplXV/Cc+r70u76SSyaRJTD3BGQR9CCPyp4jNolzbaPCZJ1CKYp2OFUdMZ68d60dP1qI6eLkyOsIVneRh9wL1Jx7VNZ3tjrDyz6dJFPLF8srR+hGR+FZc0lo9gVkcx4o0fUTp32u2uPLuLZxdeQpLbto+6Ky/CviKO78RaalzbTJqF5DFHO0QAiyyFgxHUEbSPxrtYtZsJp0tDNGt7ID/o7t8+B14rjfFWl3mn+KtO1qzjBst8cPkxnbh8Ebm9RzVwfN7siZJ7o2tZisdR8RSQ6ReJZ63A6G6ZI8NNEOdmeh+tV/Cmn6XNPrYsGjubK6n3S28mTsfnIwe1UNSne8sRfeHrq2bVIUOJiAHKA+v5j8KisdZg0y7iNrFAmoaxEX+0K+YzMB09uaai+WyBKx0csLadrIlvL+KHQWgEK2coJCv7cfjXc+Cyv9qyheB5BxjpjctcZp1tc694agi8W28L3olOfJO0OB908d/Wtz4T6wNYur0/Zjata77YxE9NrKKwqfC/IyqO0Gee3VtcaxoEVtOktrJDIJEKryCCeRWnqlnaafZyXa2zi5l2mSRRld+MB2XtnjJH1oorrb1SOmSVrnHXl1qIV7O+do7nBdVdchh/d/Sup8Hxy6voV7p8MxgMsREboSrQyDpj2zRRWlXSndGVzH8R6Lrekajo9+rs1yuxpWT5QSp6/jXuXhi8h1G1D2hYPIS7FhyuTnH4dKKK4sR79JSe5FdLl5jX1S1iOnTeYgchTgt6+teVHWooEnSSMTOhOY41wT7UUVlhFzJ3Jwi5ou5B4f8AFVi9yLe4tpbdppFigVU4U4PWt7R3Ev2201BEleJ96fIMSIeVbH5j6iiiumtTUdjdxLWma9Hd6rbQ2MbzWl0JB9oU8ROgyVYEd8YrQF/aTSSRR3EPnxY81A4ymemfSiiuecEnoYy0Zm3TaVo+ovd3FwLea+2Blc8MQdqn2zmuZ1vSNC0W5N5c6VK0NxOTNLEu8IxHBK+mT270UVpSvda7jWpS8KaVYv5gtBcoLWcjypwSpVhyBnqp64rpIdBh/wCEd1LTYESJWVnXy02kAnrj1HFFFOtJqVir6EoMmrWU1pJG0d5FLE7AHHzAjLKfQg5/Soru6WCdwUIfqCByKKKUVeVikzb1We7/AOEKku43ysahygHJXvWf4bvBcRLwQkq5APrRRWcUuSXqYQd0/UiWytl1wyMiI0nWQjk8d60PGej2V1oASTO5TlNn8qKKHJ80dRzb5kYnglYzYSwrA8SqcYlHXsc04RC40ScIl1p/2fcIkg+V0CE42gdR3x3oorSfxs0uYFlB/bNnb65DpsM2twnyxLMDD8o6n0zXVlEubTbIiSqRkr1XNFFFTSVuw0znvDvhC10VLkqDMJSygkY2oT90+v1rBtbe10rxXb6BdaUq6XK32mwmOW2zDqCfw6UUVdObnJ3YPY6DxlqkFlbrH5k6SRA3DhEyduQK3vh7C9/4g/te0us6dcWLfuwm3dKXTLn3wMc0UVMo8tLmRlVd4NH/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Medium power view of a biopsy specimen from the erythematous area of the distal esophagus. The specimen contains cardiac type mucosa with marked chronic inflammation (mononuclear cell infiltrate) diagnostic of chronic carditis. No goblet cells were identified.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Donald Antonioli, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Barrett's esophagus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Medium power view of a biopsy specimen from the distal esophagus in a different patient showing intestinal metaplasia diagnostic of Barrett's esophagus. The diagnostic feature is the presence of goblet cells (arrow), characterized by apical basophilic cytoplasm, a dilated lateral cell border and a compressed basal nucleous.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Donald Antonioli, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_63_2040=[""].join("\n");
var outline_f1_63_2040=null;
var title_f1_63_2041="Clinical features and diagnosis of pulmonary hypertension in adults";
var content_f1_63_2041=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features and diagnosis of pulmonary hypertension in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/63/2041/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/63/2041/contributors\">",
"     Lewis J Rubin, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/63/2041/contributors\">",
"     William Hopkins, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/63/2041/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/63/2041/contributors\">",
"     Jess Mandel, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/63/2041/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/63/2041/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/63/2041/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients suspected of having pulmonary hypertension (PH) undergo extensive diagnostic testing. The purpose of diagnostic testing is to confirm that PH exists and identify the underlying cause.",
"   </p>",
"   <p>",
"    The clinical features, diagnostic evaluation, and diagnostic criteria for PH are reviewed here. Classification, epidemiology, etiologies, pathogenesis, natural history, treatment, and prognosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/47/19193?source=see_link\">",
"     \"Overview of pulmonary hypertension in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/8/7304?source=see_link\">",
"     \"Pathogenesis of pulmonary hypertension\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/24/35210?source=see_link\">",
"     \"Treatment of pulmonary hypertension in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17914458\">",
"    <span class=\"h1\">",
"     CLINICAL FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms and signs of PH may be difficult to recognize because they are nonspecific. This is particularly true if the PH is caused by an underlying condition, since the clinical manifestations of PH are often obscured by the underlying disease (eg, chronic obstructive pulmonary disease).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17915165\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with PH initially experience exertional dyspnea, lethargy, and fatigue. These symptoms are frequently attributed incorrectly to age, deconditioning, or a coexisting medical condition. As a result, many patients do not present until either their exertional dyspnea becomes severe or they begin to experience additional sequelae, such as peripheral edema or exertional chest pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17914986\">",
"    <span class=\"h2\">",
"     Medical history",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial symptoms of PH are the result of an inability to adequately increase cardiac output during exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. These include exertional dyspnea, lethargy, and fatigue. Additional findings emerge as the PH progresses and right ventricular hypertrophy and failure develop. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/17/36119?source=see_link&amp;anchor=H5#H5\">",
"     \"Cor pulmonale\", section on 'Symptoms'",
"    </a>",
"    .) These include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Exertional chest pain (ie, angina) is usually due to subendocardial hypoperfusion caused by increased right ventricular wall stress and myocardial oxygen demand. However, it is occasionally caused by dynamic compression of the left main coronary artery by an enlarged pulmonary artery; this risk is greatest for patients with a pulmonary artery trunk at least 40 mm in diameter [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/3-5\">",
"       3-5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Exertional syncope is due to the inability to increase cardiac output during activity.",
"     </li>",
"     <li>",
"      Peripheral edema is due to increased right sided cardiac pressures",
"     </li>",
"     <li>",
"      Anorexia",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      abdominal pain in the right upper quadrant due to passive hepatic congestion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Less common symptoms include cough, hemoptysis, and hoarseness (Ortner's syndrome). The hoarseness is caused by compression of the left recurrent laryngeal nerve by a dilated main pulmonary artery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17914993\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Progression from PH alone to PH accompanied by right ventricular hypertrophy and then right ventricular failure is characterized by evolving physical signs. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/17/36119?source=see_link&amp;anchor=H46193587#H46193587\">",
"     \"Cor pulmonale\", section on 'Physical findings'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The initial physical finding of PH is usually increased intensity of the pulmonic component of the second heart sound, which may become palpable. The second heart sound is narrowly split or single in patients with preserved right ventricular function. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/56/22410?source=see_link\">",
"     \"Auscultation of heart sounds\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=see_link\">",
"     \"Auscultation of cardiac murmurs\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/43/9909?source=see_link\">",
"     \"Examination of the precordial pulsation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As right ventricular hypertrophy develops, a prominent A wave may emerge within the jugular venous pulse. This may be accompanied by a right-sided fourth heart sound and either a left parasternal heave or a downward subxiphoid thrust. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/59/33719?source=see_link\">",
"     \"Examination of the jugular venous pulse\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Right ventricle failure (or a right bundle branch block) widens the splitting of the second heart sound. Auscultation may reveal a systolic ejection murmur and, in more severe disease, a diastolic pulmonic regurgitation murmur",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a high-pitched systolic murmur of tricuspid regurgitation. These right-sided murmurs and gallops are augmented with inspiration. The systemic venous hypertension caused by right ventricular failure can lead to a variety of findings, such as elevated jugular venous pressure, a right ventricular third heart sound, and a prominent V wave in the jugular venous pulse. Hepatomegaly, a pulsatile liver, peripheral edema, ascites, and pleural effusion may also exist [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some patients with PH due to severe COPD develop edema even in the absence of right heart failure [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/8\">",
"     8",
"    </a>",
"    ]. The pathogenesis of edema in such patients is not well understood [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. It has been hypothesized that edema may develop in these patients due to hypercapnia or hypoxemia. Hypercapnia is associated with an appropriate increase in proximal bicarbonate reabsorption, which minimizes the fall in arterial pH. This increase in proximal bicarbonate transport also promotes the passive reabsorption of sodium chloride and water, and may contribute to edema formation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic testing is indicated whenever PH is suspected. The purpose of the diagnostic testing is to confirm that PH exists, determine its severity, and identify its cause (",
"    <a class=\"graphic graphic_algorithm graphicRef72553 \" href=\"UTD.htm?4/20/4416\">",
"     algorithm 1",
"    </a>",
"    ). We suggest beginning the evaluation with an echocardiogram [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When the echocardiogram does not suggest PH (see",
"    <a class=\"local\" href=\"#H6\">",
"     'Echocardiography'",
"    </a>",
"    below), clinicians need to be guided by clinical suspicion. The diagnostic evaluation should be directed toward alternative diagnoses if the clinical suspicion for PH is low, whereas right heart catheterization should be considered if the clinical suspicion for PH is high.",
"   </p>",
"   <p>",
"    When the echocardiogram is suggestive of PH (see",
"    <a class=\"local\" href=\"#H6\">",
"     'Echocardiography'",
"    </a>",
"    below), clinicians should determine whether or not there is enough left heart disease on the echocardiogram to explain the degree of estimated PH:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with enough left heart disease on the echocardiogram to explain the degree of estimated PH do not require further diagnostic testing for PH. If there is uncertainty, right and left heart catheterization may be helpful. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Right heart catheterization'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Patients who have no left heart disease, left heart disease that seems insufficient to explain the degree of estimated PH, or a potential second etiology, should undergo additional diagnostic testing to look for an alternative cause of the PH. The testing may include pulmonary function testing, ventilation-perfusion scanning, overnight oximetry, polysomnography,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      laboratory testing (eg, autoimmune serologies, HIV serology, and liver function tests). The sequence of testing should be prioritized according to the history and physical examination. As an example, pulmonary function testing is an appropriate initial test in a heavy smoker.",
"      <br/>",
"      <br/>",
"      Right heart catheterization is indicated to confirm the PH and assess its severity, although this is often done at the time that therapy is initiated. Exercise testing may be performed as well, to determine the functional severity of disease (",
"      <a class=\"graphic graphic_table graphicRef62080 \" href=\"UTD.htm?24/47/25339\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Right heart catheterization'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/24/35210?source=see_link\">",
"       \"Treatment of pulmonary hypertension in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17914522\">",
"    <span class=\"h2\">",
"     Diagnostic tests",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Chest radiograph",
"    </span>",
"    &nbsp;&mdash;&nbsp;The classic chest radiograph of a patient with PH shows enlargement of the central pulmonary arteries with attenuation of the peripheral vessels, resulting in oligemic lung fields (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef69446 \" href=\"UTD.htm?11/57/12181\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef72063 \" href=\"UTD.htm?6/57/7058\">",
"     image 2",
"    </a>",
"    ). Right ventricular enlargement (diminished retrosternal space) and right atrial dilatation (prominent right heart border) may also be seen. Occasionally, the underlying cause of the PH is apparent on the chest radiograph (eg, interstitial lung disease).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Electrocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;The electrocardiogram (ECG) of a patient with PH may demonstrate signs of right ventricular hypertrophy or strain (",
"    <a class=\"graphic graphic_waveform graphicRef67622 \" href=\"UTD.htm?43/21/44378\">",
"     waveform 1",
"    </a>",
"    ), including right axis deviation, an R",
"    <span class=\"nowrap\">",
"     wave/S",
"    </span>",
"    wave ratio greater than one in lead V1, incomplete or complete right bundle branch block, or increased P wave amplitude in lead II (P pulmonale) due to right atrial enlargement (",
"    <a class=\"graphic graphic_figure graphicRef63181 \" href=\"UTD.htm?36/30/37357\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef64928 \" href=\"UTD.htm?5/28/5575\">",
"     waveform 2",
"    </a>",
"    ). Most ECG signs are specific but not sensitive for the detection of right ventricular disease. ECG changes do not correlate with disease severity or prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/13,14\">",
"     13,14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Echocardiography is performed to estimate the pulmonary artery systolic pressure and to assess right ventricular size, thickness, and function (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef80275 \" href=\"UTD.htm?30/52/31555\">",
"     image 3",
"    </a>",
"    ). In addition, echocardiography can evaluate right atrial size, left ventricular systolic and diastolic function, and valve function, while detecting pericardial effusions and intracardiac shunts (",
"    <a class=\"graphic graphic_movie graphicRef80448 \" href=\"UTD.htm?6/56/7040\">",
"     movie 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef57251 \" href=\"UTD.htm?17/39/18047\">",
"     movie 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/15,16\">",
"     15,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Echocardiography uses Doppler ultrasound to estimate the pulmonary artery systolic pressure. This technique takes advantage of the tricuspid regurgitation that usually exists. The maximum tricuspid regurgitant jet velocity is recorded and the pulmonary artery systolic pressure (PASP) is then calculated:",
"   </p>",
"   <p>",
"    &nbsp;PASP = (4 x [TRV]",
"    <sup>",
"     2",
"    </sup>",
"    ) + RAP",
"   </p>",
"   <p>",
"    where TRV is the maximum tricuspid regurgitant jet velocity and RAP is the right atrial pressure estimated from the size and respiratory variation of flow in the inferior vena cava. Doppler echocardiography is limited when an adequate tricuspid regurgitant jet cannot be identified. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/0/15365?source=see_link\">",
"     \"Principles of Doppler echocardiography\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with PH may have echocardiographic signs of right ventricular pressure overload, including paradoxical bulging of the septum into the left ventricle during systole and hypertrophy of the right ventricular free wall and trabeculae (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef71065 \" href=\"UTD.htm?28/2/28719\">",
"     image 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef67911 \" href=\"UTD.htm?19/59/20402\">",
"     movie 3",
"    </a>",
"    ). As the right ventricle fails, there is dilation and hypokinesis, septal flattening, right atrial dilation, and tricuspid regurgitation (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef67160 \" href=\"UTD.htm?43/32/44559\">",
"     image 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef55501 \" href=\"UTD.htm?9/18/9506\">",
"     movie 4",
"    </a>",
"    ). The tricuspid regurgitation is not due to an intrinsic abnormality of the tricuspid valve; it is a secondary manifestation of dilation of the tricuspid annulus and right ventricle (ie, functional tricuspid regurgitation) (",
"    <a class=\"graphic graphic_movie graphicRef80498 \" href=\"UTD.htm?2/25/2448\">",
"     movie 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50766 \" href=\"UTD.htm?14/19/14641\">",
"     image 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/17\">",
"     17",
"    </a>",
"    ]. Other findings associated with pulmonary hypertension are pulmonic insufficiency and midsystolic closure of the pulmonic valve [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. The echocardiographic findings of PH are summarized in the figure (",
"    <a class=\"graphic graphic_figure graphicRef77640 \" href=\"UTD.htm?39/52/40782\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Based upon a Doppler echocardiographic study, it can be determined if PH is likely, unlikely, or possible [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/20\">",
"     20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      PH is likely if the PASP is &gt;50 and the TRV is &gt;3.4",
"     </li>",
"     <li>",
"      PH is unlikely if the PASP is &le;36, the TRV is &le;2.8, and there are no other suggestive findings",
"     </li>",
"     <li>",
"      PH is possible with other combinations of findings",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Doppler echocardiography may be misleading in the assessment of patients with suspected pulmonary hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/21,22\">",
"     21,22",
"    </a>",
"    ], especially when an inadequate tricuspid regurgitant jet is over-interpreted. This was illustrated by an observational study of 65 patients with various types of PH [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/21\">",
"     21",
"    </a>",
"    ]. The pulmonary arterial pressure estimated by Doppler echocardiography was at least 10 mmHg higher or lower than that obtained by right heart catheterization in 48 percent of patients and, in many cases, the difference in pulmonary artery pressure determined by the two modalities was significantly greater than 10 mmHg. Overestimation and underestimation of pulmonary arterial pressure occurred with similar frequency, although the magnitude of the underestimation was greater. A major limitation of the study was that catheterization and Doppler echocardiography were not performed simultaneously.",
"   </p>",
"   <p>",
"    We believe that there should be a low threshold to evaluate patients with suspected pulmonary hypertension via right heart catheterization. Despite its limitations, Doppler echocardiography detects PH with greater accuracy than clinical history and physical examination [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Pulmonary function tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary function tests (PFTs) are performed to identify and characterize underlying lung disease that may be contributing to PH. An obstructive pattern is suggestive of COPD, while restrictive disease suggests interstitial lung disease, neuromuscular weakness, or chest wall disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/53/4952?source=see_link\">",
"     \"Overview of pulmonary function testing in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is usually severe interstitial lung disease (with lung volumes below 50 percent of predicted) or obstructive lung disease that produces PH. In most circumstances, PH should not be attributed to lung disease if the PFTs are only mildly abnormal since PH itself can cause PFT abnormalities. As an example, a study of 79 patients with idiopathic pulmonary arterial hypertension (IPAH) demonstrated that more than half of patients had a mild to moderate decrease of forced expiratory volume in one second (FEV1) or forced vital capacity (FVC) compared to age and sex matched controls [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/25\">",
"     25",
"    </a>",
"    ]. The diffusing capacity for carbon monoxide (DLCO) is usually decreased in PH [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/25,26\">",
"     25,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Overnight oximetry",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nocturnal oxyhemoglobin desaturation can be identified by overnight oximetry. It is common in patients with PH and may prompt supplemental oxygen therapy during sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/27\">",
"     27",
"    </a>",
"    ]. Overnight oximetry is not an acceptable diagnostic test for sleep related breathing disorders, such as obstructive sleep apnea. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/24/35210?source=see_link&amp;anchor=H12#H12\">",
"     \"Treatment of pulmonary hypertension in adults\", section on 'Oxygen therapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/20/17734?source=see_link&amp;anchor=H12#H12\">",
"     \"Portable monitoring in obstructive sleep apnea in adults\", section on 'Pulse oximetry'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Polysomnography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polysomnography is the gold standard diagnostic test for sleep related breathing disorders, such as obstructive sleep apnea (OSA). It should be performed when the clinical suspicion for OSA is high, or the results of overnight oximetry are discordant with clinical expectation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/20/17734?source=see_link\">",
"     \"Portable monitoring in obstructive sleep apnea in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/30/38374?source=see_link\">",
"     \"Polysomnography in obstructive sleep apnea in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     V/Q scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ventilation-perfusion",
"    <span class=\"nowrap\">",
"     (V/Q)",
"    </span>",
"    scanning is used to evaluate patients for thromboembolic disease. A normal",
"    <span class=\"nowrap\">",
"     V/Q",
"    </span>",
"    scan accurately excludes chronic thromboembolic disease with a sensitivity of 96 to 97 percent and a specificity of 90 to 95 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/28\">",
"     28",
"    </a>",
"    ]. When the",
"    <span class=\"nowrap\">",
"     V/Q",
"    </span>",
"    scan suggests that chronic thromboembolic disease exists, pulmonary angiography is necessary to confirm the positive",
"    <span class=\"nowrap\">",
"     V/Q",
"    </span>",
"    scan and to define the extent of disease (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef67815 \" href=\"UTD.htm?6/45/6864\">",
"     image 7",
"    </a>",
"    ).",
"    <span class=\"nowrap\">",
"     V/Q",
"    </span>",
"    scans are an important part of the diagnostic evaluation because PH due to chronic thromboembolic disease is potentially reversible with surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/9/7320?source=see_link\">",
"     \"Clinical manifestations and diagnosis of chronic thromboembolic pulmonary hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Laboratory tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood tests performed during the diagnostic evaluation of PH include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      HIV serology to screen for HIV-associated PH",
"     </li>",
"     <li>",
"      Liver function tests to screen for portopulmonary hypertension",
"     </li>",
"     <li>",
"      Antinuclear antibody (ANA), rheumatoid factor (RF), and antineutrophil cytoplasmic antibody (ANCA) titers to screen for PH due to the connective tissue diseases",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the appropriate clinical setting, laboratory studies looking for evidence of chronic hemolytic anemia (eg, sickle cell disease) or schistosomiasis are appropriate. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/54/42856?source=see_link\">",
"     \"Diagnosis of sickle cell syndromes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7398?source=see_link\">",
"     \"Diagnosis of schistosomiasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    N-terminal pro-brain natriuretic peptide (NT-proBNP) is the precursor of brain natriuretic peptide (BNP). Both peptides are released from the myocardial tissue of the right and left ventricle when stretched. Increasing evidence suggests that NT-proBNP and BNP are helpful in diagnosing heart failure. It has been hypothesized that measurement of either peptide may also be helpful in the diagnosis of PH, since right heart failure often complicates PH. Preliminary data are promising, although accuracy diminishes if renal dysfunction exists [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/29-32\">",
"     29-32",
"    </a>",
"    ]. NT-proBNP and BNP should not be used in the routine diagnostic evaluation of patients with suspected PH until their value is confirmed by larger prospective studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Exercise testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exercise testing is usually performed using the six-minute walk test (6MWT) or cardiopulmonary exercise testing. The latter can be performed with gas exchange measurements, echocardiography,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    right heart catheterization.",
"   </p>",
"   <p>",
"    Exercise testing during the diagnostic evaluation of PH serves several purposes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Screens for alternative causes of the patient's symptoms",
"     </li>",
"     <li>",
"      Detects exercised-induced PH, which may be an intermediate stage that exists between normal and resting PH [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/33,34\">",
"       33,34",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Determines the patient's World Health Organization (WHO) functional class [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/35\">",
"       35",
"      </a>",
"      ], which guides therapy (",
"      <a class=\"graphic graphic_table graphicRef62080 \" href=\"UTD.htm?24/47/25339\">",
"       table 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Establishes a baseline from which the response to therapy can be measured [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/36,37\">",
"       36,37",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Provides prognostic information, since a longer distance walked during the 6MWT is associated with longer survival [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/35\">",
"       35",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Right heart catheterization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Right heart catheterization is necessary to confirm the diagnosis of PH (see",
"    <a class=\"local\" href=\"#H17914506\">",
"     'Diagnostic criteria'",
"    </a>",
"    below) and accurately determine the severity of the hemodynamic derangements.",
"   </p>",
"   <p>",
"    Right heart catheterization is also helpful in distinguishing patients who have PH due to left heart disease, such as systolic dysfunction, diastolic dysfunction, or valvular heart disease (",
"    <a class=\"graphic graphic_table graphicRef66348 \" href=\"UTD.htm?42/38/43628\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/38\">",
"     38",
"    </a>",
"    ]. Such patients have a mean pulmonary capillary wedge pressure (PCWP) &ge;15 mmHg, as measured by right heart catheterization. However, the mean PCWP alone is insufficient to definitively diagnose PH due to left heart disease because it may be falsely elevated due to dilatation of the pulmonary arteries and incomplete \"wedging\" of the balloon catheter. To avoid this dilemma, patients with a mean PCWP &ge;15 mmHg should have their left heart filling pressure directly assessed by measuring the left ventricular end diastolic pressure (LVEDP) via left heart catheterization. Failure to do so means patients may be incorrectly diagnosed as having PH due to left heart disease, which has important therapeutic implications. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/24/35210?source=see_link\">",
"     \"Treatment of pulmonary hypertension in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risk of incorrectly diagnosing patients with PH due to left heart disease on the basis of a falsely elevated mean PCWP was demonstrated by a retrospective analysis of hemodynamic data from 3926 patients with PH who underwent simultaneous right and left heart catheterization [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/39\">",
"     39",
"    </a>",
"    ]. Among the 3346 patients who had a mean PCWP &gt;15 mmHg, 152 patients (5 percent) had a normal left ventricular filling pressure, defined as a LVEDP &le;15 mmHg. The authors of the study focused on how frequently the mean PCWP was &le;15 mmHg when the LVEDP was &gt;15 mmHg, but it should be emphasized that the mean PCWP is virtually always less than the LVEDP because the latter reflects the pressure at the end of left atrial contraction.",
"   </p>",
"   <p>",
"    An additional benefit of right heart catheterization is that the presence",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    severity of a congenital or acquired left-to-right shunt can be confirmed when noninvasive studies are not definitive.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17914506\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC CRITERIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The World Health Organization (WHO) classifies patients with PH into five groups based upon etiology [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/38\">",
"     38",
"    </a>",
"    ]. Patients in the first group are considered to have pulmonary arterial hypertension (ie, group 1 PAH), whereas patients in the remaining four groups are considered to have pulmonary hypertension (ie, group 2 PH through group 5 PH) (",
"    <a class=\"graphic graphic_table graphicRef66348 \" href=\"UTD.htm?42/38/43628\">",
"     table 2",
"    </a>",
"    ). When all five groups are discussed collectively, the designation PH is used. This classification system is described in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/47/19193?source=see_link&amp;anchor=H3#H3\">",
"     \"Overview of pulmonary hypertension in adults\", section on 'Classification'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5397869\">",
"    <span class=\"h2\">",
"     Pulmonary hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of PH requires right heart catheterization. PH is confirmed when the mean pulmonary artery pressure is &ge;25 mmHg at rest [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/35\">",
"     35",
"    </a>",
"    ]. A mean pulmonary artery pressure of 8 to 20 mmHg at rest is considered normal, while a mean pulmonary artery pressure of 21 to 24 mmHg at rest has uncertain clinical implications.",
"   </p>",
"   <p>",
"    Two definitions of PH that were previously accepted are no longer used. They include a mean pulmonary artery pressure &gt;30 mmHg with exercise (measured by right heart catheterization) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/40\">",
"     40",
"    </a>",
"    ] and an estimated systolic pulmonary artery pressure &gt;40 mmHg (estimated by Doppler echocardiography) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2041/abstract/41\">",
"     41",
"    </a>",
"    ]. The latter corresponds to a tricuspid regurgitant velocity of 3.0 to 3.5",
"    <span class=\"nowrap\">",
"     m/sec.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5397876\">",
"    <span class=\"h2\">",
"     Pulmonary arterial hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of PAH also requires right heart catheterization. Several criteria must be met:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mean pulmonary artery pressure is &ge;25 mmHg at rest",
"     </li>",
"     <li>",
"      Mean pulmonary capillary wedge pressure &lt;15 mmHg (to exclude PH owing to left heart disease [ie, group 2 PH])",
"     </li>",
"     <li>",
"      Chronic lung diseases and other causes of hypoxemia are mild or absent (to exclude PH owing to left lung disease or hypoxemia [ie, group 3 PH])",
"     </li>",
"     <li>",
"      Venous thromboembolic disease is absent (to exclude chronic thromboembolic PH [ie, group 4 PH])",
"     </li>",
"     <li>",
"      Certain miscellaneous disorders are absent, including systemic disorders (eg, sarcoidosis), hematologic disorders (eg, myeloproliferative diseases), and metabolic disorders (eg, glycogen storage disease). The purpose is to exclude PH with unclear multifactorial mechanisms (group 5 PH).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The diagnosis of PAH is supported by an increased pulmonary vascular resistance and transpulmonary gradient (the difference between the mean pulmonary artery pressure and the mean pulmonary capillary wedge pressure).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17914514\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of early PH is wide because there are many causes of exertional dyspnea, which is the most common initial symptom. The evaluation and differential diagnosis of dyspnea is described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/10/16553?source=see_link\">",
"     \"Approach to the patient with dyspnea\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Once the PH progresses to right ventricular hypertrophy and failure (ie, peripheral edema, exertional chest pain, exertional syncope, and right upper quadrant pain), the differential diagnosis becomes considerably narrower:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Left-sided heart failure &ndash; Left ventricular systolic and diastolic heart failure are well-known causes of peripheral edema, right upper quadrant pain due to hepatic congestion, and syncope due to arrhythmias or insufficient cardiac output. Exertional chest pain may also occur. Left-sided heart failure and PH can be distinguished via echocardiography",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      right and left heart catheterization. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19945?source=see_link\">",
"       \"Evaluation of the patient with suspected heart failure\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Coronary artery disease &ndash; Myocardial ischemia is the most common cause of exertional chest pain and it can also cause ischemia-induced arrhythmias with exertional syncope. Coronary artery disease is identified by stress testing",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      left heart catheterization. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/57/26521?source=see_link\">",
"       \"Stress testing for the diagnosis of coronary heart disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Liver disease &ndash; Acute and chronic liver diseases cause peripheral edema and the former can also cause right upper quadrant pain. Liver disease can be detected by liver function testing and right upper quadrant ultrasound. Liver biopsy is the gold standard, but it is seldom necessary.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Budd-Chiari syndrome &ndash; Budd-Chiari syndrome refers to thrombosis of the hepatic veins",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      the intrahepatic or suprahepatic inferior vena cava. It causes peripheral edema due to venous outflow obstruction and right upper quadrant pain due to hepatic congestion. Budd-Chiari syndrome can be identified by Doppler ultrasonography, computed tomography (CT), magnetic resonance imaging (MRI), or venography. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/22/3434?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and treatment of the Budd-Chiari syndrome\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?38/61/39889?source=see_link\">",
"       \"Patient information: Pulmonary hypertension in adults (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Patients with pulmonary hypertension (PH) initially experience exertional dyspnea, lethargy, and fatigue. These symptoms are frequently attributed incorrectly to age, deconditioning, or a coexisting medical condition. As a result, many patients do not present until their exertional dyspnea becomes severe or they begin to experience additional sequelae, such as peripheral edema, exertional chest pain, or exertional syncope. (See",
"      <a class=\"local\" href=\"#H17914458\">",
"       'Clinical findings'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Diagnostic testing is indicated whenever PH is suspected. The purpose of the diagnostic testing is to confirm that PH exists, determine its severity, and identify its cause. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest beginning with an echocardiogram (",
"      <a class=\"graphic graphic_algorithm graphicRef72553 \" href=\"UTD.htm?4/20/4416\">",
"       algorithm 1",
"      </a>",
"      ):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Echocardiogram is NOT suggestive of PH &ndash; For patients whose echocardiogram is NOT suggestive of PH, the diagnostic evaluation should be guided by clinical suspicion. If the clinical suspicion for PH is low, evaluation of the patient's symptoms should be directed toward alternative diagnoses. Alternatively, if the clinical suspicion for PH remains high despite the echocardiographic findings, right heart catheterization should be performed. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Echocardiogram is suggestive of PH &ndash; No further diagnostic testing for PH is required if there is enough left heart disease on the echocardiogram to explain the degree of estimated PH. However, additional diagnostic testing is required if there is either no evidence of left heart disease or the extent of left heart disease seems insufficient to explain the degree of estimated PH. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.) The sequence of testing should be prioritized according to the patient's history and physical examination. (See",
"      <a class=\"local\" href=\"#H17914522\">",
"       'Diagnostic tests'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diagnosis of PH requires right heart catheterization. PH is confirmed when the mean pulmonary artery pressure is &ge;25 mmHg at rest. (See",
"      <a class=\"local\" href=\"#H17914506\">",
"       'Diagnostic criteria'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pulmonary arterial hypertension (PAH) is one type of PH. The diagnosis of PAH requires right heart catheterization and that several criteria be met (see",
"      <a class=\"local\" href=\"#H17914506\">",
"       'Diagnostic criteria'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Mean pulmonary artery pressure is &ge;25 mmHg at rest",
"     </li>",
"     <li>",
"      Mean pulmonary capillary wedge pressure &lt;15 mmHg",
"     </li>",
"     <li>",
"      Chronic lung diseases and other causes of hypoxemia are mild or absent",
"     </li>",
"     <li>",
"      Venous thromboembolic disease is absent",
"     </li>",
"     <li>",
"      Certain miscellaneous disorders are absent, including systemic disorders (eg, sarcoidosis), hematologic disorders (eg, myeloproliferative diseases), and metabolic disorders (eg, glycogen storage disease)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The differential diagnosis of early PH is wide because there are many causes of exertional dyspnea, which is the most common initial symptom. However, once the PH progresses to right ventricular hypertrophy and failure (ie, peripheral edema, exertional chest pain, exertional syncope, and right upper quadrant pain), the differential diagnosis becomes considerably narrower and includes left-sided heart failure, coronary artery disease, liver disease, and Budd-Chiari syndrome. (See",
"      <a class=\"local\" href=\"#H17914514\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/1\">",
"      Runo JR, Loyd JE. Primary pulmonary hypertension. Lancet 2003; 361:1533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/2\">",
"      Peacock AJ. Primary pulmonary hypertension. Thorax 1999; 54:1107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/3\">",
"      Mesquita SM, Castro CR, Ikari NM, et al. Likelihood of left main coronary artery compression based on pulmonary trunk diameter in patients with pulmonary hypertension. Am J Med 2004; 116:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/4\">",
"      Rich S, McLaughlin VV, O'Neill W. Stenting to reverse left ventricular ischemia due to left main coronary artery compression in primary pulmonary hypertension. Chest 2001; 120:1412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/5\">",
"      Kawut SM, Silvestry FE, Ferrari VA, et al. Extrinsic compression of the left main coronary artery by the pulmonary artery in patients with long-standing pulmonary hypertension. Am J Cardiol 1999; 83:984.",
"     </a>",
"    </li>",
"    <li>",
"     Fishman AP. Pulmonary hypertension and cor pulmonale. In: Pulmonary Disease, Fishman AP (Ed), McGraw Hill, New York 1989.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/7\">",
"      Tang KJ, Robbins IM, Light RW. Incidence of pleural effusions in idiopathic and familial pulmonary arterial hypertension patients. Chest 2009; 136:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/8\">",
"      Weitzenblum E, Apprill M, Oswald M, et al. Pulmonary hemodynamics in patients with chronic obstructive pulmonary disease before and during an episode of peripheral edema. Chest 1994; 105:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/9\">",
"      CAMPBELL EJ, SHORT DS. The cause of oedema in \"corpulmonale\". Lancet 1960; 1:1184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/10\">",
"      Richens JM, Howard P. Oedema in cor pulmonale. Clin Sci (Lond) 1982; 62:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/11\">",
"      Schafer JA. Robert F. Pitts Memorial Lecture. Mechanisms coupling the absorption of solutes and water in the proximal nephron. Kidney Int 1984; 25:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/12\">",
"      McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 2009; 119:2250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/13\">",
"      Bossone E, Paciocco G, Iarussi D, et al. The prognostic role of the ECG in primary pulmonary hypertension. Chest 2002; 121:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/14\">",
"      Ahearn GS, Tapson VF, Rebeiz A, Greenfield JC Jr. Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease. Chest 2002; 122:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/15\">",
"      Bossone E, Bodini BD, Mazza A, Allegra L. Pulmonary arterial hypertension: the key role of echocardiography. Chest 2005; 127:1836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/16\">",
"      Hinderliter AL, Willis PW 4th, Long W, et al. Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. PPH Study Group. Primary pulmonary hypertension. Am J Cardiol 1999; 84:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/17\">",
"      Mikami T, Kudo T, Sakurai N, et al. Mechanisms for development of functional tricuspid regurgitation determined by pulsed Doppler and two-dimensional echocardiography. Am J Cardiol 1984; 53:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/18\">",
"      Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 1984; 70:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/19\">",
"      Arkles JS, Opotowsky AR, Ojeda J, et al. Shape of the right ventricular Doppler envelope predicts hemodynamics and right heart function in pulmonary hypertension. Am J Respir Crit Care Med 2011; 183:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/20\">",
"      Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC), European Respiratory Society (ERS), International Society of Heart and Lung Transplantation (ISHLT), et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009; 34:1219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/21\">",
"      Fisher MR, Forfia PR, Chamera E, et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 2009; 179:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/22\">",
"      Rich JD, Shah SJ, Swamy RS, et al. Inaccuracy of Doppler echocardiographic estimates of pulmonary artery pressures in patients with pulmonary hypertension: implications for clinical practice. Chest 2011; 139:988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/23\">",
"      Berger M, Haimowitz A, Van Tosh A, et al. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J Am Coll Cardiol 1985; 6:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/24\">",
"      Himelman RB, Struve SN, Brown JK, et al. Improved recognition of cor pulmonale in patients with severe chronic obstructive pulmonary disease. Am J Med 1988; 84:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/25\">",
"      Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol 2003; 41:1028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/26\">",
"      Meyer FJ, Ewert R, Hoeper MM, et al. Peripheral airway obstruction in primary pulmonary hypertension. Thorax 2002; 57:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/27\">",
"      Minai OA, Pandya CM, Golish JA, et al. Predictors of nocturnal oxygen desaturation in pulmonary arterial hypertension. Chest 2007; 131:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/28\">",
"      Tunariu N, Gibbs SJ, Win Z, et al. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med 2007; 48:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/29\">",
"      Leuchte HH, Baumgartner RA, Nounou ME, et al. Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 2006; 173:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/30\">",
"      Fijalkowska A, Kurzyna M, Torbicki A, et al. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest 2006; 129:1313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/31\">",
"      Blyth KG, Groenning BA, Mark PB, et al. NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension. Eur Respir J 2007; 29:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/32\">",
"      Leuchte HH, El Nounou M, Tuerpe JC, et al. N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension. Chest 2007; 131:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/33\">",
"      Tolle JJ, Waxman AB, Van Horn TL, et al. Exercise-induced pulmonary arterial hypertension. Circulation 2008; 118:2183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/34\">",
"      Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 2009; 34:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/35\">",
"      Badesch DB, Champion HC, Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54:S55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/36\">",
"      Gr&uuml;nig E, Lichtblau M, Ehlken N, et al. Safety and efficacy of exercise training in various forms of pulmonary hypertension. Eur Respir J 2012; 40:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/37\">",
"      Mathai SC, Puhan MA, Lam D, Wise RA. The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension. Am J Respir Crit Care Med 2012; 186:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/38\">",
"      Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54:S43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/39\">",
"      Halpern SD, Taichman DB. Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure. Chest 2009; 136:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2041/abstract/40\">",
"      Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43:40S.",
"     </a>",
"    </li>",
"    <li>",
"     Rich S (ed). Executive summary from the World Symposium on Primary Pulmonary Hypertension, Evian, France, September 6-10, 1998, co-sponsored by The World Health Organization.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8249 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-9C35C7E240-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_63_2041=[""].join("\n");
var outline_f1_63_2041=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17914458\">",
"      CLINICAL FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17915165\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17914986\">",
"      Medical history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17914993\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17914522\">",
"      Diagnostic tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Chest radiograph",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Electrocardiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Echocardiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Pulmonary function tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Overnight oximetry",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Polysomnography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - V/Q scan",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Exercise testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Right heart catheterization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17914506\">",
"      DIAGNOSTIC CRITERIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5397869\">",
"      Pulmonary hypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5397876\">",
"      Pulmonary arterial hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17914514\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/8249\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/8249|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?4/20/4416\" title=\"algorithm 1\">",
"      Evaluation of suspected PH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/8249|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?11/57/12181\" title=\"diagnostic image 1\">",
"      CXR pulmonary artery HT PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?6/57/7058\" title=\"diagnostic image 2\">",
"      Pulmonary hypertension Lateral",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?30/52/31555\" title=\"diagnostic image 3\">",
"      Echocardiogram apical 4-chamber with contrast showing dilated RV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?28/2/28719\" title=\"diagnostic image 4\">",
"      Echocardiogram short axis with RV pressure overload",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?43/32/44559\" title=\"diagnostic image 5\">",
"      Echocardiogram apical 4-chamber showing right heart enlargement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?14/19/14641\" title=\"diagnostic image 6\">",
"      Tricuspid regurgitation Doppler",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?6/45/6864\" title=\"diagnostic image 7\">",
"      IPAH angio",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/8249|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/30/37357\" title=\"figure 1\">",
"      Right atrial enlargement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/52/40782\" title=\"figure 2\">",
"      Schematic of echo findings in PH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/8249|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?6/56/7040\" title=\"movie 1\">",
"      TTE two ASDs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?17/39/18047\" title=\"movie 2\">",
"      VSD small four chamber color Doppler echo",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?19/59/20402\" title=\"movie 3\">",
"      Pulmonary hypertension short axis echo",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?9/18/9506\" title=\"movie 4\">",
"      Pulmonary hypertension four chamber echocardiogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?2/25/2448\" title=\"movie 5\">",
"      Apical 4 chamber echocardiogram with color Doppler TR",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/8249|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/47/25339\" title=\"table 1\">",
"      Classification PH function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?42/38/43628\" title=\"table 2\">",
"      WHO pulmonary hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/8249|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?43/21/44378\" title=\"waveform 1\">",
"      ECG of right ventricular hypertrophy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?5/28/5575\" title=\"waveform 2\">",
"      ECG of atrial enlargement",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/10/16553?source=related_link\">",
"      Approach to the patient with dyspnea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=related_link\">",
"      Auscultation of cardiac murmurs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/56/22410?source=related_link\">",
"      Auscultation of heart sounds",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/9/7320?source=related_link\">",
"      Clinical manifestations and diagnosis of chronic thromboembolic pulmonary hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/22/3434?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of the Budd-Chiari syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/17/36119?source=related_link\">",
"      Cor pulmonale",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7398?source=related_link\">",
"      Diagnosis of schistosomiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/54/42856?source=related_link\">",
"      Diagnosis of sickle cell syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19945?source=related_link\">",
"      Evaluation of the patient with suspected heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/59/33719?source=related_link\">",
"      Examination of the jugular venous pulse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/43/9909?source=related_link\">",
"      Examination of the precordial pulsation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/53/4952?source=related_link\">",
"      Overview of pulmonary function testing in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/47/19193?source=related_link\">",
"      Overview of pulmonary hypertension in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/8/7304?source=related_link\">",
"      Pathogenesis of pulmonary hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?38/61/39889?source=related_link\">",
"      Patient information: Pulmonary hypertension in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/30/38374?source=related_link\">",
"      Polysomnography in obstructive sleep apnea in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/20/17734?source=related_link\">",
"      Portable monitoring in obstructive sleep apnea in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/0/15365?source=related_link\">",
"      Principles of Doppler echocardiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/57/26521?source=related_link\">",
"      Stress testing for the diagnosis of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/24/35210?source=related_link\">",
"      Treatment of pulmonary hypertension in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_63_2042="Food allergens: Overview of clinical features and cross-reactivity";
var content_f1_63_2042=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Food allergens: Overview of clinical features and cross-reactivity",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/63/2042/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/63/2042/contributors\">",
"     Scott H Sicherer, MD, FAAAAI",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/63/2042/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/63/2042/contributors\">",
"     Robert A Wood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/63/2042/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/63/2042/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/63/2042/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 2, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A limited number of foods are responsible for most significant allergic reactions. These",
"    <span class=\"nowrap\">",
"     foods/food",
"    </span>",
"    groups are milk, egg, peanut, soy, nuts from trees, fish, shellfish, and seeds. However, virtually any food can trigger an allergic reaction in some persons [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will review clinically relevant features of food allergens, including (when known) epidemiology, natural course, practical observations, and cross-reactivity. Other topics discuss molecular aspects of food allergens, evaluation of food allergies, avoidance of food allergens, the natural history of food allergy, and oral allergy syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/56/23433?source=see_link\">",
"     \"Molecular features of food allergens\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/12/5321?source=see_link\">",
"     \"Diagnostic evaluation of food allergy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/48/18185?source=see_link\">",
"     \"Management of food allergy: Avoidance\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/28/12746?source=see_link\">",
"     \"The natural history of childhood food allergy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/41/5785?source=see_link\">",
"     \"Pathogenesis of oral allergy syndrome (pollen-food allergy syndrome)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW OF CROSS-REACTIVITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;When a patient has a confirmed allergy to one food, evaluation of related foods may be indicated to determine if these foods are also problematic. However, a &ldquo;positive&rdquo; allergy test to a related food may simply represent immunologic cross-reactivity due to the presence of a homologous protein that does not have clinical significance, which is more common than true clinical cross-reactivity [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/2\">",
"     2",
"    </a>",
"    ]. Thus, an individual with an allergy to peanut (a legume) is likely to have &ldquo;positive&rdquo; serum immunoglobulin E (IgE) tests or skin prick tests to multiple legumes that are clinically tolerated (see",
"    <a class=\"local\" href=\"#H8\">",
"     'Legume cross-reactivity'",
"    </a>",
"    below). Approximate rates of clinical cross-reactivity are summarized in the figure (",
"    <a class=\"graphic graphic_figure graphicRef77726 \" href=\"UTD.htm?2/35/2622\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Concern about allergy can arise if a related food was never ingested or was not a regular part of the diet and was not recently ingested. In these cases, it may be reasonable to evaluate the patient for allergy to the related food to determine clinical tolerance, depending upon epidemiologic, social, and nutritional consequences and concerns. Further evaluation is generally not needed if a related food is already ingested routinely without reactions.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tree nuts, fish, and shellfish are more commonly clinically cross-reactive. Caution and possible allergy testing (including oral food challenges) are warranted if ingestion of related foods not already tolerated is being considered.",
"     </li>",
"     <li>",
"      Grains, fruits, vegetables, and legumes are less cross-reactive and",
"      <span class=\"nowrap\">",
"       evaluation/individualization",
"      </span>",
"      is generally recommended to expand the diet.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     COW'S MILK",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several prospective epidemiologic studies indicate that cow's milk allergy (CMA) affects up to 2.5 percent of infants, and overall about 0.9 percent of the population [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. Tolerance is often achieved by age three to five years, although persistence beyond this age is increasingly reported [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/6\">",
"     6",
"    </a>",
"    ]. The rate of allergy loss slows after the age of five years, but may occur through adolescence. Non-IgE mediated food allergy of infancy resolves more quickly than IgE mediated allergy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/28/12746?source=see_link&amp;anchor=H17#H17\">",
"     \"The natural history of childhood food allergy\", section on 'Cow's milk'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=see_link\">",
"     \"Food protein-induced proctitis/colitis and enteropathy of infancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A variety of clinical manifestations are observed with both IgE and cell mediated etiologies [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/7\">",
"     7",
"    </a>",
"    ]. IgE-mediated reactions include urticaria and angioedema, rhinoconjunctivitis, gastrointestinal anaphylaxis, generalized anaphylaxis, and oral allergy syndrome. Non-IgE-mediated food allergies present more as subacute",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    chronic symptoms that are commonly isolated to the gastrointestinal tract or skin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14808?source=see_link\">",
"     \"Clinical manifestations of food allergy: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    IgE antibodies are directed against a variety of allergenic proteins in cow's milk, including casein and whey [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/8\">",
"     8",
"    </a>",
"    ]. Reactions to cow's milk can be severe and even fatal anaphylaxis from cow's milk allergy has occurred [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Some cow's milk-allergic children tolerate small amounts of cow's milk protein, generally in a more processed form (eg, dairy in baked goods). The impact this type of exposure has on potential tolerance induction is unknown [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29640?source=see_link\">",
"     \"Milk allergy: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Alternative mammalian milks have been considered as substitutes in cow's milk allergic individuals. Unfortunately, most of the readily available animal milks are problematic for those with CMA. In vitro studies show extensive cross-reactivity among sheep, cow, and goat milks [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/12\">",
"     12",
"    </a>",
"    ] and among cow, ewe, goat, and buffalo milks, with no significant binding to camel's milk [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/13\">",
"     13",
"    </a>",
"    ]. Oral challenge studies of goat's milk show this to be unsafe for patients with CMA, since 92 percent (24 of 26) reacted [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/14\">",
"     14",
"    </a>",
"    ]. However, only 4 percent (1 of 25) of children with CMA allergy reacted to mare's milk [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/15\">",
"     15",
"    </a>",
"    ]. Ass's milk may also be less allergenic for those with cow's milk allergy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/9/40087?source=see_link\">",
"     \"Milk allergy: Management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Infants with IgE mediated CMA usually tolerate soy (~85 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/17\">",
"     17",
"    </a>",
"    ] or extensively hydrolyzed cow's milk based formulas (~95 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Children with non-IgE mediated CMA may be less likely to tolerate soy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=see_link\">",
"     \"Food protein-induced proctitis/colitis and enteropathy of infancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Between 13 and 20 percent of children with IgE mediated CMA in referred populations also react to beef [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/20\">",
"     20",
"    </a>",
"    ]. Heating and other cooking processes can reduce the allergenicity of beef [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/21\">",
"     21",
"    </a>",
"    ], so well-cooked beef is less likely to cause a problem for those with CMA.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     HEN'S EGG",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergy to hen's egg affects up to 2.5 percent of",
"    <span class=\"nowrap\">",
"     infants/young",
"    </span>",
"    children, and overall about 0.3 percent of the population [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/3,5,22\">",
"     3,5,22",
"    </a>",
"    ]. Tolerance is usually achieved by age five years [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]. However, the rate of resolution of egg allergy may be slowing [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/25\">",
"     25",
"    </a>",
"    ]. The major allergenic proteins are found in the egg white. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/28/12746?source=see_link&amp;anchor=H22#H22\">",
"     \"The natural history of childhood food allergy\", section on 'Hen's egg'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/9/33944?source=see_link\">",
"     \"Egg allergy: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/58/13223?source=see_link\">",
"     \"Egg allergy: Management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sensitization to hen's egg in infancy is associated with an increased risk of sensitization to respiratory allergens later in life [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/26\">",
"     26",
"    </a>",
"    ]. Allergic responses to egg can be severe and death from egg-induced anaphylaxis has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/9\">",
"     9",
"    </a>",
"    ]. Some egg sensitized children tolerate egg in baked products [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/27\">",
"     27",
"    </a>",
"    ]. Others develop urticaria from skin contact with egg, and yet ingest it without symptoms. This phenomenon appears to occur when IgE antibodies are directed against some of the more labile epitopes of allergenic hen's egg proteins [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/28,29\">",
"     28,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cross-reactive proteins among various avian egg proteins are common [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/30\">",
"     30",
"    </a>",
"    ], but the clinical implications have not been systematically studied. Reactions to duck and goose egg, in the absence of hen's egg allergy, have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/31\">",
"     31",
"    </a>",
"    ]. Some patients with hen's egg allergy also react to chicken meat (see",
"    <a class=\"local\" href=\"#H15\">",
"     'Meats'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     LEGUMES: PEANUT, SOY, AND OTHERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peanut and soy are prominent legume allergens. Legumes share homologous proteins (conserved proteins), but features of clinical reactions vary. Regional dietary habits and pollen exposure may influence the epidemiology of legume allergy. As an example, allergy to lentil is more common than peanut allergy in Spain [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Peanut",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergy to peanut affects approximately 0.75 percent of the general population. Prevalence appears to be increasing, at least among children [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/3,33\">",
"     3,33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38457?source=see_link\">",
"     \"Peanut, tree nut, and seed allergy: Clinical features\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/27/9654?source=see_link\">",
"     \"Peanut, tree nut, and seed allergy: Diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/9/32919?source=see_link\">",
"     \"Peanut, tree nut, and seed allergy: Management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Peanut allergy established in childhood appears to be long-lived, although some children with a peanut allergy that developed in early childhood eventually tolerate peanut. Recurrence of resolved peanut allergy has been observed. The main risk factor for recurrence was discontinuation of peanut ingestion for many months after the successful food challenge. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/28/12746?source=see_link&amp;anchor=H26#H26\">",
"     \"The natural history of childhood food allergy\", section on 'Peanut and tree nut'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Peanut allergy is potentially severe. Peanut allergic reactions are generally the most common culprit in case series of fatal food-induced anaphylaxis. The highest risk group is adolescents with asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/9,10,34\">",
"     9,10,34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/0/38920?source=see_link\">",
"     \"Food-induced anaphylaxis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/13/1241?source=see_link\">",
"     \"Fatal anaphylaxis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Highly refined peanut oil is usually tolerated by persons with peanut allergy. However, processing variations exist and sources may not be easily traced, so avoidance of even refined peanut oils may be advisable [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/35-37\">",
"     35-37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The majority of peanut allergic individuals react to non pollen-related stable proteins that result in systemic and potentially severe reactions. However, peanut also contains birch pollen related proteins [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/38\">",
"     38",
"    </a>",
"    ] and may cause oral allergy syndrome in a subset of birch pollen allergic individuals. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/41/5785?source=see_link&amp;anchor=H12#H12\">",
"     \"Pathogenesis of oral allergy syndrome (pollen-food allergy syndrome)\", section on 'Peanut'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Soybean",
"    </span>",
"    &nbsp;&mdash;&nbsp;A legume like peanut, soybean is responsible for a variety of clinical manifestations of allergy, both IgE-mediated and cell-mediated. Soy allergy affects primarily infants and young children. Population prevalence has not been widely studied, but appears to be up to 0.7 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/39\">",
"     39",
"    </a>",
"    ]. Soy allergy is typically transient [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/23\">",
"     23",
"    </a>",
"    ]. Deaths from soy allergy are rare and have been reported primarily in Sweden [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Processed soybean oil is typically considered safe for patients with soy allergy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/41\">",
"     41",
"    </a>",
"    ]. Soy lecithin is a phospholipid derivative of soy that contains a trace amount of soy protein [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. It is used commonly as a processing aid in food products. The risk of residual protein in soy lecithin triggering a reaction in a person with soy allergy has not been extensively studied. We generally do not instruct patients with soy allergy to avoid soy lecithin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Legume cross-reactivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is common to find positive IgE antibody tests to several legumes in individuals who are clinically reactive to one type. Clinical cross-reactions are uncommon despite the high rate of cross-sensitization [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/44-50\">",
"     44-50",
"    </a>",
"    ]. Thus, most patients with legume allergy need not avoid the entire legume family.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Thirty-one percent (10 of 32) of children with peanut allergy confirmed by double-blind, placebo-controlled food challenge (DBPCFC) had a positive skin test to soy, but only 3 percent (1 of 32) had a clinical reaction to soy [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/50\">",
"       50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In vitro IgE tests were performed in 62 children with at least one positive legume prick skin test. Seventy-nine percent had serologic evidence of IgE binding to more than one legume and 37 percent bound all six legumes that were tested (peanut, soybean, lima bean, pea, garbanzo bean, and green bean) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Open or DBPCFCs were performed in 69 atopic children with at least one positive skin test to a legume [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/46\">",
"       46",
"      </a>",
"      ]. Oral challenges to five legumes (peanut, soybean, pea, lima bean, green bean) resulted in 43 reactions in 41 patients (59 percent). Only 5 percent (2 of 41) of patients reacted to more than one legume when challenged, while 52 percent (36 of 69) reacted to two or more legumes on prick skin testing.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Particular legumes may be more allergenic or have greater cross-reactivity [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/47-49\">",
"     47-49",
"    </a>",
"    ]. Children with lentil allergy frequently react to other legumes. In one series, 35 of 43 children with allergy to lentil also reacted to at least one other legume, most commonly chickpea (n = 8), pea (n = 6), or both chickpea (garbanzo bean) and pea (n = 23) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Increasing reports of sensitization and allergy to lupine flour are emerging, particularly in Europe [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/52-54\">",
"     52-54",
"    </a>",
"    ]. Allergy to lupine is related to peanut allergy in some patients and is a distinct allergy in others [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/55-58\">",
"     55-58",
"    </a>",
"    ]. Eleven of 24 children with peanut allergy in France had positive skin tests to lupine and seven of eight children who underwent DBPCFCs (n = 6) or labial challenges (n = 2) to lupine reacted [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/49\">",
"     49",
"    </a>",
"    ]. Among 47 peanut allergic children in the United Kingdom, 16 were sensitized to lupine and two out of nine reacted during oral challenges (ie, minimum risk 4 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/55\">",
"     55",
"    </a>",
"    ]. However, many lupine-sensitized individuals do not react upon ingestion, so individualized evaluations are warranted [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     TREE NUTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergy to nuts from trees (eg, walnut, cashew, Brazil nut, pistachio) may affect up to 4.3 percent of individuals, but more conservative estimates are in the range of 0.5 to 1.1 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/4,39,59\">",
"     4,39,59",
"    </a>",
"    ]. Tree nut allergy is considered to be long-lived, although a small portion of children may outgrow it. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/28/12746?source=see_link&amp;anchor=H26#H26\">",
"     \"The natural history of childhood food allergy\", section on 'Peanut and tree nut'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38457?source=see_link\">",
"     \"Peanut, tree nut, and seed allergy: Clinical features\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/27/9654?source=see_link\">",
"     \"Peanut, tree nut, and seed allergy: Diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/9/32919?source=see_link\">",
"     \"Peanut, tree nut, and seed allergy: Management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Tree nut allergic reactions can be severe and account for a relatively high proportion of fatal reactions in several case series [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/9,10,34\">",
"     9,10,34",
"    </a>",
"    ]. Variation in severity of clinical reactions may be related in part to the particular proteins to which immune responses are directed [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As an example, certain nuts (eg, almond, hazelnut) contain labile proteins that are pollen cross reactive (eg, birch). Exposure to these proteins leads to localized symptoms of oral allergy syndrome (pollen-food allergy syndrome). These nuts also contain stable proteins. Sensitization to these proteins most likely occurs through the gastrointestinal route or possibly the skin. Stable proteins are more likely to trigger systemic reactions.",
"   </p>",
"   <p>",
"    Certain tree nuts also share homologous proteins with peanut and other tree nuts, as shown by RAST inhibition [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. A high rate of coallergy to peanut and some tree nuts (30 to 50 percent) is observed among referral populations [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/45,63,64\">",
"     45,63,64",
"    </a>",
"    ]. The clinical relevance of such observations is not fully explored [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serological studies have indicated a high degree of IgE binding to multiple tree nuts [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/45,64\">",
"     45,64",
"    </a>",
"    ]. Challenges to one or more tree nuts were performed in 14 children and at least two reacted to multiple nuts (as many as five types) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/50\">",
"     50",
"    </a>",
"    ]. Coallergy to multiple tree nuts was reported in over a third of patients evaluated for tree nut allergy in two series [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/45,65\">",
"     45,65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Certain tree nut allergies appear to coexist more commonly: cashew and pistachio; walnut and pecan [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/64,66,67\">",
"     64,66,67",
"    </a>",
"    ]. Cross-reactivity is seen between pistachio, cashew, and mango seed (but NOT the fruit) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/68\">",
"     68",
"    </a>",
"    ]. Coconut is sometimes considered a nut because it shares homologous proteins with walnut; however, it is not a common allergen [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/64,69\">",
"     64,69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some authorities suggest avoidance of all tree nuts for persons with peanut allergy or any single tree nut allergy, because of safety concerns (eg, cross-contact) and epidemiological risks. However, others feel individualization is possible when tree nuts known to be tolerated are eaten without risk of cross-contact with causal ones [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/45,70\">",
"     45,70",
"    </a>",
"    ]. We take into consideration the age of the child, test results, potential cross-reactivity of the nuts (eg, we do not typically allow pistachio if a patient has an allergy to cashew), and",
"    <span class=\"nowrap\">",
"     patient/family",
"    </span>",
"    preferences before suggesting liberalization of the diet to include some nuts and not others. If certain nuts are consumed, we review issues of cross-contact and avoidance. As an example, we may instruct the patient to only eat the allowed nut(s) from the shell (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/48/18185?source=see_link\">",
"     \"Management of food allergy: Avoidance\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     FISH AND SHELLFISH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical features and cross-reactivity to fish and shellfish are discussed separately. Briefly, there is a high rate of clinical cross reactivity among fish and among shellfish because of homologous proteins (tropomyosin for shellfish and parvalbumin for finned fish), but not between fish and shellfish. The amount of expressed parvalbumin may partly account for variation among allergenicity of various finned fish [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/71\">",
"     71",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/61/16346?source=see_link\">",
"     \"Seafood allergies: Fish and shellfish\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     GRAINS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The estimated prevalence of wheat allergy, based upon studies which included both specific IgE testing and oral food challenges, is up to 0.5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/39\">",
"     39",
"    </a>",
"    ]. Wheat allergy may be slightly more common in adults and is often due to cross-sensitization with grass pollen. The prevalence of allergy to other cereal grains (eg, rye, barley, oat, rice) is not well studied. Wheat allergy that develops in early childhood is typically outgrown in the preschool-aged years [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/23,72\">",
"     23,72",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The variety of adverse immune responses to wheat include: acute IgE mediated reactions, inhalational reactions (eg, Baker's asthma), reactions that occur when wheat ingestion is followed by exercise (eg, wheat-dependent, exercise-induced anaphylaxis [WDEIA]), and cell-mediated reactions (eg, atopic dermatitis and gastrointestinal allergic disorders, including celiac disease). IgE mediated reactions are most commonly seen in children and are usually transient [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/23\">",
"     23",
"    </a>",
"    ], except for exercise-associated reactions. Inhalation reactions are seen more often in adults, especially those with occupational exposures.",
"   </p>",
"   <p>",
"    The type of immune response and triggering allergen partially define the clinical manifestation of the allergy. As examples, Baker's asthma is caused by inhalation of water soluble proteins and IgE to omega-5 gliadin is responsible for acute reactions in children and in WDEIA [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/73,74\">",
"     73,74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cereal grains share homologous proteins with grass pollens and each other [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/75,76\">",
"     75,76",
"    </a>",
"    ]. This may account for the high rate of cosensitization to these foods [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/75\">",
"     75",
"    </a>",
"    ]. However, rates of clinical reactivity are much lower. Among 145 children with positive prick skin tests to cereal grains, only 21 percent exhibited clinical reactivity during challenges. In addition, among those with reactions to one grain, 80 percent were tolerant of all other grains. Caution is warranted, but clinical reactivity to multiple grains appears uncommon.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SEEDS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergies to seeds (eg, sesame, poppy, mustard, flax, sunflower, and rape) are being reported with increasing frequency [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/77-87\">",
"     77-87",
"    </a>",
"    ]. Reactions can be severe. Some of the causal allergens have been identified as homologous seed storage proteins [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/77,88-90\">",
"     77,88-90",
"    </a>",
"    ]. Cross-reactivity with foods (peanut, hazelnut, kiwi, other seeds) and pollens is potentially important, but the full clinical implications are not established. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38457?source=see_link\">",
"     \"Peanut, tree nut, and seed allergy: Clinical features\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/27/9654?source=see_link\">",
"     \"Peanut, tree nut, and seed allergy: Diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/9/32919?source=see_link\">",
"     \"Peanut, tree nut, and seed allergy: Management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     FRUITS/VEGETABLES",
"    </span>",
"    &nbsp;&mdash;&nbsp;IgE mediated reactions to fruits and vegetables are the most common type of food allergy reported by adults. Reactions are typically mild, confined to the oral cavity, and related to initial sensitization to pollens that share homologous proteins with the implicated",
"    <span class=\"nowrap\">",
"     fruits/vegetables.",
"    </span>",
"    They are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/52/11082?source=see_link\">",
"     \"Clinical manifestations and diagnosis of oral allergy syndrome (pollen-food allergy syndrome)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/35/37430?source=see_link\">",
"     \"Management and prognosis of oral allergy syndrome (pollen-food allergy syndrome)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/41/5785?source=see_link\">",
"     \"Pathogenesis of oral allergy syndrome (pollen-food allergy syndrome)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     LATEX-FRUIT SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Associated hypersensitivity to plant-derived foods is common in individuals who are allergic to natural rubber latex (NRL). It is not always clear whether latex sensitization precedes or follows the onset of food allergy, or which route of sensitization (skin, mucous membrane contact, or inhalation) underlies the condition. Food allergy reactions in these patients can be severe. This syndrome is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/52/11082?source=see_link\">",
"     \"Clinical manifestations and diagnosis of oral allergy syndrome (pollen-food allergy syndrome)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/35/37430?source=see_link\">",
"     \"Management and prognosis of oral allergy syndrome (pollen-food allergy syndrome)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     MEATS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergy to mammalian and avian meats is uncommon in children and typically affects those with atopic dermatitis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    multiple food allergies [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/91\">",
"     91",
"    </a>",
"    ]. There may be a hereditary component in some cases [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/92\">",
"     92",
"    </a>",
"    ]. Meat allergy is usually outgrown in childhood and is rare in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/91,93\">",
"     91,93",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36072?source=see_link\">",
"     \"Allergy to meats\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The best characterized meat allergens are serum albumin and immunoglobulins from cow, and serum albumin from chicken [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/91\">",
"       91",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The avian protein alpha-livetin is found in feathers, egg yolk, and meat. Some persons who become sensitized to this protein from environmental exposure to bird may develop clinical allergy to egg, and possibly avian meat, although cooking the meat probably destroys the allergen [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/92,94-98\">",
"       92,94-98",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Chicken alpha-parvalbumin was implicated in a patient who had severe allergic reactions to poultry products, but tolerated eggs [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/94\">",
"       94",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A carbohydrate allergen, galactose-alpha-1,3-galactose (alpha-gal), was identified in tissues of non-primate mammals, including cows, sheep, and pigs [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/95,96\">",
"       95,96",
"      </a>",
"      ]. Systemic reactions to ingestion of meat from these animals were reported in adults, and were notable for the delayed onset of symptoms (ie, typically 3 to 6 hours after ingestion). This allergen is also implicated in hyperacute rejection of pig-to-primate xenografts and anaphylactic reactions to the drug",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/58/10151?source=see_link\">",
"       cetuximab",
"      </a>",
"      in patients with colon cancer. Although most individuals with meat allergy tolerate bovine gelatin, those sensitized to alpha-gal may be at higher risk of reacting to gelatin [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/99\">",
"       99",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/19/38202?source=see_link&amp;anchor=H48#H48\">",
"       \"Infusion reactions to therapeutic monoclonal antibodies used for cancer therapy\", section on 'Cetuximab'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Three general patterns of cross-reactivity or co-allergy are noted in patients with meat allergy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/91\">",
"     91",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Reactions to meats from related species &mdash; Patients with allergy to a mammalian meat (eg, beef) may react to other mammalian meats (eg, lamb, pork), and patients with avian meat allergies (eg, chicken) may react to other avian meats (eg, turkey, quail) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/97,98,100\">",
"       97,98,100",
"      </a>",
"      ]. Cross-sensitization (eg, evidence of IgE antibodies, which is not equivalent to clinical cross-reactivity) between the two groups is seen in less than 50 percent of patients. The risk of reaction to multiple species of avian meats (eg, turkey, quail) is increased when chicken meat allergy is present without egg allergy [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/98,101\">",
"       98,101",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Reactions to meat and other foods (such as milk or egg) &mdash; Up to 20 percent of children allergic to cow's milk are also reactive to beef [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/102\">",
"       102",
"      </a>",
"      ]. Conversely, concomitant milk allergy is much more common in children who initially present with an allergy to beef. In one series, 93 percent of children allergic to beef were also reactive to cow's milk [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Reactions to meat and animal danders &mdash; Patients reactive to both animal meats",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      milk and animal epithelia are often sensitized to serum albumins, which are homologous across species and present in a variety of animal tissues, including the epithelial cells found in dander [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/103\">",
"       103",
"      </a>",
"      ]. There are case reports of reactions to pork in patients with allergy to cat dander, and to horse meat in patients sensitized to horse and rabbit danders [",
"      <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/91,104\">",
"       91,104",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13625674\">",
"    <span class=\"h1\">",
"     SHORT-CHAIN GALACTOOLIGOSACCHARIDE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most known food allergens are proteins. However, carbohydrate epitopes can also act as allergens, as is seen with delayed IgE-mediated reactions to alpha-gal in meat (see",
"    <a class=\"local\" href=\"#H15\">",
"     'Meats'",
"    </a>",
"    above). Another potential carbohydrate allergen is the prebiotic short-chain galactooligosaccharide (scGOS). There are several case series of acute allergic reactions to beverages containing scGOS, including cow&rsquo;s milk formula, in children over two years of age and adults [",
"    <a class=\"abstract\" href=\"UTD.htm?1/63/2042/abstract/105-107\">",
"     105-107",
"    </a>",
"    ]. Reported symptoms included an itchy rash and lower respiratory symptoms (wheezing, difficulty breathing). These patients tolerated other dairy products and had no history of cow&rsquo;s milk allergy. All reported cases were from Southeast Asia (Japan, Vietnam, and Singapore), suggesting that there is a primary sensitizing agent specific to the region. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36072?source=see_link\">",
"     \"Allergy to meats\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/14/31977?source=see_link\">",
"     \"Prebiotics and probiotics for prevention of allergic disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SPICES AND NATURAL FOOD ADDITIVES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term \"spice\" is often used to describe a variety of flavoring agents. Spices represent a huge array of types of foods, including many seeds and peppers, and plant leaves, tubers, bulbs, and bark. Many spices have been the culprit in an allergic reaction.",
"   </p>",
"   <p>",
"    Food additives include a variety of substances that are added to foods for flavor, color, preservation, or texture enhancement. Non-protein substances added to foods are unlikely to cause IgE mediated allergic reactions. Some protein-containing food additives, derived from natural sources, may trigger allergic reactions.",
"   </p>",
"   <p>",
"    Allergic reactions associated with specific spices and natural food additives are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/46/40681?source=see_link\">",
"     \"Allergic and asthmatic reactions to food additives\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?28/47/29429?source=see_link\">",
"       \"Patient information: Food allergy symptoms and diagnosis (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?34/35/35379?source=see_link\">",
"       \"Patient information: Food allergy treatment and avoidance (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The major food allergens are milk, egg, wheat, soy, peanut, tree nuts, fish, shellfish, and seeds. However, many other foods can elicit allergic reactions. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Many related foods contain homologous proteins (conserved proteins), which present potential for clinical cross-reactions. However, allergy testing to related foods reveals a higher rate of positive tests to cross-reactive proteins than true clinical reactions to the related foods. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Overview of cross-reactivity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Certain related foods are more commonly clinically cross-reactive (eg, tree nuts, fish, shellfish, animal milk). Caution and possible allergy testing (including oral food challenges) are warranted if ingestion of related foods not already tolerated is being considered. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Cow's milk'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Tree nuts'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/61/16346?source=see_link\">",
"       \"Seafood allergies: Fish and shellfish\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Certain related foods are less likely to be involved in clinically relevant cross reactions (eg, grains, fruits, vegetables, legumes) and each case must be considered on an individual basis. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Legume cross-reactivity'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Grains'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/35/37430?source=see_link\">",
"       \"Management and prognosis of oral allergy syndrome (pollen-food allergy syndrome)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/1\">",
"      Bush RK, Hefle SL. Food allergens. Crit Rev Food Sci Nutr 1996; 36 Suppl:S119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/2\">",
"      Sicherer SH. Clinical implications of cross-reactive food allergens. J Allergy Clin Immunol 2001; 108:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/3\">",
"      Rona RJ, Keil T, Summers C, et al. The prevalence of food allergy: a meta-analysis. J Allergy Clin Immunol 2007; 120:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/4\">",
"      Sicherer SH. Epidemiology of food allergy. J Allergy Clin Immunol 2011; 127:594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/5\">",
"      Liu AH, Jaramillo R, Sicherer SH, et al. National prevalence and risk factors for food allergy and relationship to asthma: results from the National Health and Nutrition Examination Survey 2005-2006. J Allergy Clin Immunol 2010; 126:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/6\">",
"      Skripak JM, Matsui EC, Mudd K, Wood RA. The natural history of IgE-mediated cow's milk allergy. J Allergy Clin Immunol 2007; 120:1172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/7\">",
"      Fiocchi A, Sch&uuml;nemann HJ, Brozek J, et al. Diagnosis and Rationale for Action Against Cow's Milk Allergy (DRACMA): a summary report. J Allergy Clin Immunol 2010; 126:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/8\">",
"      Wal JM. Bovine milk allergenicity. Ann Allergy Asthma Immunol 2004; 93:S2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/9\">",
"      Bock SA, Mu&ntilde;oz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001; 107:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/10\">",
"      Bock SA, Mu&ntilde;oz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol 2007; 119:1016.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/11\">",
"      Nowak-Wegrzyn A, Bloom KA, Sicherer SH, et al. Tolerance to extensively heated milk in children with cow's milk allergy. J Allergy Clin Immunol 2008; 122:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/12\">",
"      Spuergin P, Walter M, Schiltz E, et al. Allergenicity of alpha-caseins from cow, sheep, and goat. Allergy 1997; 52:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/13\">",
"      Restani P, Gaiaschi A, Plebani A, et al. Cross-reactivity between milk proteins from different animal species. Clin Exp Allergy 1999; 29:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/14\">",
"      Bellioni-Businco B, Paganelli R, Lucenti P, et al. Allergenicity of goat's milk in children with cow's milk allergy. J Allergy Clin Immunol 1999; 103:1191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/15\">",
"      Businco L, Giampietro PG, Lucenti P, et al. Allergenicity of mare's milk in children with cow's milk allergy. J Allergy Clin Immunol 2000; 105:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/16\">",
"      Vita D, Passalacqua G, Di Pasquale G, et al. Ass's milk in children with atopic dermatitis and cow's milk allergy: crossover comparison with goat's milk. Pediatr Allergy Immunol 2007; 18:594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/17\">",
"      Zeiger RS, Sampson HA, Bock SA, et al. Soy allergy in infants and children with IgE-associated cow's milk allergy. J Pediatr 1999; 134:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/18\">",
"      Businco L, Dreborg S, Einarsson R, et al. Hydrolysed cow's milk formulae. Allergenicity and use in treatment and prevention. An ESPACI position paper. European Society of Pediatric Allergy and Clinical Immunology. Pediatr Allergy Immunol 1993; 4:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/19\">",
"      Kemp AS, Hill DJ, Allen KJ, et al. Guidelines for the use of infant formulas to treat cows milk protein allergy: an Australian consensus panel opinion. Med J Aust 2008; 188:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/20\">",
"      Martelli A, De Chiara A, Corvo M, et al. Beef allergy in children with cow's milk allergy; cow's milk allergy in children with beef allergy. Ann Allergy Asthma Immunol 2002; 89:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/21\">",
"      Fiocchi A, Restani P, Riva E, et al. Heat treatment modifies the allergenicity of beef and bovine serum albumin. Allergy 1998; 53:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/22\">",
"      Eggesb&oslash; M, Botten G, Halvorsen R, Magnus P. The prevalence of allergy to egg: a population-based study in young children. Allergy 2001; 56:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/23\">",
"      Bock SA. Prospective appraisal of complaints of adverse reactions to foods in children during the first 3 years of life. Pediatrics 1987; 79:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/24\">",
"      Wood RA. The natural history of food allergy. Pediatrics 2003; 111:1631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/25\">",
"      Savage JH, Matsui EC, Skripak JM, Wood RA. The natural history of egg allergy. J Allergy Clin Immunol 2007; 120:1413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/26\">",
"      Kulig M, Bergmann R, Niggemann B, et al. Prediction of sensitization to inhalant allergens in childhood: evaluating family history, atopic dermatitis and sensitization to food allergens. The MAS Study Group. Multicentre Allergy Study. Clin Exp Allergy 1998; 28:1397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/27\">",
"      Ando H, Mov&eacute;rare R, Kondo Y, et al. Utility of ovomucoid-specific IgE concentrations in predicting symptomatic egg allergy. J Allergy Clin Immunol 2008; 122:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/28\">",
"      Yamada K, Urisu A, Kakami M, et al. IgE-binding activity to enzyme-digested ovomucoid distinguishes between patients with contact urticaria to egg with and without overt symptoms on ingestion. Allergy 2000; 55:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/29\">",
"      Urisu A, Yamada K, Tokuda R, et al. Clinical significance of IgE-binding activity to enzymatic digests of ovomucoid in the diagnosis and the prediction of the outgrowing of egg white hypersensitivity. Int Arch Allergy Immunol 1999; 120:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/30\">",
"      Langeland T. A clinical and immunological study of allergy to hen's egg white. VI. Occurrence of proteins cross-reacting with allergens in hen's egg white as studied in egg white from turkey, duck, goose, seagull, and in hen egg yolk, and hen and chicken sera and flesh. Allergy 1983; 38:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/31\">",
"      A&ntilde;&iacute;barro B, Seoane FJ, Vila C, Lombardero M. Allergy to eggs from duck and goose without sensitization to hen egg proteins. J Allergy Clin Immunol 2000; 105:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/32\">",
"      Crespo JF, Pascual C, Burks AW, et al. Frequency of food allergy in a pediatric population from Spain. Pediatr Allergy Immunol 1995; 6:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/33\">",
"      Sicherer SH, Mu&ntilde;oz-Furlong A, Godbold JH, Sampson HA. US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol 2010; 125:1322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/34\">",
"      Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992; 327:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/35\">",
"      Hourihane JO, Bedwani SJ, Dean TP, Warner JO. Randomised, double blind, crossover challenge study of allergenicity of peanut oils in subjects allergic to peanuts. BMJ 1997; 314:1084.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/36\">",
"      Taylor SL, Busse WW, Sachs MI, et al. Peanut oil is not allergenic to peanut-sensitive individuals. J Allergy Clin Immunol 1981; 68:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/37\">",
"      Morisset M, Moneret-Vautrin DA, Kanny G, et al. Thresholds of clinical reactivity to milk, egg, peanut and sesame in immunoglobulin E-dependent allergies: evaluation by double-blind or single-blind placebo-controlled oral challenges. Clin Exp Allergy 2003; 33:1046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/38\">",
"      Mittag D, Akkerdaas J, Ballmer-Weber BK, et al. Ara h 8, a Bet v 1-homologous allergen from peanut, is a major allergen in patients with combined birch pollen and peanut allergy. J Allergy Clin Immunol 2004; 114:1410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/39\">",
"      Zuidmeer L, Goldhahn K, Rona RJ, et al. The prevalence of plant food allergies: a systematic review. J Allergy Clin Immunol 2008; 121:1210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/40\">",
"      Foucard T, Malmheden Yman I. A study on severe food reactions in Sweden--is soy protein an underestimated cause of food anaphylaxis? Allergy 1999; 54:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/41\">",
"      Bush RK, Taylor SL, Nordlee JA, Busse WW. Soybean oil is not allergenic to soybean-sensitive individuals. J Allergy Clin Immunol 1985; 76:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/42\">",
"      Awazuhara H, Kawai H, Baba M, et al. Antigenicity of the proteins in soy lecithin and soy oil in soybean allergy. Clin Exp Allergy 1998; 28:1559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/43\">",
"      Gu X, Beardslee T, Zeece M, et al. Identification of IgE-binding proteins in soy lecithin. Int Arch Allergy Immunol 2001; 126:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/44\">",
"      Bernhisel-Broadbent J, Taylor S, Sampson HA. Cross-allergenicity in the legume botanical family in children with food hypersensitivity. II. Laboratory correlates. J Allergy Clin Immunol 1989; 84:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/45\">",
"      Sicherer SH, Burks AW, Sampson HA. Clinical features of acute allergic reactions to peanut and tree nuts in children. Pediatrics 1998; 102:e6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/46\">",
"      Bernhisel-Broadbent J, Sampson HA. Cross-allergenicity in the legume botanical family in children with food hypersensitivity. J Allergy Clin Immunol 1989; 83:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/47\">",
"      Matheu V, de Barrio M, Sierra Z, et al. Lupine-induced anaphylaxis. Ann Allergy Asthma Immunol 1999; 83:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/48\">",
"      Hefle SL, Lemanske RF Jr, Bush RK. Adverse reaction to lupine-fortified pasta. J Allergy Clin Immunol 1994; 94:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/49\">",
"      Moneret-Vautrin DA, Gu&eacute;rin L, Kanny G, et al. Cross-allergenicity of peanut and lupine: the risk of lupine allergy in patients allergic to peanuts. J Allergy Clin Immunol 1999; 104:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/50\">",
"      Bock SA, Atkins FM. The natural history of peanut allergy. J Allergy Clin Immunol 1989; 83:900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/51\">",
"      Mart&iacute;nez San Ireneo M, Ib&aacute;&ntilde;ez MD, S&aacute;nchez JJ, et al. Clinical features of legume allergy in children from a Mediterranean area. Ann Allergy Asthma Immunol 2008; 101:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/52\">",
"      Sanz ML, de Las Marinas MD, Fern&aacute;ndez J, Gamboa PM. Lupin allergy: a hidden killer in the home. Clin Exp Allergy 2010; 40:1461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/53\">",
"      Campbell CP, Yates DH. Lupin allergy: a hidden killer at home, a menace at work; occupational disease due to lupin allergy. Clin Exp Allergy 2010; 40:1467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/54\">",
"      de Jong NW, van Maaren MS, Vlieg-Boersta BJ, et al. Sensitization to lupine flour: is it clinically relevant? Clin Exp Allergy 2010; 40:1571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/55\">",
"      Shaw J, Roberts G, Grimshaw K, et al. Lupin allergy in peanut-allergic children and teenagers. Allergy 2008; 63:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/56\">",
"      Holden L, Sletten GB, Lindvik H, et al. Characterization of IgE binding to lupin, peanut and almond with sera from lupin-allergic patients. Int Arch Allergy Immunol 2008; 146:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/57\">",
"      Peeters KA, Nordlee JA, Penninks AH, et al. Lupine allergy: not simply cross-reactivity with peanut or soy. J Allergy Clin Immunol 2007; 120:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/58\">",
"      Hieta N, Hasan T, M&auml;kinen-Kiljunen S, Lammintausta K. Lupin allergy and lupin sensitization among patients with suspected food allergy. Ann Allergy Asthma Immunol 2009; 103:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/59\">",
"      Ben-Shoshan M, Harrington DW, Soller L, et al. A population-based study on peanut, tree nut, fish, shellfish, and sesame allergy prevalence in Canada. J Allergy Clin Immunol 2010; 125:1327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/60\">",
"      Beyer K, Grishina G, Bardina L, et al. Identification of an 11S globulin as a major hazelnut food allergen in hazelnut-induced systemic reactions. J Allergy Clin Immunol 2002; 110:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/61\">",
"      de Leon MP, Glaspole IN, Drew AC, et al. Immunological analysis of allergenic cross-reactivity between peanut and tree nuts. Clin Exp Allergy 2003; 33:1273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/62\">",
"      Fern&aacute;ndez C, Fiandor A, Martinez-Garate A, Martinez Quesada J. Allergy to pistachio: crossreactivity between pistachio nut and other Anacardiaceae. Clin Exp Allergy 1995; 25:1254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/63\">",
"      Hourihane JO, Kilburn SA, Dean P, Warner JO. Clinical characteristics of peanut allergy. Clin Exp Allergy 1997; 27:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/64\">",
"      Maloney JM, Rudengren M, Ahlstedt S, et al. The use of serum-specific IgE measurements for the diagnosis of peanut, tree nut, and seed allergy. J Allergy Clin Immunol 2008; 122:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/65\">",
"      Ewan PW. Clinical study of peanut and nut allergy in 62 consecutive patients: new features and associations. BMJ 1996; 312:1074.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/66\">",
"      Goetz DW, Whisman BA, Goetz AD. Cross-reactivity among edible nuts: double immunodiffusion, crossed immunoelectrophoresis, and human specific igE serologic surveys. Ann Allergy Asthma Immunol 2005; 95:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/67\">",
"      Ranc&eacute; F, Bidat E, Bourrier T, Sabouraud D. Cashew allergy: observations of 42 children without associated peanut allergy. Allergy 2003; 58:1311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/68\">",
"      Roux KH, Teuber SS, Sathe SK. Tree nut allergens. Int Arch Allergy Immunol 2003; 131:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/69\">",
"      Teuber SS, Peterson WR. Systemic allergic reaction to coconut (Cocos nucifera) in 2 subjects with hypersensitivity to tree nut and demonstration of cross-reactivity to legumin-like seed storage proteins: new coconut and walnut food allergens. J Allergy Clin Immunol 1999; 103:1180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/70\">",
"      Hourihane JO, Warner JO. Allergy to peanut. Lancet 1996; 348:1523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/71\">",
"      Griesmeier U, V&aacute;zquez-Cort&eacute;s S, Bublin M, et al. Expression levels of parvalbumins determine allergenicity of fish species. Allergy 2010; 65:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/72\">",
"      Sampson HA, Scanlon SM. Natural history of food hypersensitivity in children with atopic dermatitis. J Pediatr 1989; 115:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/73\">",
"      Palosuo K, Varjonen E, Kekki OM, et al. Wheat omega-5 gliadin is a major allergen in children with immediate allergy to ingested wheat. J Allergy Clin Immunol 2001; 108:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/74\">",
"      Palosuo K, Varjonen E, Nurkkala J, et al. Transglutaminase-mediated cross-linking of a peptic fraction of omega-5 gliadin enhances IgE reactivity in wheat-dependent, exercise-induced anaphylaxis. J Allergy Clin Immunol 2003; 111:1386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/75\">",
"      Jones SM, Magnolfi CF, Cooke SK, Sampson HA. Immunologic cross-reactivity among cereal grains and grasses in children with food hypersensitivity. J Allergy Clin Immunol 1995; 96:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/76\">",
"      Donovan GR, Baldo BA. Crossreactivity of IgE antibodies from sera of subjects allergic to both ryegrass pollen and wheat endosperm proteins: evidence for common allergenic determinants. Clin Exp Allergy 1990; 20:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/77\">",
"      Beyer K, Bardina L, Grishina G, Sampson HA. Identification of sesame seed allergens by 2-dimensional proteomics and Edman sequencing: seed storage proteins as common food allergens. J Allergy Clin Immunol 2002; 110:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/78\">",
"      Morisset M, Moneret-Vautrin DA, Maadi F, et al. Prospective study of mustard allergy: first study with double-blind placebo-controlled food challenge trials (24 cases). Allergy 2003; 58:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/79\">",
"      Sporik R, Hill D. Allergy to peanut, nuts, and sesame seed in Australian children. BMJ 1996; 313:1477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/80\">",
"      Agne PS, Bidat E, Agne PS, et al. Sesame seed allergy in children. Eur Ann Allergy Clin Immunol 2004; 36:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/81\">",
"      Caminiti L, Vita D, Passalacqua G, et al. Tahini, a little known sesame-containing food, as an unexpected cause of severe allergic reaction. J Investig Allergol Clin Immunol 2006; 16:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/82\">",
"      Keskin O, Sekerel BE. Poppy seed allergy: a case report and review of the literature. Allergy Asthma Proc 2006; 27:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/83\">",
"      Panasoff J. Poppy seed anaphylaxis. J Investig Allergol Clin Immunol 2008; 18:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/84\">",
"      Le&oacute;n F, Rodr&iacute;guez M, Cuevas M. Anaphylaxis to Linum. Allergol Immunopathol (Madr) 2003; 31:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/85\">",
"      Palma-Carlos AG, Palma-Carlos ML, Tengarrinha F. Allergy to sunflower seeds. Eur Ann Allergy Clin Immunol 2005; 37:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/86\">",
"      Poikonen S, Puumalainen TJ, Kautiainen H, et al. Turnip rape and oilseed rape are new potential food allergens in children with atopic dermatitis. Allergy 2006; 61:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/87\">",
"      Gangur V, Kelly C, Navuluri L. Sesame allergy: a growing food allergy of global proportions? Ann Allergy Asthma Immunol 2005; 95:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/88\">",
"      Asero R, Mistrello G, Roncarolo D, et al. A case of sesame seed-induced anaphylaxis. Allergy 1999; 54:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/89\">",
"      Ranc&eacute; F, Dutau G, Abbal M. Mustard allergy in children. Allergy 2000; 55:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/90\">",
"      Leduc V, Moneret-Vautrin DA, Tzen JT, et al. Identification of oleosins as major allergens in sesame seed allergic patients. Allergy 2006; 61:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/91\">",
"      Restani P, Ballabio C, Tripodi S, Fiocchi A. Meat allergy. Curr Opin Allergy Clin Immunol 2009; 9:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/92\">",
"      Orhan F, Sekerel BE. Beef allergy: a review of 12 cases. Allergy 2003; 58:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/93\">",
"      Fuentes Aparicio V, S&aacute;nchez Marc&eacute;n I, P&eacute;rez Montero A, et al. Allergy to mammal's meat in adult life: immunologic and follow-up study. J Investig Allergol Clin Immunol 2005; 15:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/94\">",
"      Kuehn A, Lehners C, Hilger C, Hentges F. Food allergy to chicken meat with IgE reactivity to muscle alpha-parvalbumin. Allergy 2009; 64:1557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/95\">",
"      Commins SP, Satinover SM, Hosen J, et al. Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose. J Allergy Clin Immunol 2009; 123:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/96\">",
"      Commins SP, Platts-Mills TA. Anaphylaxis syndromes related to a new mammalian cross-reactive carbohydrate determinant. J Allergy Clin Immunol 2009; 124:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/97\">",
"      Ayuso R, Lehrer SB, Tanaka L, et al. IgE antibody response to vertebrate meat proteins including tropomyosin. Ann Allergy Asthma Immunol 1999; 83:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/98\">",
"      Cahen YD, Fritsch R, W&uuml;thrich B. Food allergy with monovalent sensitivity to poultry meat. Clin Exp Allergy 1998; 28:1026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/99\">",
"      Mullins RJ, James H, Platts-Mills TA, Commins S. Relationship between red meat allergy and sensitization to gelatin and galactose-&alpha;-1,3-galactose. J Allergy Clin Immunol 2012; 129:1334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/100\">",
"      Restani P, Fiocchi A, Beretta B, et al. Meat allergy: III--Proteins involved and cross-reactivity between different animal species. J Am Coll Nutr 1997; 16:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/101\">",
"      Kelso JM, Cockrell GE, Helm RM, Burks AW. Common allergens in avian meats. J Allergy Clin Immunol 1999; 104:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/102\">",
"      Werfel SJ, Cooke SK, Sampson HA. Clinical reactivity to beef in children allergic to cow's milk. J Allergy Clin Immunol 1997; 99:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/103\">",
"      Vicente-Serrano J, Caballero ML, Rodr&iacute;guez-P&eacute;rez R, et al. Sensitization to serum albumins in children allergic to cow's milk and epithelia. Pediatr Allergy Immunol 2007; 18:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/104\">",
"      Savi E, Rossi A, Incorvaia C. Cat-pork syndrome: a case report with a thee years follow-up. Eur Ann Allergy Clin Immunol 2006; 38:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/105\">",
"      Jyo T, Kuwabara M, Kodommari Y, et al. Cases of immediate-type allergy in oyster shuckers due to galacto-oligosaccharide. J Hiroshima Med Assoc 1993; 25:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/106\">",
"      Vo TH, Le NH, Patel MS, et al. Acute allergic reactions in Vietnamese children after drinking a new milk product. Foodborne Pathog Dis 2012; 9:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/63/2042/abstract/107\">",
"      Chiang WC, Huang CH, Llanora GV, et al. Anaphylaxis to cow's milk formula containing short-chain galacto-oligosaccharide. J Allergy Clin Immunol 2012; 130:1361.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2413 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-125.39.66.147-B9BF6B98CC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_63_2042=[""].join("\n");
var outline_f1_63_2042=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW OF CROSS-REACTIVITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      COW'S MILK",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      HEN'S EGG",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      LEGUMES: PEANUT, SOY, AND OTHERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Peanut",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Soybean",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Legume cross-reactivity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      TREE NUTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      FISH AND SHELLFISH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      GRAINS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SEEDS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      FRUITS/VEGETABLES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      LATEX-FRUIT SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      MEATS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13625674\">",
"      SHORT-CHAIN GALACTOOLIGOSACCHARIDE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SPICES AND NATURAL FOOD ADDITIVES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/2413\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/2413|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/35/2622\" title=\"figure 1\">",
"      Cross-reactivity among related food allergens",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/46/40681?source=related_link\">",
"      Allergic and asthmatic reactions to food additives",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36072?source=related_link\">",
"      Allergy to meats",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/52/11082?source=related_link\">",
"      Clinical manifestations and diagnosis of oral allergy syndrome (pollen-food allergy syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14808?source=related_link\">",
"      Clinical manifestations of food allergy: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/12/5321?source=related_link\">",
"      Diagnostic evaluation of food allergy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/9/33944?source=related_link\">",
"      Egg allergy: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/58/13223?source=related_link\">",
"      Egg allergy: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/13/1241?source=related_link\">",
"      Fatal anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=related_link\">",
"      Food protein-induced proctitis/colitis and enteropathy of infancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/0/38920?source=related_link\">",
"      Food-induced anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/19/38202?source=related_link\">",
"      Infusion reactions to therapeutic monoclonal antibodies used for cancer therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/35/37430?source=related_link\">",
"      Management and prognosis of oral allergy syndrome (pollen-food allergy syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/48/18185?source=related_link\">",
"      Management of food allergy: Avoidance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29640?source=related_link\">",
"      Milk allergy: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/9/40087?source=related_link\">",
"      Milk allergy: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/56/23433?source=related_link\">",
"      Molecular features of food allergens",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/41/5785?source=related_link\">",
"      Pathogenesis of oral allergy syndrome (pollen-food allergy syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/47/29429?source=related_link\">",
"      Patient information: Food allergy symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?34/35/35379?source=related_link\">",
"      Patient information: Food allergy treatment and avoidance (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38457?source=related_link\">",
"      Peanut, tree nut, and seed allergy: Clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/27/9654?source=related_link\">",
"      Peanut, tree nut, and seed allergy: Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/9/32919?source=related_link\">",
"      Peanut, tree nut, and seed allergy: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/14/31977?source=related_link\">",
"      Prebiotics and probiotics for prevention of allergic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/61/16346?source=related_link\">",
"      Seafood allergies: Fish and shellfish",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/28/12746?source=related_link\">",
"      The natural history of childhood food allergy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_63_2043="Timing of tissue damage";
var content_f1_63_2043=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F68864&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F68864&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Timing of tissue damage and repair after caustic injury of the esophagus",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Injury",
"       </td>",
"       <td class=\"subtitle1\">",
"        Time",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute injury",
"       </td>",
"       <td>",
"        Day 0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inflammation, vascular thrombosis",
"       </td>",
"       <td>",
"        1 to 7 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Granulation tissue",
"       </td>",
"       <td>",
"        10 to 21 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fibrosis/stricture",
"       </td>",
"       <td>",
"        3 weeks",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_63_2043=[""].join("\n");
var outline_f1_63_2043=null;
var title_f1_63_2044="Phytophotodermatitis causes";
var content_f1_63_2044=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F75581&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F75581&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Some potential causes of phytophotodermatitis*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Plant family",
"       </td>",
"       <td class=\"subtitle1\">",
"        Common name(s)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"9\">",
"        Apiaceae (Umbelliferae)",
"       </td>",
"       <td>",
"        Angelica",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Celery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cow parsley, wild chervil",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cow parsnip, hogweed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dill",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fennel",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Giant hogweed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Parsley",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Parsnip",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"7\">",
"        Rutaceae",
"       </td>",
"       <td>",
"        Bergamot orange",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bitter orange",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Burning bush, gas plant",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Grapefruit",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lemon",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lime",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rue",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Moraceae",
"       </td>",
"       <td>",
"        Fig",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fabaceae (Leguminosae)",
"       </td>",
"       <td>",
"        Bavachee, scurf-pea (Psoaralea corylifolia)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cruciferae",
"       </td>",
"       <td>",
"        Mustard",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ranunculaceae",
"       </td>",
"       <td>",
"        Buttercup",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypericaceae",
"       </td>",
"       <td>",
"        St. John's wort (can cause systemic phytophotodermatitis)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Other plants have also been implicated.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_63_2044=[""].join("\n");
var outline_f1_63_2044=null;
var title_f1_63_2045="Laboratory evaluation for inborn errors of metabolism";
var content_f1_63_2045=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F67745&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F67745&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Laboratory evaluation for suspected inborn errors of metabolism",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comments",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"        Initial evaluation*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\" colspan=\"2\" rowspan=\"1\">",
"        Blood tests",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        CBC with differential",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Blood glucose",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Electrolytes, BUN, creatinine, uric acid",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Arterial blood gas",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Serum ammonia",
"       </td>",
"       <td>",
"        Should be obtained from artery or vein without a tourniquet; the tube should be placed on ice for transport to the laboratory and analyzed immediately. If the plasma ammonia concentration is &gt;100 micromol/L (1.7 mcg/mL), the measurement should be repeated immediately.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        AST, ALT, bilirubin, PT",
"       </td>",
"       <td>",
"        If the patient has signs or symptoms of myopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        LDH, aldolase, creatine, kinase",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\" colspan=\"2\" rowspan=\"1\">",
"        Urine tests",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Color, odor",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Urinalysis",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Reducing substances",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Myoglobin",
"       </td>",
"       <td>",
"        If the patient has signs or symptoms of myopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"        Specialized tests",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\" colspan=\"2\" rowspan=\"1\">",
"        Blood tests",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Quantitative plasma amino acids",
"       </td>",
"       <td>",
"        Plasma amino acid analysis must be performed quantitatively rather than qualitatively.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Lactate and pyruvate",
"       </td>",
"       <td>",
"        Lactate and pyruvate should be measured in arterial blood, and transported on ice",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Acylcarnitine profile",
"       </td>",
"       <td>",
"        Analysis of acylcarnitine conjugates is performed by tandem mass spectrometry and can be measured in a plasma sample or a filter-paper bloodspot; serum is preferred because of inherent problems in quantitating compounds from a filter-paper blood spot",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\" colspan=\"2\" rowspan=\"1\">",
"        Urine tests",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Qualitative urine organic acids",
"       </td>",
"       <td>",
"        Minimum of 2 to 5 mL in sterile container without preservative",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CBC: complete blood count; ALT: alanine aminotransferase; BUN: blood urea nitrogen; PT: prothrombin time; AST: aspartate aminotransferast; LDH: lactate dehydrogenase.",
"     <br>",
"      * If possible, blood and urine samples should be obtained for both the initial and specialized tests at the time of presentation. Samples for specialized tests should be processed and stored appropriately for further testing if indicated.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_63_2045=[""].join("\n");
var outline_f1_63_2045=null;
var title_f1_63_2046="VTE frequency in acute ICH";
var content_f1_63_2046=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F57706&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F57706&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Frequency of venous thromboembolism in acute intracerebral hemorrhage*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Study",
"       </td>",
"       <td class=\"subtitle1\">",
"        Design",
"       </td>",
"       <td class=\"subtitle1\">",
"        N",
"       </td>",
"       <td class=\"subtitle1\">",
"        Prophylaxis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Observation period",
"       </td>",
"       <td class=\"subtitle1\">",
"        Asympt VTE",
"       </td>",
"       <td class=\"subtitle1\">",
"        Clinically-evident VTE",
"       </td>",
"       <td class=\"subtitle1\">",
"        Clinically-evident PE",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Iwuchukwu (2009)",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"       <td rowspan=\"2\">",
"        Retro case series",
"       </td>",
"       <td rowspan=\"2\">",
"        91",
"       </td>",
"       <td>",
"        Late heparinoid&bull;",
"       </td>",
"       <td rowspan=\"2\">",
"        NR",
"       </td>",
"       <td rowspan=\"2\">",
"        NR",
"       </td>",
"       <td>",
"        15 percent",
"       </td>",
"       <td>",
"        2 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Early heparinoid",
"       </td>",
"       <td>",
"        0 percent",
"       </td>",
"       <td>",
"        0 percent",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Gregory (2003)",
"        <sup>",
"         [2]",
"        </sup>",
"       </td>",
"       <td>",
"        Retro admin database&Delta;",
"       </td>",
"       <td>",
"        1926",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        9 days",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        2 percent",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Lacut (2005)",
"        <sup>",
"         [3]",
"        </sup>",
"       </td>",
"       <td rowspan=\"2\">",
"        RCT",
"       </td>",
"       <td rowspan=\"2\">",
"        133",
"       </td>",
"       <td>",
"        Elastic stockings",
"       </td>",
"       <td rowspan=\"2\">",
"        10 days",
"       </td>",
"       <td>",
"        16 percent",
"       </td>",
"       <td>",
"        0 percent",
"       </td>",
"       <td>",
"        0 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IPC",
"       </td>",
"       <td>",
"        5 percent",
"       </td>",
"       <td>",
"        0 percent",
"       </td>",
"       <td>",
"        0 percent",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Christensen (2008)",
"        <sup>",
"         [4]",
"        </sup>",
"       </td>",
"       <td>",
"        RCT",
"       </td>",
"       <td>",
"        350&loz;",
"       </td>",
"       <td>",
"        none",
"       </td>",
"       <td>",
"        90 days",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        4 percent",
"       </td>",
"       <td>",
"        1 percent",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Ogata (2008)",
"        <sup>",
"         [5]",
"        </sup>",
"       </td>",
"       <td>",
"        Prosp case series",
"       </td>",
"       <td>",
"        52",
"       </td>",
"       <td>",
"        none",
"       </td>",
"       <td>",
"        14 days",
"       </td>",
"       <td>",
"        40 percent",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        1 percent",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Orken (2009)",
"        <sup>",
"         [6]",
"        </sup>",
"       </td>",
"       <td rowspan=\"2\">",
"        RCT",
"       </td>",
"       <td rowspan=\"2\">",
"        75",
"       </td>",
"       <td>",
"        Elastic stockings",
"       </td>",
"       <td rowspan=\"2\">",
"        7 days",
"       </td>",
"       <td>",
"        3 percent",
"       </td>",
"       <td>",
"        0 percent",
"       </td>",
"       <td>",
"        3 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Enoxaparin",
"       </td>",
"       <td>",
"        8 percent",
"       </td>",
"       <td>",
"        0 percent",
"       </td>",
"       <td>",
"        0 percent&sect;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Maramattom (2006)",
"        <sup>",
"         [7]",
"        </sup>",
"       </td>",
"       <td>",
"        Retro case series",
"       </td>",
"       <td>",
"        144",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        8 days",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        1 percent",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Goldstein (2009)",
"        <sup>",
"         [8]",
"        </sup>",
"       </td>",
"       <td>",
"        Retro case series",
"       </td>",
"       <td>",
"        988",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        7 days",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        1 percent",
"       </td>",
"       <td>",
"        2 percent",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Kawase (2009)",
"        <sup>",
"         [9]",
"        </sup>",
"       </td>",
"       <td>",
"        Prosp case series",
"       </td>",
"       <td>",
"        81",
"       </td>",
"       <td>",
"        Elastic stockings",
"       </td>",
"       <td>",
"        14 days",
"       </td>",
"       <td>",
"        21 percent",
"       </td>",
"       <td>",
"        0 percent",
"       </td>",
"       <td>",
"        1 percent",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     VTE: venous thromboembolism; PE: pulmonary embolism; Asympt: asymptomatic, with VTE detected by ultrasonography or fibrinogen scanning; Retro: retrospective; Prosp: prospective; admin: administrative; RCT: randomized clinical trial; NR: not reported; IPC: intermittent pneumatic compression.",
"     <br>",
"      * Studies are included if they reported on at least 50 patients with intracerebral hemorrhage (ICH).",
"      <br>",
"       <span class=\"bullet\">",
"        &bull;",
"       </span>",
"       Early heparinoid was given within 96 hours of ICH onset.",
"       <br>",
"        &Delta; Based on ICD-9 codes from Maryland Health Services database for all nonfederal hospital discharges in 1999.",
"        <br>",
"         <span class=\"lozenge\">",
"          &loz;",
"         </span>",
"         Data from the combined control (placebo) arms of two randomized trials employing factor VIIa infusion.",
"         <br>",
"          &sect; One symptomatic PE was detected in each group (3 percent in each) by CT pulmonary angiography.",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Iwuchukwu, IO, Mckinney, J, Rosenberg, M. DVT prophylaxis and risk of bleeding in intracerebral hemorrhage. Ann Neurol 2009; 66(suppl 13):S57 (abstract).",
"       </li>",
"       <li>",
"        Gregory, PC, Kuhlemeier, KV. Prevalence of venous thromboembolism in acute hemorrhagic and thromboembolic stroke. Am J Phys Med Rehabil 2003; 82:364.",
"       </li>",
"       <li>",
"        Lacut, K, Bressollette, L, Le Gal, G, et al. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology 2005; 65:865.",
"       </li>",
"       <li>",
"        Christensen, M, Dawson, J, Vincent, C. Risk of thromboembolic complications after intracerebral hemorrhage according to ethnicity. Adv Ther 2008; 25:831.",
"       </li>",
"       <li>",
"        Ogata, T, Yasaka, M, Wakugawa, Y, et al. Deep venous thrombosis after acute intracerebral hemorrahge. J Neurol Sci 2008; 272:83.",
"       </li>",
"       <li>",
"        Orken, DN, Kenangil, G, Ozhurt, H, et al. Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage. The Neurologist 2009; 15:329.",
"       </li>",
"       <li>",
"        Maramattom, BV, Weigand, S, Reinalda, M, et al. Pulmonary complications after intracerebral hemorrhage. Neurocrit Care 2006; 5:115.",
"       </li>",
"       <li>",
"        Goldstein, JN. Fazen, LE, Wendell, L, et al. Risk of thromboembolism following acute intracerebral hemorrhage. Neurocrit Care 2009; 10:28.",
"       </li>",
"       <li>",
"        Kawase, K, Okazaki, S, Toyoda, K, et al. Sex difference in the prevalence of deep-vein thrombosis in Japanese patients with acute intracerebral hemorrhage. Cerebrovasc Dis 2009; 27:313.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_63_2046=[""].join("\n");
var outline_f1_63_2046=null;
var title_f1_63_2047="Peritoneal equilibration test";
var content_f1_63_2047=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F65815&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F65815&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 511px\">",
"   <div class=\"ttl\">",
"    Peritoneal equilibration test",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 491px; height: 276px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Time-dependent changes during peritoneal dialysis in dialysate (D) concentration of glucose (left panel) or creatinine (right panel) as a proportion of original dialysate glucose concentration (DO) or plasma creatinine concentration (P), respectively. The absorption of glucose from the dialysate gradually lowers the D/DO ratio, while the diffusion of creatinine into the dialysate raises the D/P ratio. Slow transporters may be inadequately dialyzed due to diminished solute removal. Rapid transporters can achieve a D/P creatinine ratio above 0.8 and a D/DO glucose below 0.3 at four hours; they may be predisposed to malnutrition from increased amino acid losses in the dialysate and to decreased fluid removal due to absorption of glucose.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Twardowski, ZJ, Blood Purif 1989; 7:95.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_63_2047=[""].join("\n");
var outline_f1_63_2047=null;
